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Summary 
1. The effects of glucose on the electrophysiological properties of rat hypothalamic 
arcuate nucleus (ARC) neurones were investigated. Neurones were recorded in 
10 mM (hyperglycaemic) and 2 mM (euglycaemic) glucose-containing aCSF. The 
major findings were that input resistance increased in 10 mM glucose, there was an 
increase in the activity of neurones in 2 mM glucose and there were a greater 
percentage of neurones expressing lh in 10 mM glucose. Subthreshold active 
conductances were differentially expressed in ARC neurones including: anomalous 
inward rectification Q. ), time- and voltage-dependent inward rectification 00, 
A-like transient outward rectification (IA) and T-type calcium-like conductance. 
Characterisation of the differential expression of these conductances may represent 
one way of functionally classifying ARC neurones. 
2. Whole-cell patch clamp recording techniques were used in isolated hypothalamic 
brain slice preparations to investigate the effects of 5-HT on ARC neurones. Bath 
application of 5-HT induced a membrane depolarisation in a sub-population of ARC 
neurones (30%), a response that persisted in the presence of TTX indicating a direct 
eftect. 5-HT excited ARC neurones through three potential mechanisms: closure of 
one or more resting potassium conductances; activation of a non-selective cation 
channel, or a combination of the two; or activation of a pump in the membrane. This 
response was mediated through the 5-HT2A. 5-HT2B and/or 5-HT2C receptors 
revealed using a range of 5-HT receptor agonists and antagonists. 5-HT was shown 
to excite CART-expressing neurones suggesting an anorexigenic role for 5-HT, via 
5-HT2 receptors at the level of the ARC. 
3.5-HT induced a membrane hyperpolarisation in a sub-population of ARC 
neurones (37%). The 5-HT-induced hyperpolarisation persisted in the presence of 
TTX indicating a direct effect on ARC neurones. 5-HT inhibited ARC neurones 
most likely through the activation of one or more potassium conductances, including 
an inwardly rectifying potassium conductance. Potential roles for 5-HTIA, 5-HTIB 
and 5-HT7 receptors were suggested from studies utilising 5-HT receptor agonists 
and antagonists. 5-HT inhibited orexigenic NPY/AgRP neurones, identified by their 
response to ghrelin and by their electrophysiological properties, suggesting an 
anorexigenic role for 5-HT, acting via 5-HTI and 5-HT7 receptors on NPY/AgRP 
neurones at the level of the ARC. 
4. The effects of feeding-related signals on hypothalamic neuropeptide expression 
were investigated using real-time-PCR. A new protocol measuring gene expression 
from hypothalamic explants was developed. Effects of GABA and AMPA on c-fos 
expression were investigated and subsequent studies showed leptin and glucose 
modulated the expression of NPY, POMC and AgRP, in fed and fasted animals. 
Further work is required to validate this novel approach to studying the central 
control of energy balance. 
xii 
Abbreviations 
5-HT 5-Hydroxytryptamine 
aCSF Artificial cerebrospinal. fluid 
ACTH Adrenocorticotropin 
ADP Adenosine monophosphate 
AgRP Agouti-related peptide 
AMG Amygdala 
AMPA Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AMPK AMP-activated protein kinase, 
a-MSH a-melanocyte stimulating hormone 
ANS Autonomic nervous system 
AP5 2-amino-5-phosphonopentanoate 
ARC Arcuate nucleus 
ATP Adenosine triphosphate 
BBB Blood brain barrier 
BDNF Brain derived neurotrophic factor 
P-MSH P-melanocyte stimulating hormone 
BMI Body mass index 
cAMP Cyclic adenosine-mono-phosphate 
CART Cocaine and amphetamine regulated transcript 
CCK Cholecystokinin 
cDNA Complimentary deoxyribonucleic acid 
CNS Central nervous system 
CRF Corticotrophin releasing factor 
CSF Cerebrospinal fluid 
DAT Digital audio tape 
d-fen D-fenfluramine 
DMH Dorsomedial hypothalamus 
DMSO Dimethylsulphoxide 
DNA Deoxyribonucleic acid 
DR Dorsal raphe 
EGTA Ethylene glycol-bis(2-aminoethylether)-N, NN', N'-tetraacetic acid 
EPSC Excitatory post-synaptic current 
xiii 
EPSP Excitatory post-synaptic potential 
GABA y-aminobutyric acid 
y-MSH y-melanocyte stimulating hormone 
GAD Glutamic acid decarboxylase 
GALP Galanin-like peptide 
GE Glucose-excited 
GH Growth hormone 
GHSR GH secretagogue receptor 
GI Glucose-inhibited 
GI-T Gastrointestinal tract 
GIRK G-protein coupled inwardly-rectifying potassium channel 
GLUT Glucose transporter 
HEPES 4-(2-hydroxyethyl)piperazine- I -ethanesulfonicacid 
IA A-like outward rectifier 
Ian Anomalous inward rectifier 
Ih Hyperpolarisation-activated non-selective cation channel 
IPSC Inhibitory post-synaptic current 
IPSP Inhibitory post-synaptic potential 
I-V Current-voltage, relationship 
JAK-STAT Janus-Kinase-Signal transducer and activator of transcription 
KATP ATP-sensitive potassium channel 
LC Locus coerulus 
LH Lateral hypothalamus 
MCH Melanin concentrating hormone 
ME Median eminence 
mRNA Messenger ribonucleic acid 
NBQX 6-nitro-7-sulphamoylbenzo(t)-quinoxaline-2,3-dione 
NC-IUPHAR Nomenclature Committee of the International Union of Pharmacology 
NDS Normal donkey sermn 
NGF Nerve growth factor 
NGS Normal goat serum 
NMDA N-methyl-D-aspartate 
NPY Neuropeptide Y 
xiv 
NTS Nucleus of the tractus solitarius 
PAG Periaqueductal. gray area 
PCR Polymerase chain reaction 
P13K Phosphatidylinositol 3-kinase 
PLC Phospholipase C 
POA Preoptic area 
POMC Pre-pro-opiomelanocortin 
PVN Paraventricular nucleus 
PYY Peptide tyrosine tyrosine 
RNA Ribonucleic acid 
RT-PCR Reverse transcriptase polymerase chain reaction 
SCN Suprachiasmatic nucleus 
SPN Sympathetic preganglionic neurones 
SUR Sulphonylurea 
TASK Tandem-pore potassium channel 
TBS-T Tris-buffered saline containing 1% Triton X-100 
TGF-0 Transforming growth factor beta 
TTX Tetrodotoxin 
VGAT Vesicular GABA transporter 
VGLUT Vesicular glutamate transporter 
VMN Ventromedial nucleus 
VP Vasopressin 
WHO World Health Organisation 
xv 
Chapter One 
Chapter 
1 
General Introduction 
-I- 
Chapter One 
1.1 Central Control of Energy Homeostasis 
Energy homeostasis is a complex process involving the integration and 
co-ordination of multiple metabolic, endocrine and neuronal signals within the body. 
The central nervous system (CNS) is largely responsible for regulating energy 
homeostasis. In particular, within the brain the hypothalamus and brainstem are 
reciprocally connected and play an important role in the central control of energy 
homeostasis by assessing and integrating the metabolic status of the body and 
engaging the autonomic nervous system (ANS) to produce efferent responses. 
Outside the CNS, signals arising from peripheral sites including the liver, the 
gastrointestinal tract (GI-T), adipose tissue, adrenal glands and pancreas relay the 
metabolic status of the body to the hypothalamus and the brainstem. The GI-T has 
direct vagal afferent connections with the brainstem, particularly with the nucleus of 
the tractus solitarius (NTS), which allows neuronal communication between the 
GI-T and the brain. Metabolic signals from the GI-T include the satiety signals 
cholecystokinin (CCK) and peptide tyrosine tyrosine (PYY) and the orexigenic 
hormone ghrelin, which act upon the brainstern to inform it about the contents of the 
gut. Adipocytokines, from adipose tissue, glucocorticoids from the adrenal glands, 
insulin from the pancreas and glucose from the liver also all feedback to the 
hypothalamus and brainstern to provide further information on the energy status of 
the body. As well as hormonal and neuropeptide signalling, essential nutrients such 
as proteins, carbohydrates and fatty acids also play an important role in signalling to 
the CNS the energy status of the body (Schwartz et aL, 1999). 
As well as being affected by these signals from the periphery, the 
hypothalamus also receives inputs from within the CNS to control energy 
homeostasis. These inputs come from higher centres such as the prefrontal cortex, 
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hippocampus, olfactory systems and the amygdala which add to the multitude of 
factors regulating energy homeostasis. These higher centres bring in cognitive, 
motivational and emotional cues, such as the desire for palatable food (Berthoud, 
2004) to add further complexity to the regulation of energy homeostasis. 
Collectively, these signals and pathways constitute a negative feedback loop, 
which exists to bring about a co-ordinated response to maintain feeding and energy 
expenditure (see figure 1.1). For general reviews on the central control of energy 
homeostasis, see Schwartz et al., 1999,2000 and Zigman. & Elmquist, 2003. 
1.1.1 Central nervous system control of bod -weight ýy 
Body-weight is controlled by a strict balance between energy intake (i. e. food 
consumption) and energy expenditure (i. e. exercise). A disruption in this balance will 
lead to a change in body-weight, which could result in one of two extreme conditions. 
if energy intake exceeds energy expenditure, i. e. we eat more than we can bum off, 
then there will be an increase in body-weight, which may eventually result in obesity. 
If energy expenditure exceeds energy intake, then there will be a decrease in body- 
weight that could result in the condition anorexia. For the majority of people neither 
of these conditions will occur because body-weight is strictly regulated by the CNS 
and small fluctuations in energy balance are controlled within tight limits. However 
in a few cases, energy homeostasis can become disrupted resulting in an inability to 
maintain body-weight within these usual limits. 
Within the CNS, there are two principal pathways that are responsible for 
controlling body-weight. These are the anabolic and catabolic pathways, which work 
as parallel and opposing pathways to maintain body-weight around a defined set 
point. Stimulation of the anabolic pathway promotes a state of positive energy 
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balance by increasing food intake and inhibiting energy expenditure, whereas 
stimulation of the catabolic pathway leads to a decrease in food intake and an 
increase in energy expenditure. There are many orexigenic and anorexigenic 
peptides and hormones that are important in controlling these pathways and in 
regulating energy homeostasis which will be discussed later. 
1.2 The Autonomic Nervous System 
Homeostasis is defined as the maintenance of the internal environment. The 
ANS plays a key role in regulating homeostasis. It is predominantly an efferent 
system of nerves that innervates nearly all tissues and organs within the body, 
excluding skeletal muscle. The ANS is responsible for controlling visceral functions 
such as heart rate, blood pressure, body temperature, contraction and relaxation of 
smooth muscle and secretions fiom glands. The ANS consists of three divisions, the 
parasympathetic nervous system, the sympathetic nervous system and the enteric 
nervous system. The enteric nervous system innervates the gastrointestinal tract, the 
pancreas and the gall bladder and functions to control gastrointestinal motility and 
secretions. 
The PamsYmPathetic and sympathetic nervous systems are principally 
responsible for controlling the function of all internal organs, loosely termed 'the 
viscera' referring to all organs and glands except skeletal muscle. Both systems 
consist of preganglionic neurones that make synaptic connections with 
postganglionic: neurones, which then make contact with effector organs. Differences 
between the two systems are reflected in part through the location of preganglionic 
neurones in the CNS and the neurotransmitter(s) released at the synapses. 
Parasympathetic preganglionic neurones are located in several nuclei of the 
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brainstem, and in the sacral segments of the spinal cord, whereas the sympathetic 
preganglionic neurones arise between the lower cervical and upper lumbar spinal 
segments of the cord. The principal neurotransmitter released by preganglionic 
neurones in both systems is acetylcholine whereas it differs for the postganglionic 
neurones, with the parasympathetic system utilising acetylcholine and the 
sympathetic system predominantly using noradrenaline, with the exception of the 
sweat glands which use acetylcholine. 
In general, the parasympathetic system serves to conserve energy, by 
reducing blood pressure and heart rate, and facilitating digestion. The sympathetic 
system has the opposite effect, at its most extreme preparing the body for the classic 
Tight or fight' response, by increasing heart rate and blood pressure and diverting 
blood flow to the skeletal muscle. Although both systems have opposing functions, 
they function synergistically to maintain homeostasis. 
Ile parasympathetic and sympathetic nervous systems represent the efferent 
output of the ANS. However the ANS is able to receive afferent signals and one of 
the most important CNS regions where these signals are integrated is the 
hypothalamus in the brain. The hypothalamus is therefore a very important centre for 
regulating ANS activity and essentially for helping to maintain the homeostasis of 
the body. 
1.3 Hypothalamic Control of Energy Homeostasis 
The hypothalamus regulates many important homeostatic behaviours 
including energy balance, thirst, temperature and sexual activity. Within the 
hypothalamus there are many nuclei that are responsible for controlling particular 
functions. For example, the suprachiasmatic nucleus (SCN) is responsible for 
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controlling circadian rhythms, the preoptic area (POA) is important in reproduction 
and thermoregulation and the lateral hypothalamus (LH) controls sleep and arousal. 
Energy homeostasis is controlled by several interconnected nuclei including the 
arcuate nucleus (ARC), LH, ventromedial nucleus (VMN), dorsomedial 
hypothalamus (DMH) and the paraventricular nucleus (PVN). The various nuclei 
within the hypothalamus contain reciprocal connections, producing a complex 
network which functions to coordinate and integrate responses to regulate energy 
homeostasis (see figure 1.2). Nuclei within the hypothalamus contain populations of 
neurones that include orexigenic (stimulate feeding) or anorexigenic (inhibit feeding) 
neurones, which work synergistically to regulate energy homeostasis. 
The hypothalamus was first identified as being important in the control of 
feeding and energy homeostasis through the use of electrical stimulation and lesion 
studies to ablate regions of the hypothalamus. Hetherington & Ranson (1940) and 
later Anand & Brobeck (1951) put forward the model of the 'dual-centre' 
hypothesis, whereby there is a lateral hypothalamic feeding centre and a 
ventromedial hypothalamic satiety centre. Stimulation of the LH induced obesity 
whereas lesions in the LH caused decreased food intake and body-weight. The 
opposite effect was seen in the VMN: stimulation led to a suppression of food intake 
and lesions of the VMN induced morbid obesity. 
Over the years there has been extensive research to try to determine how the 
body regulates feeding and energy homeostasis. In the 1950s, Kennedy proposed the 
lipostat hypothesis, where body fat is the principal regulator of energy homeostasis 
(Kennedy, 1953). This stated that 'humoral signals are generated in proportion to the 
amount of fat stored and signal to the brain to alter food intake and energy 
expenditure'. Evidence for this hypothesis was eventually found with the discovery 
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of leptin, an important adiposity factor (Zhang et al., 1994). A second hypothesis 
was put forward by Mayer, who believed that glucose was the key regulator of 
energy homeostasis. This was subsequently termed the 'glucostat hypothesis', 
whereby the brain is able to sense and respond to carbohydrates to regulate feeding 
(Mayer, 1953,1955). Subsequent research has shown that both leptin and glucose 
are important in the regulation of energy homeostasis; evidence for this will be 
discussed later. 
Of the multiple nuclei within the hypothalamus that control energy 
homeostasis, the nucleus that has received the most attention and is probably the 
most important for regulating feeding and body-weight is the ARC. 
1.3.1 Arcuate nudeus 
The ARC plays a fundamental role in the control of feeding and energy 
homeostasis. It is situated adjacent to the third ventricle, immediately above the 
median eminence and occupies an arc like region, hence its name. It consists of a 
heterogeneous collection of neurones, which have functions involved in feeding, 
glucose homeostasis, pain, reproduction, and stress responses to name a few 
(Chronwall, 1985). It is a major integrative centre within the hypothalamus and 
receives multiple afferent inputs (Chronwall, 1985). Inputs come from areas within 
the hypothalamus, including the VMN (Krieger et al., 1979), SCN (Saeb-Parsy et 
al., 2000) and the LH (Saper et al., 1979), as well as from areas external to the 
hypothalamus including dorsal raphd neurones (Azmitia & Segal, 1978) and the NTS 
(Ricardo & Koh, 1978), as well as the amygdala and preoptic area (Anschel et al., 
1982; see figure 13A). 
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Neurones from the ARC send projections to multiple brain areas, including 
other hypothalamic nuclei, to activate second order neurones (Chronwall, 1985; 
Cone et al., 2001; Williams et al., 2001). Efferent projections from the ARC go to 
the SCN and preoptic area, the PVN (Harris & Sanghera, 1974; Makara & Hodacs, 
1975; Sawchenko, & Swanson, 1983; Baker & Herkenham, 1995; Saeb-Parsy et al., 
2000), the medial preoptic, anterior periventricular and ventromedial nuclei 
(Zaborszky & Makara, 1979), LH, DMH and amygdala (Sim & Joseph, 1991). There 
is also a well-documented projection between the ARC and the median eminence 
(Rethelyi & Halasz, 1970; Wiegand & Price, 1980). Projections from the ARC also 
go to the spinal cord (Schwanzel-Fukuda et al., 1984) as well as areas in the 
brainstem including the periaqueductal gray, dorsal raphd and locus coeruleus (Sim 
& Joseph, 1991; see figure 13B) 
Many of the efferent connections from the ARC go to the same areas that 
send afferent connections to the ARC, indicating reciprocal connections between 
many areas. 
The ARC is ideally situated to co-ordinate feeding and energy homeostasis as 
it sits just above the circumventricular organ the median eminence, which has a 
specialised blood-brain-barrier (BBB; Broadwell et aL, 1983; Fry et al., 2007). This 
means that peripheral factors such as hormones can easily access the ARC and it is 
therefore able to sense and respond to factors that other areas of the brain could not. 
Further evidence that the ARC is an important site in the regulation of feeding is the 
fact that it contains a heterogeneous population of neuronal subtypes, which express 
a diverse array of molecules known to be involved in feeding. These include 
neuropeptide Y (NPY), pre-pro-opiomelanocortin (POMC), cocaine and 
amphetamine regulated tramcript (CART), agouti-related peptide (AgRP), 
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neurornedin U and galanin-like peptide (GALP; Chronwall, 1985; Cone et al., 2001). 
Certain neuronal subtypes within the ARC also express receptors for other 
substances which are known to be involved in energy homeostasis, for example, 
leptin, ghrelin, orexin, 5-HT (5-hydroxytryptainine; serotonin) and noradrenaline 
(Elias et al., 1998b; Broberger, 2005; Elmquist et al., 2005). The ARC is therefore 
proposed to be the fimdamental integrative centre for the control of feeding and 
energy homeostasis. 
Within the hypothalamus there are multiple neuropeptides, hormones and 
other signalling factors that are involved in the control of energy homeostasis. 
Orexigenic molecules stimulate the anabolic pathway, by increasing food intake and 
inhibiting energy expenditure. Anorexigenic molecules stimulate the catabolic 
pathway, causing a decrease in food intake and an increase in energy expenditure 
(see table I- I). 
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Table 1.1 Orexigenic and anorexigenic signalling molecules involved in energy 
homeostasis 
Orexigenic Anorexigenic 
Ghrelin CCK 
NPY Glucagon-like peptide-I 
Orexin A/B PYY3-36 
AgRP Leptin 
MCH Insulin 
Endocannabinoids a-MSH 
Noradrenaline CRF 
Galanin Neuromedin U 
GABA CART 
Uncoupling 
_proteins 
POW 
Dynorphin Oxyntomodulin 
AMP kinase Serotonin 
Noradrenaline 
GABA 
Neurotensin 
Obestatin 
Neuromedin S 
Enterostatin 
Pancreatic polypeptide 
Bombesin 
GALP 
Within the ARC, there are principally two important neuronal subgroups that 
control the anabolic and catabolic pathways, those expressing NPY/AgRP and those 
expressing POMC/CART (see figure 1.4). NPY neurones are expressed in the 
ventromedial part of the ARC whereas POMC neurones are found more laterally. 
NPY and POMC are never found expressed in the same neurone (Schwartz et al., 
1999; Elmquist et al., 2005). Downstream targets of neurones within the ARC 
include neurones within the LH and the PVN. Specificay in the LH, there exist two 
key populations of neurones, orexin and melanin concentrating hormone (MCH), 
which are innervated by NPY/AgRp and POMC neurones (Elias et al., 1998b), and 
within the PVN, corticotrophin releasing factor (CRF) neurones are targets of ARC 
neurones (Baker & Herkenham, 1995). The roles of some of the most important 
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orexigenic and anorexigenic peptides involved in energy homeostasis will now be 
discussed in detail. 
1.4 Orexigenic Neuropeptides 
L 4.1 NPY 
NPY is part of the pancreatic polypeptide family that includes peptides, such 
as PYY. It is a 36 amino acid peptide, that was discovered in the hypothalamus in 
1982 (Tatemoto et al., 1982) and is one of the most abundant peptides in the brain 
(Adrian et al., 1983), with the highest levels being found in the PVN and the ARC 
(Chronwall, 1985). Like PYY (Morley et aL, 1985), NPY is a potent orexigen as 
injection into the PVN and cerebral ventricles causes hyperphagia, and obesity 
(Stanley et al., 1986; Zaýevski et al., 1993) and food deprivation increases both 
NPY and NPY mRNA (Sahu et al., 1988; Sanacora et al., 1990; White et al., 1990; 
Kalm et al., 1991; Schwartz et al., 1993). NPY neurones have been shown to release 
the inhibitory neurotransmitter GABA, which exerts a tonic inhibition on 
neighbouring anorexigenic POMC neurones. This means that when NPY neurones; 
are active, the neighbouring POMC neurones are inhibited, reducing the 
anorexigenic effects they produce and thereby furthering the orexigenic effects of 
NPY (Horvath et al., 1997; Cowley et at, 2001). NPY has also been shown to 
inhibit POMC mRNA expression via the Y2 receptor (Garcia de Yebenes et al., 
1995) and inhibit POMC neuronal activity directly via the Yj receptor (Roseberry et 
al., 2004). Whether NPY or GABA release is the most important signal from NPY 
neurones remains to be determined but it would appear that both play a role in 
feeding. 
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There are 5 types of NPY receptor, YI-Y5, although only Y1, Y2 and Y5 are 
thought to be involved in feeding (Gerald et al., 1996). They are all G-protein 
coupled receptors, either to GV. proteins. Predominantly, in the ARC the Yj receptor 
is found on POMC neurones whereas the Y2 receptor is located on NPY neurones 
and is thought to act as a presynaptic autoreceptor (Broberger et al., 1997). Mice 
with deletion of the Y2 receptor have increased food intake and body-weight 
(Naveilhan et al., 1999) whereas Yj receptor knockout mice show a reduced 
response to fast-induced re-feeding (Pedrazzini et al., 1998). The Y5 receptor is 
involved in the feeding response to centrally administered NPY but it is not a critical 
feeding receptor (Marsh et al., 1998). 
1.4.2AgRP 
AgRP is an endogenous antagonist for the melanocortin 3 and 4 receptors 
(MC3-R and MC4-R) and is expressed in the CNS (Ollmann et al., 1997; Shutter et 
aL, 1997). It is an orexigenic peptide that is co-expressed with NPY but not with 
POMC in the ARC (Hahn et al., 1998) and administration of AgRP leads to an 
increase in food intake and body-weight (Ollmann et al., 1997). Ablation of AgRP 
neurones results in acute reduction of feeding showing that they are critical in energy 
homeostasis (Gropp et al., 2005). AgRP is thought to increase feeding by inhibiting 
activity at MC-4 receptors thus blocking anorexigenic pathways. 
L4.3 Orexin 
Orexins, (taken from the Greek orexis meaning appetite) or hypocretins as 
they are also known, were discovered as a novel family of neuropeptides that bind to 
G-protein coupled receptors (de Lecea et al., 1998; Sakurai et al., 1998). They are 
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abundantly expressed in the LH and are present in two fonns, orexin A and orexin B, 
which are both derived from the precursor prepro-orexin. They bind to two closely 
related G-protein coupled receptors, orexin receptor I and 2. Central injections of 
orexin stimulate feeding and food restriction leads to an increase in orexin mRNA 
levels (Sakurai et al., 1998 -, Dube et al., 1999). The orexigenic effects of orexin may 
arise due to the inhibition of POMC neurones (Ma, et aL, 2007) or to the activation of 
NPY neurones, (Yamanaka et al., 2000). Orexins are also strongly implicated in 
arousal and waking as mutations in the orexin gene or orexin type 2-receptor result 
in narcolepsy (Lin et al., 1999; Saper et al., 2005). 
1.4.4 MCH 
MCH is a 19 amino acid peptide that is expressed exclusively in the LH and 
zona incerta (Bittencourt et al., 1992). MCH mRNA levels are increased by food 
deprivation and central injections of MCH increases food intake (Qu et al., 1996; 
Ludwig et al., 1998). Mice lacking MCH are hypophagic and lean and over- 
expression of MCH leads to obesity and hyperleptinemia (Shimada et al., 1998). 
MCH increases the release of both NPY and AgRP, but decreases the release of 
a-MSH and CART from hypothalamic explants (Abbott et al., 2003). MCH also acts 
as an antagonist at the melanocortin receptors (Ludwig et al., 1998). 
1.5 Anorexigenic Neuropeptides 
L 5.1 POMC 
POMC is the precursor for a family of melanocortin peptides, including 
a-melanocyte stimulating hormone (a-MSH), P-melanocyte stimulating hormone 
(P-MSH), y-melanocyte stimulating hormone (, y-MSH), adrenocorticotropin (ACTH) 
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and p-endorphin. ACTH and a-MSH both markedly inhibit feeding when injected 
into the cerebral ventricles (Poggioli et al., 1986). POMC is only expressed at two 
sites within the brain: the hypothalamus and the NTS in the brainstem (Jacobowitz & 
O'Donohue, 1978; Watson & Akil, 1979). Ablation of POMC neurones causes 
obesity (Xu et al., 2005). Within the ARC, POMC neurones are found adjacent to 
NPY neurones and are believed to principally release a-MSH (Jegou et aL, 1993). 
Melanocortin peptides bind to five different melanocortin receptors MCI-5-R but 
only MC3-R and MC4-R are expressed in the brain and are involved in energy 
homeostasis (Tatro, 1990; Mountjoy et al., 1994; Kishi el al., 2003). The MC4-R is 
strongly implicated in the control of feeding as knockout of this receptor leads to 
increased body-weight and obesity (Huszar et al., 1997), and MC4-R agonists cause 
anorexia while antagonists of this receptor stimulate feeding (Fan et aL, 1997). One 
of the most common monogenic causes of obesity in humans is due to disrupted 
MC4-R signalling (Yeo et al., 1998). The MC3-R is expressed on POMC neurones, 
indicating that melanocortins could exert a feedback role onto POMC neurones 
(Jegou et al., 2000). This is supported by the fact that a MC3-R agonist suppressed 
hypothalamic POMC expression and stimulated feeding (Lee et al., 2008). 
1.5.2 CUT 
CART was first identified as a transcript up-regulated by cocaine and 
amphetamine in the striatum (Douglass et al., 1995). It is the third most abundant 
transcript in the rat hypothalamus (Gautvik et al., 1996). CART decreases food 
intake and fasting reduces CART expression making it an anorexigenic peptide 
(Kristensen et al., 1998; Lambert et al., 1998). CART is widely expressed in the rat 
brain and is present in the same neurones as POMC within the ARC (Elias et al., 
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1998a), but it is not expressed with NPy. It is also co-localised with melanin 
concentrating hormone (MCH) neurones within the LH (Broberger, 1999). This is 
unusual as MCH is orexigenic, leading to a neuronal group containing both 
orexigenic and anorexigenic peptides. In humans however, CART is not expressed 
on POMC neurones but is instead found on a minority of NPY neurones indicating a 
possible orexigenic role for CART in the human hypothalamus (Menyhert et al., 
2007). 
1.5.3 CRF 
CRF is a 41 amino acid peptide that is primarily produced in the PVN. It has 
an important role in controlling hypothalamic-pituitary-adrenal activity but it is also 
involved in energy balance. It is involved in the catabolic pathway as it leads to a 
suppression of food intake and an increase in energy expenditure (Arase et al., 1988; 
Rothwell, 1990). 
L5.4 CCK 
CCK is a GI-T peptide, released from the endocrine-I cells in the small 
intestine, in response to food intake and is known to induce satiety and reduce food 
intake (Gibbs et al., 1973). It is thought to mediate the short-term control of feeding 
as repeated administration does not lead to a decrease in body-weight (Cummings & 
Overduin, 2007). CCK acts via two G-protein coupled receptors, CCKI and CCK2 
(Wank et al., 1992), which are widely expressed in the CNS (Moran et al., 1986), 
with particularly high levels in the caudate nucleus, cerebral cortex and 
hypothalamus (Hays et al., 1981). Receptors in the hypothalamus as well as on the 
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vagus nerve are thought to be responsible for its role in energy homeostasis (Noble et 
al., 1999). 
Alongside hypothalamic peptides, there are also signalling factors that are 
important in the control of energy homeostasis. These include the neurotransmitters 
y-wninobutyric acid (GABA) and glutamate. 
1.5.5 Neurotransmitters 
The role of fast acting neurotransmitters (GABA and glutaxnate) in feeding 
and energy homeostasis has been largely neglected due to the focus on the vast 
number of neuropeptides thought to be involved. However both GABA and 
glutamate are thought to play an important role in the regulation of feeding (van den 
Pol, 2003). A role for GABA is suggested as both glutamic acid decarboxylase 
(GAD) and the vesicular GABA transporter (VGAT) have been found in NPY 
neurones (Horvath et al., 1997; Ovesjo et al., 2001) and more recently GAD mRNA 
was also discovered in a population of POMC neurones (Hentges et al., 2004). A 
population of POMC neurones however has also been shown to be glutamatergic as 
the vesicular glutainate transporter (VGLUT2) has been found in POMC neurones 
(Collin et aL, 2003). Therefore orexigenic NPY neurones are proposed to be 
GABAergic whereas different populations of POMC neurones are either GABAergic 
or glutamatergic. 
1.6 Hormonal and Nutrient Signalling 
There are several circulating factors that are thought to impinge on the 
hypothalamus and contribute to the regulation of energy homeostasis. These include 
the adiposity factors leptin and insulin, which are proposed to be long-term 
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regulators of feeding, and glucose and ghrelin, which are thought to be involved on a 
more short-term basis and help to regulate meal initiation. In addition adipocytokines 
released from adipose tissue play an important role as do signals from the GI-T 
including most importantly PYY. 
1.6.1 Leplin 
Leptin (taken from the Greek leptos meaning thin) was discovered as the 
protein product of the ob gene and is the long sought after adiposity factor proposed 
by Kennedy (Zhang et al., 1994; for review, see Friedman & Halaas, 1998). It is 
produced from adipose tissue in direct proportion to the amount of fat stored and 
signals this information to the brain. There are at least 6 splice variants of the leptin 
receptor (Ob-R a-f) but the abundant form in the hypothalamus is the long form of 
the receptor (Ob-Rb; Tartaglia et al., 1995; Lee et al., 1996). Ob-Rb is expressed in 
many hypothalamic nuclei involved in energy homeostasis, including the ARC, LH, 
VMN, and PVN (Hakansson et al., 1998). The leptin receptor is a type I cytokine 
receptor and activates the JAK2-STAT3 pathway and other pathways downstream 
including the phosphatidylinositol 3-kinase (P13K) pathway (Tartaglia et al., 1995; 
Fruhbeck, 2006). 
Mice lacking leptin (oblob) or the leptin receptor (dbldb) are obese (Lee et 
al., 1996). Administration of leptin causes an inhibition of feeding and a decrease in 
body-weight (Carnpfield et al., 1995; Halaas et al., 1995; Pelleymounter et al., 1995; 
Weigle et al., 1995; Schwartz et al., 1996). Leptin can reverse the obesity seen in 
leptin deficient (oblob) mice, but not in dbldb mice. However in some individuals, 
an increase in leptin has no effect as leptin resistance develops. This may be either 
- 17- 
Chapter One 
due to impaired leptin receptor signalling or due to lack of leptin access to the brain 
perhaps due to impaired transport across the BBB. 
Direct injection of leptin into the ARC, VMN and LH decreases food intake 
and body-weight, with the ARC being the primary site of the satiety effect of leptin 
(Satoh et al., 1997). Leptin acts in the ARC to stimulate POMC/CART neurones and 
inhibit NPY/AgRP neurones (Stephens et al., 1995; Schwartz et al., 1996,1997; 
Thomton et al., 1997; van den Top et aL, 2004). Both neuronal subtypes express the 
leptin receptor (Mercer et aL, 1996; Cheung et al., 1997). In oblob mice, dbldb mice 
and falfa rats, NPY and AgRP mRNA is increased (Beck et al., 1990; Chua et aL, 
1991; Wilding et al., 1993; Shutter et aL, 1997) and POMC and CART mRNA is 
reduced (Schwartz et al., 1996; Thornton et al., 1997). Repletion of leptin in oblob 
mice suppresses this elevated NPY expression and increases POMC expression 
(Stephens et al., 1995; Schwartz et al., 1996,1997; Thornton et al., 1997). Knockout 
of NPY reduces the hyperphagia and obesity seen in oblob mice indicating that the 
response to leptin deficiency requires NPY signalling (Erickson et al., 1996). 
As well as affecting transcriptional control, leptin can alter the firing 
properties and electrical activity of ARC neurones. Leptin has been shown to inhibit 
the firing of a subpopulation of ARC neurones, shown to be glucose-sensing 
neurones by their sensitivity to changes in extracellular glucose (Spanswick et al., 
1997). This occurs through activation of the ATP-sensitive potassium channel (KATP) 
and subsequent P13K-dependent signalling (Spanswick et al., 1997; Mirshamsi et al., 
2004). Leptin has also been shown to depolarise POMC neurones via activation of a 
non-selective cation channel, also involving a P13K-dependent downstream 
signalling pathway (Hill et al., 2008; Rother et al., 2008). 
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In addition to regulating NPY/POMC neurones, leptin also targets other 
hypothalamic neurones, for example, MCH, galanin, GALP, orexin and CRF. Leptin 
increases the expression of the anorexigenic peptides CRF and GALP (Huang et al., 
1998; Kumano et al., 2003) whereas it inhibits the expression of the orexigenic 
peptides MCH, orexin and galanin (Sahu, 1998; Lopez et al., 2000). 
For a review of leptin signalling, see Sahu, 2004 and Myers et aL, 2008. 
1.6.2 Insulin 
Insulin was one of the first signals proposed to regulate energy homeostasis 
(Porte & Woods, 1981). It is produced from 0-cells in the islets of langerhans in the 
pancreas and circulates in proportion to plasma glucose levels. Insulin receptors are 
expressed within the brain, including in hypothalamic nuclei (Marks et al., 1990) and 
both insulin and leptin converge on the same downstream signalling pathway -Pl3K. 
Administration of insulin intracerebroventriculaIrly reduces food intake and body- 
weight (Brief & Davis, 1984; Ikeda et aL, 1986), partly because insulin reduces the 
levels of the orexigenic peptide NPY (Schwartz et al., 1991,1992). Genetic models 
of obese rats with insulin receptor knockouts confirm the role of insulin in energy 
homeostasis (Bruning et aL, 2000). However, obesity does not arise if insulin levels 
fall, therefore it would appear that leptin is more critical in the regulation of energy 
homeostasis. 
Like leptin, insulin is also able to regulate the firing properties of neurones as 
it has been shown to hyperpolarise a subset of ARC neurones (Spanswick et al., 
2000), including identified POMC neurones (Hill el aL, 2008), through activation of 
the KATp channel and subsequent P13K-dependent signalling pathway (Spanswick et 
al., 2000; Hill et al., 2008; Rother et al., 2008). 
-19- 
Chapter One 
1.6.3Adipocytokines 
Adipose tissue is an endocrine organ that secretes a number of 
adipocytokines, which play a key role in energy homeostasis. Adipocytokines are 
factors that are expressed and secreted by adipocytes into the circulation, of which 
the two most abundant are leptin and adiponectin. Together they act to regulate food 
intake. Leptin is secreted in direct proportion to the amount of fat stored and is 
proposed to act as a satiety signal. Opposing leptin's actions, adiponectin is proposed 
to act as a starvation signal, as it is secreted inversely to the amount of fat stored. 
Adiponectin has important insulin sensitising effects as a decrease in adiponectin 
contributes to type 2 diabetes and insulin resistance (Kadowaki et al., 2008). 
Alongside its anti-diabetic effects, adiponectin is proposed to play a central role in 
energy homeostasis. The adiponectin receptors, adipoRl and adipoR2, (Yamauchi et 
al., 2003) are expressed in the hypothalamus (Kubota et al., 2007), and it has been 
suggested that adiponectin acts as an orexigenic signal by stimulating AMP-activated 
protein kinase (AMPK). AMPK acts as an energy sensor in cells as it activates 
processes that produce energy whilst inhibiting those that consume energy. This 
leads to an increase in food intake and a decrease in energy expenditure (Minokoshi 
et aL, 2004; Kadowaki et aL, 2008). 
1.6.4 Glucose 
Glucose is the primary energy source of most mammalian cells and therefore 
it is important that there is a constant supply of glucose within the body. The liver is 
the principal organ which regulates the production and uptake of glucose and hence 
maintains glucose homeostasis. Most neurones use glucose as the fuel for their 
metabolic activity, however there are a specialised group of neurones that are also 
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able to sense glucose. These neurones monitor and integrate changes in extracellular 
glucose concentration and are able to regulate their electrical activity in response to 
these changes. Mayer first postulated over 50 years ago that glucose was sensed by 
glucoreceptors in the hypothalamus to control food intake (Mayer, 1953) and Anand 
and Oomura later showed that neurones in the LH and VMN actually used glucose to 
alter their firing properties (Anand et al., 1964; Oomura et al., 1964). These 
6glucose-sensing' neurones have subsequently been found within the ARC and other 
areas of the hypothalamus (Ashford et al., 1990a; Spanswick et al., 1997). 
Glucose-sensing neurons have been divided into glucose-excited neurones 
(GE), which increase their activity in response to increases in glucose, and glucose- 
inhibited neurones (GI) that decrease their activity in response to increases in 
glucose (Levin et aI, 1999). The mechanism by which GE neurones sense glucose 
and alter their activity is via the KATp channel (Rowe et al., 1996; Miki et al., 200 1). 
This occurs in an analogous way to the glucose-stimulated insulin release in 
pancreatic P-cells (Schuit et al., 2001). Briefly, glucose enters the cell via a GLUT 
transporter and glycolysis occurs via a glucokinase. Glycolysis increases the 
ATP/ADP ratio, which leads to closure of the KAT? channel, leading to membrane 
depolarisation, influx of calcium and generation of an action potential. The GLUT2 
transporter, glucokinase and the KATp channel have all been shown to be essential 
components of this process (Dunn-Meynell et al., 2002; Kang et al., 2004; Wang et 
al., 2004; Bady et al., 2006; Kang et al., 2006; Yang et al., 2007). In particular, the 
role of the KATp channel in the regulation of the electrical activity of glucose sensing 
neurones in the hypothalamus has been shown in many previous studies (Ashford et 
al., 1990a, b; Spanswick et al., 1997; Lee et al., 1999; Spanswick et al., 2000; Mki 
et al., 2001; Zhang et al., 2004). The KATp channel is an octameric protein consisting 
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of 4 pore forming units, the inward rectifier K+ channel (either Kir 6.1 or Kir 6.2) 
and 4 sulphonylurea receptors (SURI or SUR2). In the ARC, the most probable 
composition of KATp channels is Kir 6.2 and SURI, analogous to that found in 
pancreatic P-cells (Miki et al., 2001; van den Top et al., 2007), although a study of 
the VMH demonstrated that Kir 6.1 not Kir 6.2 was expressed (Lee et al., 1999). A 
recent study however found that not all GE neurones detect glucose via the KATp 
channel but instead sense glucose via a KATp-independent mechanism (Fioramonti et 
aL, 2004). However in this study very high glucose levels were used, between 5 and 
20 mM, and hence these neurones were named high-glucose-excited. They 
hypothesised that these neurones have the ability to sense glucose at a concentration 
above 5 m. M through a KATp-independent mechanism as they found that at 5 mM 
glucose the KATP channel was mostly closed. Therefore this mechanism may only 
occur at non-physiological glucose levels. 
The mechanism by which glucose inhibits GI neurones is much less clear. 
Studies indicate that a chloride conductance may be responsible, as activation of 
chloride channels in the membrane by elevated glucose leads to hyperpolarisation of 
the cell (Song et al., 2001; Fioramonti et al., 2007). A different mechanism has also 
been proposed, whereby glucose inhibited orexin neurones in the LH through the 
involvement of tandem-pore potassium channels (TASK; Burdakov et al., 2006). 
Both NPY neurones and POMC neurones within the ARC have been shown 
to express the KATp channel (van den Top et aL, 2007). NPY neurones were found to 
be GI neurones (Muroya et al., 1999) whereas POMC neurones were found to be GE 
neurones (Ibrahim et al., 2003), although subsequent studies failed to identify GE 
neurones as POMC neurones (Wang et al., 2004; Fioramonti et al., 2007). For a 
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review of glucose-sensing see Levin et al,, 2004,2006 and Mountjoy & Rutter, 
2007. 
As well as regulating the electrical activity of neurones within the 
hypothalamus, the KATp channel has been shown to play an essential role in the 
regulation of hepatic glucose homeostasis. Insulin, acting through hypothalamic 
KATp channels, has been shown to inhibit hepatic glucose production (Pocai et d, 
2005), and this hypothalamic control by insulin has been shown to be essential in 
preventing hyperglycaemia (Obici et d, 2002c). In addition, the expression of 
insulin receptors in the hypothalamus has been shown to be vital for the control of 
hepatic glucose production by insulin (Obici et d, 2002a). These data provide 
evidence that hypothalamic control of glucose production by insulin and the KATp 
channel is essential for liver glucose homeostasis. 
1.6.5 Ghrefin 
Ghrelin is a 28 amino acid orexigenic peptide released from the endocrine 
cells of the stomach, as well as the intestine (Date et al., 2000). The name ghrelin is 
based on the word root 'ghre' from the Proto-Indo-European languages, meaning 
grow, as it can stimulate growth hormone (GH) release (Kojima & Kangawa, 2005). 
It was discovered as the endogenous ligand for the GH secretagogue receptor 
(GHSR; Kojima et al., 1999) and is modified with an n-octanoyl group at serine 3, a 
modification essential for its biological activity. The GHSR is found extensively 
distributed all over the brain and within all areas of the hypothalamus (Guan et aL, 
1997; Zigman et al., 2006; Harrold et al., 2008). Administration of ghrelin strongly 
stimulates feeding and suppresses energy expenditure in rats and humans (Tschop et 
al., 2000; Wren et al., 2001ab; Lawrence et aL, 2002; Wang et al., 2002; 
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Faulconbridge et al., 2003; Currie et al., 2005) as well as stimulating gastric 
emptying (Asakawa et al., 2001). Administration of an antagonist to the gbrelin 
receptor leads to a reduction in body-weight and decrease in feeding (Asakawa et al., 
2003). Elevated levels of plasma ghrelin have been associated with a common form 
of human obesity called Prader-Willi syndrome suggesting that hyperghrelinemia 
can contribute to obesity (Cummings et al., 2002a). Interventions to lower plasma 
gluelin may therefore be useful in the treatment of obesity for sufferers of Prader- 
Willi syndrome. 
Ghrelin is one of the most potent stimulants of short-term feeding, greater 
than any other known peptide except NPY (Asakawa el al., 2001). It is thought to be 
involved in the initiation of individual meals, as studies have shown there to be a 
pre-prandial rise and a postprandial decline in plasma ghrelin levels (Cummings et 
al., 2001,2002b). Ghrelin acts in the ARC to stimulate NPY/AgRP neurones; as NPY 
neurons in the ARC express GHSR (Willesen et al., 1999) and ghrelin increases 
NPY and AGRP mRNA expression in both fed and fasted rats (Kamegai el aL, 2000, 
2001; Nakazato et al., 2001; Seoane et al., 2003). Further evidence that ghrelin acts 
via the NPY pathway is that antagonism of NPY receptors attenuates the orexigenic 
effects of ghrelin (Shintani et al., 2001) and that knockout of NPY and AgRP 
completely abolishes the orexigenic effect of ghrelin (Chen et al., 2004). For a 
review of ghrelin signalling see Kojima & Kangawa, 2005. 
1.6.6PYY 
There are many peptides and hormones produced in the GI-T that play a key 
role in the central control of energy homeostasis. GI-T signals principally target the 
hindbrain, either via vagal afferents from the gut that innervate the NTS or by being 
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released into the circulation and crossing the BBB. One of the most important GI-T 
signals is PYY. 
PYY is a 36 amino acid peptide belonging to the pancreatic polypeptide 
family, to which NPY also belongs. It is secreted from L cells in the ileum 
postprandially and exists in two fOrMS, PYYI-36 and PYY3-36- PYYI-36, which binds 
to the Y1, Y2 and Y5 receptors, and is cleaved into PYY3-36 which preferentially 
binds to the Y2 receptor (Keire et al., 2000,2002). Both fonns increase food intake 
when administered centrally but decrease food intake in the periphery. This decrease 
in feeding is proposed to occur through PYY3-36 acting at the Y2 receptor on NPY 
neurones to reduce NPY expression and dis-inhibit POMC neurones (Morley et al., 
1985; Batterharn et al., 2002; Batterham & Bloom, 2003; Chaflis et aL, 2003). 
Further evidence for this comes from a study showing that blockade of the Y2 
receptor with a specific Y2 antagonist attenuates the anorexigenic effect of 
peripherally administered PYY (Abbott et al., 2005). 
For a review of gastrointestinal regulation of food intake see Cummings & 
Overduin, 2007 and Mendieta-Zeron et al., 2008. 
1.7 5-HT 
Serotonin was identified in the late 1940s as a 'tonic' substance in the 
4 serum' that constricts smooth muscle and increases vascular tone (hence the name 
serotonin; Rapport, 1949). Serotonin (5-hydroxytryptamine; 5-HT) is a 
neurotransmitter that has been implicated in many different behavioural, 
psychological and physiological functions and diseases, for example, it is heavily 
involved in mood disorders such as depression, anxiety and schizophrenia, as well as 
playing a role in migraine, hypertension and eating disorders. It is associated with 
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the sleep-wake cycle, reproduction, feeding and energy homeostasis and 
thermoregulation (Bonate, 1991; Wilkinson & Dourish, 1991; Baldwin & Rudge, 
1995; Graeff et al., 1996). 
5-HT is synthesised from the amino acid tryptophan in a multistep pathway. 
Firstly, L-tryptophan is hydroxylated by tryptophan hydroxylase. 
Hydroxytryptophan is then decarboxylated to produce serotonin. 5-HT is produced 
in the enterochromaffm cells in the gut and in serotonergic neurones in the raphd 
nuclei in the brainstem, which send projections all over the brain (Azmitia & Segal, 
1978; Steinbusch, 1981). There is a subdivision of 5-HT producing neurones in the 
brainstem, with those located in the rostral region providing ascending projections to 
the forebrain whereas those in the caudal region provide descending projections to 
the spinal cord (Tork, 1990). The dorsal raphd and to a lesser extent the median 
raphd are the origin of the 5-HT innervation of the hypothalamus (Willoughby & 
Blessing, 1987) as 5-HT from the periphery and circulation does not cross the BBB, 
although the precursor tryptophan can. 
1.7.1 S-HT receptors 
5-HT exerts its effects through at least 14 distinct receptors, which have been 
arranged into 7 families, making it one of the most complex groups of 
neurotransmitter receptors. They are all metabotropic receptors, belonging to the 
G-protein coupled receptor family, except for the 5-HT3 receptor, which is a ligand- 
gated ion channel. 
The origins of the classification of the 5-HT receptor began in 1957 when 
Gaddum and Picarelli proposed the M and D receptor, after demonstrating that 
responses of the gumea pig ileum could be blocked by either morphine (M) or 
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dibenzyline (D). Subsequently further research by Peroutka and Snyder (1979) 
demonstrated that only 5-HT could displace two radioligands from two receptor 
binding sites, so these sites were labelled 5-HTI and 5-HT2. The D receptor 
corresponded to the newly discovered 5-HT2 binding site. However it was not until 
1986 that the 5-HT3 receptor was discovered which corresponded to the M receptor. 
With more extensive research and new techniques in molecular biology the 5-HT4, 
5-HT5,5-HT6 and 5-HT7 receptors were subsequently identified, along with multiple 
subtypes for tile 5-HTI and 5-HT2 receptors. The current classification was adopted 
by the Nomenclature Committee of the International Union of Pharmacology 
(NC-IUPHAR) in 1994, in which 14 receptors have been split into 7 families (Hoyer 
et al., 1994). These are shown in table 1.2. 
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Table 1.2 S-HT receptors 
Receptor Subgroups Signalling Principal distribution 
_Family 
pathway within brain 
5-HT, IA, IB ID, IE, IF Gi/o - cAMP ]A: Limbic system, raph6 
nuclei, hypothalamus 
(5-HTIc was IB: hippocampus, striaturn, 
subsequently cerebellum, basal ganglia 
discovered to be ID: caudate-putamen, 
more like the cortical areas 
5-HT2 group and JE: caudate-putamen, 
was renamed amygdala 
5-HT2c) IF., raph6 nucleus, 
hippocampus, striatum, 
thalamus 
5-HT2 2A, 213,2C Gq - PLC 2A: hippocampus, amygdala, 
hypothalamus, substantia 
nigra, cerebral cortex 
2B: cerebellum, amygdala, 
raphd nucleus 
2C. - choroid plexus, 
substantia nigra, globus 
pallidus 
5-HT3 Ion channels Amygdala, hippocampus 
5-HT4 Gs -CAMP Hypothalamus, amygdala, 
hippocampus, basal ganglia, 
substantia niEa 
5-HTs 5A, 5B Not yet known 5A: cerebellum, 
hippocampus, hypothalamus 
5B: habenula, dorsal raph6 
5-HT6 Gs - cAMP Striatum and nucleus 
I accumbens 
5-HT7 s- cAMP r Thalamus, hypothalamus, I 
hippocampus, amygdala 
5-HTI receptors couple Preferentially to the G-proteins Gi/o to inhibit cyclic 
adenosine-mono-phosphate (cAMp), whereas 5-HT2 receptors couple to Gq to 
modulate the phospholipase C (PLC) pathway. S-HT4,5-HT6 and 5-HT7 receptors 
couple to Gs to stimulate the CAMP pathway (Hoyer et al., 2002). The 5-HT5 
receptors have not yet been convincingly linked to any signalling pathway. 
5-HT3 receptors are non-selective cation channels and cause a depolarisation 
of neurones due to the influx of Ne and Ca2+ and the efflux of K+. 
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1.7.2 Functional effects mediated by the 5-HT receptors 
With the huge diversity of 5-HT receptors comes a diverse range of functions 
that are controlled by 5-HT. The functions attributed to each receptor will be 
discussed here. For a full review see B ames & Sharp (1999). 
5-HT1: The 5-HTIA receptor controls thennoregulation (Goodwin et al., 1985; 
Gudelsky et al., 1986) and sexual behaviour (Ahlenius et al., 1981), as well as 
having a role in psychiatric disorders. 5-HTIA agonists are thought to exert 
antidepressant effects (Chamey et al., 1990). The 5-HTIB receptor plays a role in 
locomotor activity and is important in controlling aggression. 5-HTji3 receptor 
knockout mice are more aggressive than wild-type (Saudou et aL, 1994). Both the 
5-HTIA and 5-HTIB receptor are also strongly implicated in the control of feeding 
(see section 1-7.3). No convincing physiological or pathophysiological functions are 
as yet ascribed to the 5-HTID and 5-HTIE receptors due to a lack of selective ligands 
for these receptors. The fimctions of the 5-HTIF receptor are also not fully known 
though it is speculated to be involved in visual and cognitive function based upon its 
location (Barnes & Sharp, 1999). 
5-HT2: It is hard to separate out the functions attributed to the 5-HT2V2C receptor 
subtypes as there is a high degree of homology between the two and there are 
relatively few ligands that distinguish between them. However the 5-HT2A receptor 
is thought to play an important role in several psychiatric disorders, such as 
depression and schizophrenia (Baldwin & Rudge, 1995; Graeff et aL, 1996). It is 
also important in temperature regulation (Gudelsky et al., 1986) as well as 
neuroendocrine responses (Fuller, 1996). The 5-HT2c receptor is widely considered 
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to be involved in the control of feeding (see section 1.7.3). As it is found in the 
choroid plexus, it is also thought to regulate the composition and volume of the 
cerebrospinal fluid (CSF; Pazos et al., 1984). It is also proposed to be important in 
movement and locomotion and have anxiolytic effects (Kennett et al., 1997b). The 
functions of the 5-HT2B receptor are not well known but agonists for this receptor are 
also thought to have anxiolytic effects (Duxon et al., 1997b). 
5-HT3: This receptor is thought to control gut motility, as well as having antiemetic 
effects. It also modulates release of the gut peptide CCK (Paudice & Raiteri, 1991; 
Grignaschi et al., 1993; Hayes & Covasa, 2005) as well as being implicated in 
cognitive function (Altman et al., 1987). Within the CNS, it controls 
neurotransmitter release as well as having roles in anxiety (Hoyer et al., 1994). 
5-HT4: The 5-HT4 receptor modulates the release of various neurotransmitters, such 
as acetylcholine and doparnine (Barnes & Sharp, 1999). However it is not proposed 
to exert any effect on behavioural functions, such as feeding or movement. 
5-HT5: Relatively little is known about the fianctions of the 5-HT5A or 5-HT5B 
receptors. 
5-HT6: The functions of this receptor are also not well known. However because this 
receptor is localised in extrapyramidal and limbic areas, it has been suggested to be 
involved in the control of motor function and mood disorders (Gerard et al., 1997). It 
is also suggested to be involved in mediating the effects of antipsychotic agents as it 
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has been localised in brain areas that are the sites of action of these drugs (Ward et 
al., 1995). 
5-HT7: The 5-HT7 receptor is strongly implicated in the regulation of circadian 
rhythms as it is localised in the SCN (Gustafson et aL, 1996; Neumaier et al., 2001). 
L 7.3 5-HT and control of energy balance 
The central serotonin system has for many years been associated with the 
regulation of food intake and body-weight (for review see Blundell, 1977,1984). 
Depletion of serotonin using neurotoxins results in hyperphagia and obesity (Breisch 
et al., 1976; Saller & Stricker, 1976) whereas substances that increase serotonin 
release, such as d-fenfluramine (d-fen), lead to a reduction in feeding and body- 
weight (Guy-Grand, 1992). 5-HT levels have been shown to increase in the LH upon 
feeding (Schwartz et al., 1989) and direct injection of 5-HT into the PVN suppressed 
food intake (Currie & Coscina, 1996). The specific receptors that mediate the effects 
of serotonin on energy homeostasis have been extensively studied in the past. The 
principal receptor subtypes involved are proposed to be 5-HTIA, 5-HT113 and 5-HT2c. 
Evidence for the involvement of the 5-HTIA receptor comes from the fact that 
the specific 5-HTIA receptor agonist 8-OH-DPAT injected sub-cutaneously elicits 
feeding and hyperphagia in rats (Dourish et al., 1985,1986; Hutson et aL, 1988) and 
this receptor has been localised. to one of the most important areas involved in energy 
homeostasis, the ARC (Collin et al., 2002). Alongside its role in stimulating feeding, 
it has also been shown that the 5-HTIA receptor is involved in the control of 
hypothalamic glucose levels, as 8-OH-DPAT reduced glucose levels in the LH 
(Voigt et al., 2004). 
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The 5-HTIB receptor has been identified as having a role in feeding and 
energy homeostasis as agonists for this receptor, including CP-94253, RU 24969 and 
mCPP injected intraperitoneally (i. p. ), promote satiety and hypophagia (Bendotti & 
Samanin, 1987; Kennett et al, 1987; Kennett & Curzon, 1988; Dryden et aL, 1996b; 
Halford & Blundell, 1996; Lee & Simansky, 1997; Lee et al., 2002). Also the 
serotonin releaser d-fen (injected via the i. p. route) exerts its inhibitory effects on 
feeding through the 5-HTIB receptor (Neill & Cooper, 1989; Grignaschi & Samanin, 
1992; Grignaschi et al., 1995) and S-HTIB knockout mice did not display 
hypophagia after fenfluramine administration (Lucas et al., 1998). In addition the 
5-HTIB receptor has been identified within the ARC, placing it in a key position to 
regulate energy homeostasis (Makarenko et al., 2002; Heisler et aL, 2006). 
5-HT2C receptors are also expressed in the ARC (Wright et al., 1995), on both 
POMC and non-POMC neurones (Heisler et al., 2002; Lam & Heisler, 2007). The 
5-HT2c receptor has been implicated in the control of feeding as several studies have 
shown that 5-HT2c agonists promote hypophagia, including Men and BVT. X 
(Heisler et al., 2002; Lam et al., 2008). Also, mice lacking 5-HT2c receptors are 
hypophagic and obese (Tecott et al., 1995). The effects of d-fen are reduced in 
5-HT2c knockout mice, and the 5-HT2C receptor antagonist SB242084 inhibits d-fen- 
induced hypophagia (Vickers et al., 1999,2001). The downstream pathways thought 
to mediate these effects include the melanocortin pathway, specifically via the 
MC4-R (Lam et al., 2008). 5-HT2c receptors have also been shown to have an effect 
on glucose tolerance independently of food intake and body-weight, suggesting that 
they might play a role in the treatment of type 2 diabetes as well as obesity (Zhou et 
al., 2007; Wade et al., 2008). However to date there have been very few drugs which 
have targeted the 5-HT2c receptor as it is very hard to distinguish pharmacologically 
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between the 5-HT2 receptors as there is a high degree of homology between them. 
However, a novel 5-HT2c selective agonist, lorcarserin, has recently been identified as 
a potential drug for the treatment of obesity (Smith et al., 2008). 
1.8 Disorders of Energy Homeostasis 
When energy horneostasis is disrupted, certain disorders can result of which 
one of the most widely recognised is obesity. Obesity is an increasingly prevalent 
global problem, with the World Health Organisation (WHO) currently estimating 
that there are 1.6 billion adults worldwide who are overweight and 400 million 
adults that are obese. The prevalence of obesity is increasing not only in adults but 
also in adolescents and children, leading to a global epidemic. Obesity was originally 
not well defined, so the WHO designed a specific measure for determining body- 
weight, the Body Mass Index (BMI). BMI is calculated as the weight of an 
individual in kg, divided by their height in metres squared: 
BMI= weight in kiz 
(height in rný 
A normal individual has a BMI between 20 and 24. A BMI over 25 is 
classified as overweight and a BMI of over 30 is classified as obese. A BMI of fewer 
than 19 is classified as underweight (World Health Organisation, 2008). Although 
BMI is recognised as a universal indicator of body-weight, it does have its 
limitations. It does not give an indication of actual body composition, leading to 
certain groups of individuals being wrongly classified. For example, bodybuilders 
who have more muscle mass than fat mass are classified as obese under the BMI 
system. Studies have also found that the cut-off points are not appropriate for the 
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universal population as significant ethnic differences have been found in body 
composition, as well as in different age groups and between genders. 
Obesity results when energy intake exceeds energy expenditure, leading to an 
increase in body-weight. Although many people believe that obesity is caused 
simply by overeating and a lack of exercise, it is becoming increasingly clear that 
this is not necessarily the case. Although the increase in high calorific food 
combined with the more sedentary lifestyle of modem society do contribute, genetic 
factors also play an important role. These include impaired hormonal signalling, lack 
of functionally important receptors or impaired neuronal circuits. Obesity is 
associated with an increased risk of developing secondary diseases such as type II 
diabetes, certain forms of cancer, and cardiovascular diseases and is therefore a huge 
financial burden on government health spending (World Health Organisation, 2008). 
The field of obesity research is rapidly expanding and it is hoped that a better 
understanding of the areas involved in feeding and energy homeostasis will bring 
about new treatments and provide hope of controlling the escalating obesity 
epidemic. 
1.8.1 Putative drugsfor the treatment of obesity 
The predominant treatment for obesity remains to be a well balanced diet and 
exercise. However in the majority of cases weight loss is short-lived and weight 
regain is common, therefore a program of drug treatment is often necessary. There 
are currently only two approved anti-obesity drugs on the market: sibutramine and 
orlistat (Rubio et al., 2007). 
Sibutramine, is a noradrenaline and 5-HT reuptake inhibitor which leads to 
enhanced satiety and decreased food intake (Luque & Rey, 2002). The use of 
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sibutramine is accompanied by many side-effects such as nausea, constipation, dry 
mouth and more severely, an increase in blood pressure (Florentin et aL, 2007). 
Orlistat is a lipase inhibitor that reduces the intestinal absorption of fat 
leading to a reduction in calorie intake. However it is accompanied by unpleasant 
gastrointestinal side-effects. 
Other drugs that were approved for use but have since been withdrawn from 
the market include rimonabant, fenfluramine and dexfenfluramine. Rimonabant was 
an antagonist for the cannabinoid I receptor but was recently withdrawn due to 
psychiatric complications. Fenfluramine and dexfenfluramine both acted on the 
serotonergic system leading to weight loss but they were accompanied by a serious 
side effect on cardiac valves and so they were withdrawn from use in 1997 
(Connolly et aL, 1997; Mark et aL, 1997). 
1.9 Project Aims 
Obesity is an increasingly prevalent problem. Consequently understanding the 
mechanisms that underlie the central regulation of feeding and energy homeostasis is 
fundamental to the future design of novel treatment strategies and therapeutics 
targeting this debilitating condition. Therefore the aims of the present study were to 
investigate extrinsic and intrinsic factors involved in the regulation of energy balance 
at the level of the hypothalamic ARC. In particular the modulation of electrical 
properties of neurones by glucose, the cellular mechanisms by which 5-HT regulates 
the excitability of neurones, the detection of 5-HT receptors in the ARC and the 
ability of feeding signals to alter the gene expression of hypothalamic neuropeptides 
were studied. Whole-cell patch-clamp recordings, immunohistochemistry and 
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molecular biology techniques were utilised in order to achieve the specific aims of the 
project which were: 
To compare the effects of hyperglycaernic and euglycaemic glucose levels on 
the electrophysiological properties of ARC neurones and characterise ARC 
neurones into functional groups based on intrinsic electrophysiological 
properties (Chapter 3) 
2. To investigate the effects of the anorexigenic neurotransmitter 5-HT on the 
excitability of ARC neurones and to identify receptors and mechanisms of 
activity by which 5-HT modulates excitability of ARC neurones (Chapters 4 
and 5) 
3. To investigate the effects of feeding signals on neuropeptide gene expression 
within the hypothalamus and to determine whether these effects are activity 
or non-activity dependent (Chapter 6) 
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Figure 1.1 The central control of energy homeostasis 
A: Peripheral signals such as insulin released ftorn the pancreas, leptin released ftom 
adipose tissue, glucose from the liver and peptides released from the gastrointestinal 
tract such as ghrelin, cholecystokinin (CCK) and peptide tyrosine tyrosine (PYY) all 
impinge onto the hypothalamus to signal the energy status of the body to the brain. 
These signals can also exert an influence at the level of the nucleus of the tractus 
solitarius (NTS) in the brainstern via the vagal nerve. The hypothalamus and 
brainstern contain reciprocal connections to produce a coordinated response to bring 
about changes in feeding and energy homeostasis. In addition the hypothalamus and 
NTS receive inputs from higher centres to finther regulate energy homeostasis. In 
this way there exists a negative feedback loop within the body that regulates energy 
homeostasis. 
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Figure 1.2 Overview of hypothalamic nuclei involved in energy homeostasis 
A: Schematic drawing of the hypothalamus showing the location of the nuclei that 
are involved in energy homeostasis. These include the arcuate nucleus (ARC), lateral 
hypothalamus (LH), ventromedial nucleus (VMN), paraventricular nucleus (PVN), 
and the dorsomedial hypothalamus (DMH). There are reciprocal conneCtiOns 
between many of the nuclei that enable them to bring about a coordinated resPonse 
to energy homeostasis. 
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Figure 1.3 Afferent and efferent connections of the ARC 
A: Schematic drawing of a sagittal section of the rat brain showing afferent 
pathways to the hypothalamic arcuate nucleus (ARC). These inputs come from 
intrahypothalamic areas such as lateral hypothalamus (LH), ventromedial nucleus 
(VMN), paraventricular nucleus (PVN), dorsomedial hypothalamus (DMH), 
suprachiasmatic nucleus (SCN), preoptic area (POA) and the median eminence 
(ME). Extrahypothalamic inputs include the amygdala (AMG), dorsal raphe (DR), 
locus coerulus (LQ and the nucleus of the tractus solitarius (NTS). 
B: Schematic drawing of a sagittal section of the rat brain showing efferent pathways 
from the hypothalamic ARC. Outputs go to intrahypothalamic areas such as LH, 
VMN, PVN, DMH, SCN, POA, and ME. Extrahypothalarnic outputs include the 
periaqueductal gray area (PAG), AMG, DR, LC and the NTS. There is also an 
efferent projection to the spinal cord. 
(Figures adapted from Yi et al., 2006) 
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Figure 1.4 Anabolic and catabolic pathways controlling energy homeostasis 
A: Within the CNS, there are two principal pathways that are responsible for 
controlling bodyweight. These are the anabolic and catabolic pathways, which work 
as parallel and opposing pathways to maintain bodyweight around a defined set 
point. Within the ARC, there are principally two important neuronal subgroups that 
control these pathways, those expressing NPY/AgRP and those expressing 
POMC/CART. Activation of NPY/AgRP neurones stimulates the anabolic pathway 
leading to an increase in food intake and inhibition of energy expenditure. Activation 
of POMC/CART neurones stimulates the catabolic pathway leading to a decrease in 
food intake and an increase in energy expenditure. 
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2.1 Electrophysiology 
2. LI Slice preparation 
Hypothalamic slice preparations were obtained from male Wistar rats 
between five and ten weeks of age, housed on a 12/12 hour light/dark cycle. All 
slices were obtained during the light phase of this cycle. Food and water were 
provided ad libitum. 
Rats were killed according to a schedule one protocol, either with anaesthesia 
(isoflurane) followed by decapitation or without anaesthesia and cervical dislocation. 
All studies were conducted in agreement with UK Animals (Scientific Procedures) 
Act 1986. Approximately 110 rats were used for the electrophysiology and 
immunohistochemistry experiments and 150 rats for the molecular biology 
experiments. The brain was rapidly removed from the cranial cavity and placed in 
freshly prepared ice-cold, gassed (95 0/0 02,5 0/0 C02) artificial cerebrospinal fluid 
(aCSF). aCSF was of the composition shown in table 2.1 with a pH of 7.4 (adjusted 
using KOH) and an osmolarity of 310-315 mOsm kg-' (adjusted using sucrose). For 
experiments where 2 mM glucose-containing aCSF was used rather than 10 mM 
glucose-containing aCSF, glucose was replaced in equimolar quantities by D- 
mannitol to maintain osmolarity. 
The brain was trimmed to a block containing the hypothalamus and glued to 
the plate of a tissue slicer using cryanoacrylate glue. Hypothalamic coronal slices 
containing the arcuate nucleus (ARC) were cut at a thickness of 300 Pim on a 
vibratome (Intracell series 1000, Royston, UK or Leica VTl000S, Leica 
Microsystems GmbH, Wetzlar, Germany) and were constantly bathed in ice cold 
aCSF. The ARC was identified as the area immediately above the median eminence 
surrounding the third ventricle (see figure 2.1). Slices were transferred to a beaker 
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containing aCSF, and were left to equilibrate for I hour prior to recording, at room 
temperature. Slices were then transferred to a custom-made recording chamber, held 
between two grids (the top grid was held on a chloride-coated silver wire which also 
acted as the bath-earth) and were continuously perfused with oxygenated aCSF at 
room temperature at a flow rate of 4-8 ml-1. 
2.1.2 Ejectrophysiological recording and data analysis 
Whole-cell current-clamp and voltage-clamp recordings were carried out 
using patch pipettes (4-10 MQ when filled with recording solution), made from thin- 
walled borosilicate glass capillaries (GC150-TFIO, Harvard Apparatus LTD, 
Edenbridge, Kent, UK) pulled on a horizontal electrode puller (P-97, Sutter 
Instrument Co., Novato, CA, USA). The pipettes were filled with intracellular 
solution of the composition shown in table 2.2. 
Recordings were obtained with an Axopatch ID amplifier (Axon 
Instruments, Foster City, CA, USA) and were monitored online on an oscilloscope 
(Gould 1602, Gould instrument systems) and stored on digital audio tapes (DAT; 
Biological DTR-1205, Intracel, Royston, UK) or directly on a PC for later offline 
analysis. Data were filtered at 1-5 kHz (for voltage-clamp studies), digitised at 
2-100 kHz (Digidata 1322A, Axon instruments) and stored on PC running pCLAMP 
8.2 data acquisition software. Data were analysed using Clampfit 8 software (Axon 
instruments) on a personal computer. 
Resting membrane potentials of silent cells were taken from the trace 
obtained in Clampex, but in active cells for which this was impossible the low-pass 
readout of the recording amplifier was used. Membrane potential values were not 
corrected for off-sets related to the occurrence of liquid junction potentials. Input 
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resistances were calculated using Ohm's law (R=V/1), by injecting small 
hyperpolarising current pulses (4 to -40 pA, 0.2 Hz, 800-1000 ms) and measuring 
the amplitude of the evoked electrotonic potential. Membrane time-constants (T) 
were calculated by performing a bi-exponential fit to the first membrane voltage 
response to a negative current step. Care was taken to perform the fits on steps in the 
linear portion of the current-voltage relationship. 
ZI. 3 Solutions and drugs 
The ionic composition of the aCSF and intracellular solution were as follows: 
Tablc 2.1: aCSF 
NaCl 
KH2PO4 
KCI 
NaHCOý 
Glucose 
D-Mann 
CaC12 
MgC12 
10 mM 2lucose-containin 
aCSF (in mM) 
127 
1.2 
1.9 
3 26.0 
10 
itol 0 
2.4 
1.3 
Table 2.2: Intracellular solution 
mm 
K-gluconate 140 
KCI 10 
HEPES 10 
Na2ATP 2 
EGTA-Na2 I 
Alexa 633 0.1 
2 mM P-lucose-containini! 
aCSF (in mM) 
127 
1.2 
1.9 
26.0 
2.0 
8.0 
2.4 
1.3 
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Osmolarity was adjusted using sucrose and pH adjusted to 7.4 using KOH. 
Alexa 633 was only included in the intracellular solution when double- labe I ling 
experiments were performed. 
Drugs were applied to the slice using 60 ml syringes connected to the main 
aCSF flow by a series of three-way taps. Drugs were prepared as a stock solution 
using either distilled water or dimethyl sulfoxide (DMSO; Sigma) as appropriate and 
diluted to the required concentration in aCSF immediately prior to use. Final DMSO 
concentrations did not exceed 0.1% and appropriate vehicle controls were 
performed. All drugs used in this study are listed in table 2.3. 
Table 2.3 Drugs 
Drug Solvent Supplier 
5-hydroxytryptamine (5-HT) 
- 
Distilled water Sigma-Aldrich, 
St. Louis, USA 
ate salt) -VA-Y-100635 (male Distilled water Sigma-Aldrich, 
5-Carboxamidotryptamine maleate 
(5-CT) 
Distilled water Tocris Cookson Ltd., 
UX 
CP 93129 dihydrochloride Distilled water Tocris 
8-Hydroxy-DPAT hydrobromide 
(8-OH-DPAT) 
- 
Distilled water Tocris 
_IýU_24969 hemisuccinate Distilled water Tocris 
Cyanopindolol hernifurnarate 
ý 
DMSO Tocris 
--§-B--224289 hydrochloride Distilled water Tocris 
a-Methyl-5-hydroxytryptamine Distilled water Tocris 
Altanserin hydrochloride 
ý 
DMSO 
_ 
Tocris 
il(o)? 2? 221 hydrochloride DMSO Tocris 
m-Chlorophenylbiguanide 
hydrochloride (mCPBG) 
Distilled water Tocris 
MDL 72222 DMSO Tocris 
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SB269970 hydrochloride Distilled water Tocris 
SB 204741 DMSO Tocris 
R-96544 hydrochloride Distilled water Tocris 
Ghrelin Distilled water Bachern, UK 
TTX Distilled water Alomone Labs, Israel 
GABA Distilled water Tocris 
AMPA Distilled water Tocris 
Leptin HCL/NaOH Calbiochem, San 
Diego, UA 
2.1.4 Reversal potentials 
Table 2.4 gives the calculated reversal potentials for ions as determined from 
the Nernst equation: Ei,,, = RT In Lioril, 
zF [ion]i 
(where Don = equilibrium potential for pen-neant ion; R= gas constant (8.315 J K- I 
mol-1); T= absolute temperature (273.16 +T [25 OQ; F= faraday's constant 
(96,485 C mol-1); Z= valency of ion; [lonjo = extracellular ionic concentration; 
Ilonli = intracellular ionic concentration) 
Table 2.4 Reversal potentials 
Ion Extracellular Intracellular Reversal potential 
Concentration Concentration (MV) 
(MM) (MM) 
Na + 153 6 81.6 
K+ 3.1 150 -97.7 
Ca 2.4 0.001 196 
Cl- 136.3 10 -65.8 
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2.2 Immunohistochemistry 
2.2.1 Immunofluorescence staining of 5-HT receptors 
150 [trn thick hypothalamic slices were prepared using methods similar to 
those described in section 2.1.1. The tissue was fixed overnight in 4% 
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The slices were washed in 
Tris-buffered saline containing 1% Triton X-100 (TBS-T; all washes were 3x 10 
mins). The slices were incubated with either 3% normal goat serum (NGS; Stratech 
Scientific Ltd. Suffolk, UK) for the 5-HTIA/IB receptors or 5% NGS for the 5-HT7 
receptor, in TBS-T for I hour under agitation on an orbital shaker. The sections were 
incubated overnight at 4'C under agitation in primary antibody (see table 2.5), in 
TBS-T containing I% NGS. Dilution rates for primary and secondary antibodies 
were chosen based on previous literature which had utilised these antibodies. After 
rinsing with TBS-T, slices were incubated for 1-2 hours with secondary antibody 
(see table 2.6). The secondary antibodies were conjugated to a fluorophore, either 
Cy2 (absorption peak 492 run, emission peak 510 rim) or Cy5 (absorption peak 
650 nm, emission peak 670 nm). Finally slices were washed in TBS-T before being 
mounted on microscope slides and covered with ProlongS Antifade (Invitrogen, 
UK) to prevent fading of immunofluorescence. The sections were examined using a 
confocal laser microscope (Leica SP2 linked to a Leica DM RE7 upright 
microscope), using the laser with a wavelength of 488 nrn for Cy2 and 633 run for 
Cy5. Appropriate controls to test for specificity of each fluorophore were performed 
by turning off each laser accordingly. All incubations were also conducted in the 
absence of primary and secondary antibody to act as negative controls for each 
experiment. 
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2. Z2 Double-immunofluoreseence staining for 5-HT receptors and cocaine and 
amphetamine-regulated transcript (CART) 
The protocol was followed as above for 5-HT receptor staining and then the 
protocol for CART staining was undertaken. After rinsing in TBS-T, the slices were 
blocked with 4% NGS in TBS-T for I hour under agitation. Sections were incubated 
overnight under agitation at 4*C in rabbit anti-CART (1: 1000) in TBS-T containing 
2% NGS. Slices were rinsed in TBS-T and incubated for I hour at room temperature 
under agitation in Cy2-conjugated goat anti-rabbit secondary antibody (1: 200). 
Slices were washed in TBS-T before being mounted and covered with Prolongg 
Antifade. The sections were examined using a confocal microscope. All incubations 
were also conducted in the absence of primary and secondary antibody to act as 
negative controls for each experiment. 
Table 2.5: Primary antibodies 
Antigen Antibody Species Dilution Source/Product 
Code 
5-HTIA Anti-serotonin Guinea Pig 1: 1000 Chemicon, 
receptor IA USA, AB15350 
5-HTIB Anti-serotonin Guinea Pig 1: 1000 Chemicon, 
receptor IB USA, AB5410 
5-HT7 Anti-serotonin Rabbit 1: 100 Calbiochem, 
receptor 7 San Diego, 
USA, PC249L 
CART Anti-CART Rabbit 1: 1000 Phoenix 
Pharmaceuticals, 
Germany, 
H-003-62 
-1 
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Table 2.6: Secondary antibodies 
Antigen Antibody Species Dilution Source/Product 
Code 
5-HTIA Cy5 Goat Goat 1: 50 Stratech 
Anti-guinea 106-175-003 
-3--HTIB Cy5 Goat Goat 1: 50 Stratech 
Anti-guinea 106-175-003 
Rig IgG 
5-HT7 Cy5 Goat Goat 1: 200 Stratech 
Anti- rabbit 111-175-003 
_ýýART Cy2 Goat Goat 1: 200 Stratech 
Anti- rabbit I 1 1 111-225-003 
2.2.31mmanofluorescencestainingfor CART and Alewa 633 
Recordings were obtained utilizing an intracellular solution containing the 
fluorescent dye Alexa 633 hydrazide (100 ýtM; Invitrogen, UK). Post-recording, 
slices were fixed overnight in a 0.1 M phosphate buffer containing 4 
paraformaldehyde (pH 7.4). Subsequently, slices (300 pm thickness) were processed 
for CART as described in section 2.2.2. 
2.3 Molecular Biology 
2.3.1 Tissue preparation 
Hypothalamic explants were prepared from age-matched (6 weeks old) male 
rats. For some experiments, animals were fasted for 24 hours prior to culling. The 
brain was removed as described in section 2.1.1 and an explant containing the whole 
hypothalamus was prepared. The approximate markers used to cut the explant are 
shown in figure 2.2 (figure adapted from Paxinos & Watson, 1998). 
The explant was immediately incubated in 2 mM glucose-containing aCSF at 
35'C for 60 mins. After this time, the explants were removed and placed into small 
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vials containing 2 mM glucose-containing aCSF at 35T. For each experiment, four 
control animals were used and these four explants were incubated in aCSF for the 
same time as the challenge time for that experiment. Four explants were used as the 
test tissues for each experiment and incubated in aCSF containing either leptin 
(100 nM; Calbiochern), gamma-aminobutyric acid (GABA; I pM or I mM; Tocris), 
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA; I ýtm or 
50 ýM; Tocris), or a specific concentration of glucose (either 0.2 mM or 5 mM). The 
challenge time varied depending on the experiment, in order to monitor gene 
expression over a detailed time scale. Control studies to determine the viability of 
tissue were not performed. At the end of the incubation time, the explant was 
removed and placed into an eppendorf and immediately snap-frozen on dry ice. The 
samples were stored in a -80'C freezer prior to molecular analysis. 
2.3.2 RNA extraction 
Total RNA was extracted from the hypothalamic explants using the RNeasy 
Lipid Tissue Mini Kit (Qiagen, Crawley, UK). Briefly, tissue samples were 
homogenized in QlAzol lysis reagent using a pellet pestle (Sigma-Aldrich, St. Louis, 
USA) and then upon addition of chloroform, centrifugation (12,000 xg for 15 min at 
4'C) was undertaken to separate the homogenate into aqueous and organic phases. 
RNA remained in the aqueous phase and was extracted and separated from any 
protein and DNA. Ethanol was added to the aqueous phase and the sample was then 
placed through an RNeasy Mini Spin Column, allowing the RNA to bind to the 
membrane whilst all contaminants were washed away. RNase-free water was used to 
elute the RNA. I pl of RNase inhibitor (Promega, Madison, WI, USA) was added to 
each sample. 
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The amount of RNA from each explant was estimated using a Nanodrop ND- 
1000 Spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA). The 
RNA was diluted to a final concentration of 150 ng/pl using RNase free water. 
2.3.3 Reverse transcription of mRNA 
II gl of RNA was added to a sterile eppendorf containing I ýtl of oligo (dt)20 
(Invitrogen, Paisley, UK) and I ýil of 10 mM deoxynucleoside triphosphates (dNTP) 
mix (Invitrogen). A negative control containing only 13 ýtl of water was also 
prepared. Samples were mixed and heated at 65'C for 5 mins. After cooling on ice 
for at least I min, 4 ýtl of 5x First-Strand Synthesis Buffer, I ýLl of O-IM DTT (as 
supplied with SuperscripJM III Reverse Transcriptase, Invitrogen), I [tl of RNase 
inhibitor and I ýtl of Superscript III RT were added to each eppendorf. The samples 
were vortexed and centrifuged and then heated to 50'C for 60 mins. Reactions were 
stopped by heat inactivating enzyme at 70'C for 15 mins. Each cDNA sample was 
stored at -20'C until required for real-time PCR. 
2.3.4 Quantitative real-time PCR 
A master mix was prepared containing, per reaction: 12.5 ýtl Taqman 2x PCR 
mastermix (Applied Biosystems), 1.25 [d of primer of target gene (see table 2.7; 
Applied Biosystems), 1.25 pI of primer for endogenous control (Human 18s rRNA, 
Applied Biosystems), 9 pl of water and I pl of cDNA (total volume 25 PI). Samples 
were loaded onto a 96-well plate, in triplicate, along with a negative control where 
cDNA was replaced with water. The plate was sealed with optical adhesive film and 
subjected to real-time PCR. All reactions were multiplexed with the house-keeping 
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gene 18s rRNA as this enabled data to be expressed in relation to an internal 
reference to allow for differences in reverse transcription efficiency. 
Real-time quantitative PCRs were carried out with an ABI Prism 7000 
Sequence Detection System. The following PCR conditions were used: one cycle at 
500C for 2 mins and one cycle at 950C for 10 mins. The amplification was followed 
by 40 cycles of denaturation at 95'C for 15 s and annealing at 60'C for I min. 
Table 2.7: PCR primers 
PRIMER ACCESSION No. ASSAY No. 
NPY M15880.1 RnOO561681-ml 
POW AF510391.1 Rn00595020-ml 
C-fos X06769.1 Rn02396759ml 
AGRP AF206017.1 RnO1431703gl 
2.3.5 Interpretation of real-time PCR data 
Data was obtained as Ct values (the cycle number at which the logarithmic 
PCR plot crosses a calculated threshold line) according to the manufacturers 
guidelines, and was used to detennine ACt values (ACt = Ct of target gene - Ct of 
endogenous control gene (I 8s)). The ACt triplicate values were averaged and any 
outliers (more than one cycle difference) were discarded. The ACt results from the 
four control animals were averaged to get a single control ACt value for each 
experiment. This ACt control value was then subtracted from the four test tissue ACt 
values to give four AACt values for each experiment (n=4). The AACt values were 
used to calculate the relative levels of expression between control and challenged 
animals using the formula: 
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Relative expression = 2-6"ý'c' 
This formula gives the control group an arbitrary value of 1 (2-()) and the challenged 
groups a value relative to this arbitrary value. All statistics were performed at the 
ACt stage to avoid potential bias due to averaging data that had been transformed 
through the equation 2-'ýýct. 
2.4 Statistical Analysis 
Statistical analysis was perfonned using Excel (Microsoft) and Instat 
(Graphpad Software Inc., San Diego, USA) with all values given as mean ± SEM. 
Statistical significance was detennined using either student's two tailed t-test, paired 
or unpaired as appropriate, Mann-Whitney test, chi-square test or Kruskal-Wallis test 
(non-parametric ANOVA). 
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Figure 2.1 Diagram showing the location of the ARC within the hypothalamus 
A: Diagram showing the location of the ARC within the hypothalamus, indicating 
the area from which electrophysiological recordings were made. The ARC is 
identified as the area between the dotted lines on the diagram. It is situated at the 
base of the hypothalamus, surrounding the third ventricle (W) and is situated 
immediately above the median eminence (ME). 
-58- 
Figure 2.1 
A 
Recording electrode 
ARC 
3 \' 
NI 1'. 
\R(' 
""" 
. 
"". 
* 
Chapter Two 
Figure 2.2 Diagram of a rat brain showing the markers used to produce the 
hypothalamic explant for RT-PCR 
A: Diagram of a coronal section from a rat brain, as taken from the Rat Brain Atlas, 
Fourth Edition, George Paxinos & Charles Watson, Academic Press 1997. The 
dotted lines indicate the approximate points at which incisions were made to the 
coronal section in order to obtain an explant containing the hypothalamus. Briefly, 
the brain was trimmed until the medial posterior arcuate nucleus of the hypothalamus 
was visible. Three incisions were then made: an incision was made 2 mm. either side 
of the midline where the central tuberomammillary nucleus meets the cerebral 
peduncle; the final incision was made 4 mm dorsal from the ventral surface of the 
hypothalamus just below the precommissural nucleus. The cutting blade was then 
moved 3 mm rostrally to the level of the optic chiasm and a4 mrn x4 min x3 mrn 
hypothalamic explant was removed. The inset picture in the top left, which has been 
expanded below, shows a rostro-caudal diagram of the rat brain; the lines show the 
3 mm depth of the hypothalamic explant. 
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3.1 Introduction 
Homeostatic mechanisms are dedicated to maintaining the levels of glucose 
in the blood within tight limits. Aspects of glucose homeostasis are under the control 
of the brain, specifically the hypothalamus and the brainstern and also the peripheral 
organs, liver and pancreas. The liver plays a major role in glucose homeostasis by 
regulating the uptake and storage of glucose via glycogenesis and the release of 
glucose from glucose stores by glycogenolysis, or production of new glucose by 
gluconeogenesis (Nordlie et al., 1999). The liver is therefore able to produce glucose 
in times of starvation to ensure that all cells have an adequate supply of glucose for 
their energy needs. The liver is under the control of hormonal signals including 
insulin and glucagon which regulate the levels of glucose within the blood. If 
glucose levels fall outside the tight limits imposed to maintain glucose homeostasis, 
certain conditions may result, for example, diabetes or hypoglycaemia. Diabetes 
arises either because of impaired insulin production due to O-cell failure (type I 
diabetes), or insulin resistance (type 2 diabetes). In both type I and type 2 diabetes, 
the failure of insulin to increase glucose uptake into cells or decrease glucose 
production leads to elevated blood glucose. If left uncontrolled, blood glucose can 
rise to dangerously high levels and therefore it is imperative that diabetes is treated 
quickly. The normal level of glucose in the blood (euglycaemia) is considered to be 
around 4-7 mM, with high blood glucose (hyperglycaemia) considered above about 
8 mM. Physiological brain glucose levels still remain unclear but studies indicate 
that at a plasma glucose level of 5-8 mM, brain glucose levels range between I and 
2.5 mM (Silver & Erecinska, 1994) and the basal level in the hypothalamus has been 
suggested to be around 1.4 mM (de Vries et al., 2003; Mayer et al., 2006). Brain 
glucose levels rarely reach the same level as that in the plasma, only approximately 
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10-30% of plasma levels (Silver & Erecinska, 1994; de Vries et al., 2003). 
However, regions with a compromised blood-brain-barrier (BBB), such as the 
arcuate nucleus (ARC), are suggested to have a glucose concentration close to that 
found in the plasma, and so ARC neurones are potentially exposed to much higher 
levels of extracellular glucose, although this has never been directly demonstrated 
(Routh, 2002; Wang et al., 2004). It seems likely that the level of glucose within the 
ARC will match more closely that of the brain rather than the plasma, as the 
contribution of the BBB is unknown. However it is possible that the physiological 
concentration of glucose within the ARC may lie somewhere between that of the 
plasma and that of the brain if the BBB does indeed expose the ARC to plasma 
glucose. Further experiments determining the levels of glucose within the ARC are 
therefore required. 
The brain controls and is critically dependent on glucose levels and it has 
therefore developed mechanisms to monitor and respond to changes in glucose 
levels. Over 50 years ago, Mayer proposed the glucostat hypothesis, where 
hypothalamic 'glucoreceptors' sensed changes in available glucose as a means of 
regulating food intake (Mayer, 1953,1955). Anand and Oomura both later 
demonstrated that there were glucose-sensing neurones in the rat brain which are 
specialised neurones that change their electrical activity in response to changes in 
extracellular glucose concentration (Anand et al., 1964; Oomura et al., 1964). They 
identified neurones in the ventromedial nucleus (VMN) and the lateral hypothalamus 
(LH) that altered their activity when glucose levels changed. Originally termed 
glucose-responsive and glucose-sensitive neurones, these neurones have 
subsequently been re-named glucose-excited and glucose-inhibited neurones, 
respectively (Levin et al., 1999). These neurones are either inhibited (glucose- 
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inhibited: GI) or excited (glucose-excited: GE) in response to increases in glucose 
levels (for review see Levin et al., 2004 and Burdakov el al., 2005). 
The mechanism by which GI neurones sense glucose is not well characterised 
(see general introduction). The mechanism by which GE neurones sense glucose and 
alter their activity is thought to occur in an analogous way to the glucose-stimulated 
insulin release in pancreatic P-cells (Schuit et al., 2001 and general introduction). 
The GLUT2 transporter, glucokinase and the ATP-sensitive potassium channel 
(KATp) all play an important role in this glucose-sensing mechanism (SPanswick et 
al., 1997; Dunn-Meynell et al., 2002; Kang et al., 2004; Wang el al., 2004; Bady et 
al., 2006; Kang et al., 2006; Yang et al., 2007). In particular, the KATP channel has 
been shown to play a key role in the regulation of the electrical activity of glucose- 
sensing neurones in the hypothalamus. Studies using selective KATP channel 
blockers, such as tolbutamide and glibenclamide, as well as knock-out studies, have 
shown that the KATP channel in neurones is essential for glucose homeostasis and the 
cellular response to changes in glucose (Ashford et al., 1990a, b; Rowe el al., 1996; 
Spanswick et al., 1997; Lee et al., 1999; Spanswick et al., 2000; Miki et al., 2001; 
Zhang et al., 2004). In addition, hypothalamic KATP channels have been shown to be 
important in hepatic glucose production: activation of these channels leading to 
lower blood glucose levels by inhibiting hepatic gluconeogenesis (Pocai el al., 
2005), whereas inhibition of these channels impairs the ability of insulin and fatty 
acids to inhibit glucose production (Obici et al., 2002b, c). These data suggest that 
KATP channels, as well as being important in glucose-sensing, are essential 
components in the regulation of glucose production. The KATP channel is therefore 
an important integrator between glucose levels and the excitability of neurones, due 
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to its ability to couple membrane excitability to cellular metabolism by directly 
sensing and integrating changes in the concentration of nucleotides. 
Glucose-sensing neurones can respond to a wide range of metabolic and 
hormonal signals making them ideal metabolic sensors to link the control of food 
intake and energy homeostasis. Within the ARC, orexigenic neuropeptide Y (NPY) 
neurones were found to be GI neurones (Muroya et al., 1999) and anorexigenic pre- 
pro-opiomelanocortin (POMC) neurones were found to be GE neurones (Ibrahim et 
al., 2003). Both NPY and POMC neurones have been shown to express KATP 
channels (van den Top et al., 2007). GE neurones also respond to peripheral 
hormones such as insulin and leptin (Spanswick et al., 1997,2000). How the KATP 
channel is proposed to respond selectively to stimuli within the functionally 
antagonistic NPY and POMC neuronal populations remains to be fully elucidated. 
One suggestion is that different compositions of the KATP channel may induce 
selective effects, but the subunit composition of ARC KATP channels is reported to be 
the same, ruling out this possibility (van den Top et aL, 2007). Therefore it is 
proposed that the selective response must occur before KATP channel activation. 
It is important to study neurones in different glucose conditions to see how 
their properties change in different feeding states, especially as extremes of glucose 
concentrations can lead to conditions such as diabetes. Understanding further the 
properties of these neurones will help to lead to better understanding of these 
conditions. Original studies looking at the activity of neurones under different 
glucose concentrations utilised extracellular glucose concentrations ranging between 
o and 20 mM (for example see Ashford et al., 1990a). However these concentrations 
represent non-physiological levels, as the brain would never be bathed in a glucose- 
free medium and even in extreme hyperglycaernia would never be exposed to 
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20 mM. Therefore these early glucose-studies do not give any insight into the 
activity of ARC neurones in physiological glucose levels. Subsequent studies have 
attempted to address this problem by utilising more likely physiological glucose 
concentrations (Song et al., 2001; Wang et al., 2004). Therefore in the present study 
ARC neurones were recorded in either 10 mM glucose-containing aCSF 
(hyperglycaemic conditions), in order to compare the activity of neurones with 
classic glucose studies which utilised non-physiological glucose (Ashford et al., 
1990a; Spanswick et al., 1997,2000), or 2 mM glucose-containing aCSF 
(euglycaemic conditions), similar to more recent studies representing physiological 
glucose (Song et al., 2001; Wang et al., 2004). Studies outside the ARC, within the 
brainstern, have also looked at the effects of changing the glucose concentration 
from 10 mM to 2 mM and 0 mM glucose on activity of neurones (Balfour el al., 
2006). The present study will enable us to see whether there were any significant 
changes in the electrical properties of ARC neurones under these different glucose 
concentrations. 
The hypothalamic ARC surrounds the ventral part of the third ventricle and 
lies above the median eminence. It is one of several hypothalamic nuclei involved in 
maintaining energy homeostasis, along with the LH, VMN, paraventricular nucleus 
(pVN) and clorsomedial hypothalamus (DMH; Williams et al., 2000; Cone el al., 
2001; Williams et al., 2001). As it is located immediately above the median 
eminence, considered a circumventricular organ with a highly compromised BBB 
(Ganong, 2000), the ARC is in a strategically ideal location to receive and integrate 
hormonal and nutrient signals related to energy homeostasis and generate appropriate 
responses. In order to maintain energy homeostasis, the ARC receives afferent inputs 
from the other hypothalamic nuclei mentioned previously as well as the brainstern 
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and periphery. Some of the neuropeptides and neurotransmitters contained in these 
inputs include orexin, serotonin, GABA, glutamate and noradrenaline to name but a 
few (Chronwall, 1985; Cone et al., 2001; Horvath et al., 2004). The ARC is also 
exposed to circulating factors like insulin, leptin, ghrelin and glucose, which are all 
important in the control of energy homeostasis as they signal the peripheral energy 
status to the central nervous system (Elias et al., 1998b; Schwartz et al., 1999; Cone 
et al., 2001; Broberger, 2005; Elmquist et al., 2005). 
The multiple input pathways and signalling factors that affect the ARC 
suggests that there is a heterogeneous population of neurones within the ARC. This 
heterogeneity leads to functional divisions within the ARC with different neurones 
performing different functions. Several neurones have already been characterised by 
the neuropeptides they release; for example, neurones which release the orexigenic 
peptides NPY and agouti-related peptide (AgRP) are distinct from those that release 
the anorexigenic peptides cocaine and amphetamine-related transcript (CART) and 
cc-melanocyte stimulating hormone (a-MSH; Chronwall, 1985; Broberger, 2005). It 
is therefore important to be able to understand and characterise the cell types within 
the ARC in order that we can learn more about how it is involved in controlling 
body-weight. However at present there is still no detailed characterisation of 
neurones within the ARC. Characterising neurones into groups based on either 
intrinsic or extrinsic properties may provide one way in which neurones can be 
functionally classified. In this study a characterisation of neurones in the ARC was 
carried out based on their electrophysiological properties. This characterisation of 
neurones builds on previous work done by van den Top (2002). In particular, 
neurones were classified according to the subthreshold active conductances they 
expressed. Active conductances are important for shaping the intrinsic properties of 
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neurones as they contribute to the integration of synaptic inputs and formulate 
appropriate outputs for neurones (Huguenard, 1996; Pape, 1996; van den Top et al., 
2004). They therefore play an important role in determining the functional output of 
neurones and represent ideal properties on which to classify neurones into functional 
groups. 
The aims of this study were to compare the activity and electrophysiological 
properties of ARC neurones recorded in 2 mM and 10 mM glucose-containing aCSF 
and to characterise neurones into potential functional groups based upon their 
electrophysiological properties. 
3.2 Results 
Whole-cell recordings were obtained from 411 ARC neurones. ARC 
neurones were identified purely on the basis of their location above the median 
eminence, on either side of the third ventricle. Recordings were obtained in aCSF 
containing either 2 mM glucose to determine the activity of neurones in a 
physiological, euglycaemic glucose concentration, or 10 mM glucose to determine 
the activity of neurones in a non-physiological hyperglycaernic glucose 
concentration, which will also enable the activity of neurones to be compared to 
previous studies that did not use physiological glucose levels. 241 neurones were 
recorded in 10 mM glucose-containing aCSF and the remaining 170 in 2 mM 
glucose-containing aCSF in which osmolarity was compensated using D-mannitol. A 
comparison between the general membrane properties of neurones recorded in 2 mM 
glucose-containing aCSF and 10 mM glucose-containing aCSF was firstly carried 
out. A more detailed comparison of the electrical properties of these neurones was 
then performed and neurones were divided into 8 distinct groups (clusters) based 
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upon the subthreshold active conductances they expressed. Subthreshold active 
conductances were looked at in this study, as the intrinsic properties of neurones are 
important for shaping the activity and output of neurones. Active conductances are 
therefore ideal properties upon which we can potentially classify neurones into 
functional groups. 
To investigate the active membrane conductances of the neurones, current- 
voltage (I-V) relationships were generated. Hyperpolarising and depolarising current 
steps of constant increment (-200 to + 40 pA, 800 ms, 0.1 Hz) were injected into the 
cell and the membrane responses recorded. Subthreshold active conductances were 
identified by inspection of the IN and it was found that some neurones expressed 
one or more subthreshold active conductances, while others did not express any. In 
the absence of any subthreshold active conductances, there was a linear relationship 
between the amount of current in ected and the voltage response, indicating a 
directly proportional relationship between current and voltage. However, the 
current-voltage relationship in some neurones was non-linear, indicating the 
expression of one or more active conductances. Statistical significance was 
determined using a Mann-Whitney test, except when comparing percentage of 
spontaneously active neurones when a chi-square test was used. 
3.2.1 Comparison of afl neurones recorded in 10 mM and 2 mM glucose- 
containing aCSF 
The resting membrane potential, input resistance, membrane time-constant 
and spontaneous firing rates of all neurones recorded in 10 MM and 2 MM glucose- 
containing aCSF were calculated, to give an overall comparison between the two 
different glucose concentrations. Table 3.1 gives an overview of this data. 
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Resting Memhrane Potential 
In 10 mM glucose-containing aCSF, the average resting membrane potential 
was -47.6 ± 0.5 mV (n=241), whilst it was -46.7 ± 0.5 mV in 2 mM glucose- 
containing aCSF (n=170). These values were not significantly different (P=0.3). The 
resting membrane potentials of neurones recorded in both 10 mM and 2 mM 
glucose-containing aCSF are shown in figure 3.1. In 10 mM glucose-containing 
aCSF, the range containing the highest proportion of neurones was -40 to -44 mV 
(27 %), although in 2 mM glucose-containing aCSF it was -45 to -49 mV (32 
The median values were -47 and -46 mV in 10 mM and 2 mM glucose-containing 
aCSF, respectively. 
Input Resistance 
In 10 mM glucose-containing aCSF, the average input resistance was 
1602 ± 53 MQ (n=241) whilst the corresponding value in 2 mM glucose-containing 
aCSF was 1387 ± 53 MQ (n=170). The input resistance was significantly lower in 
2 mM glucose-containing aCSF (P<0.0 1). 100 1- 1500 Mn was the range containing 
the largest proportion of neurones in 10 mM glucose-containing aCSF (31 %), and in 
2 mM glucose-containing aCSF it was 501-1000 MO (34 %; see figure 3.2). The 
median values were 1373 and 1255 MK2 in 10 mM and 2 mM glucose-containing 
aCSF, respectively. The distribution of input resistances in the 2 mM glucose- 
containing aCSF plot was skewed to the left compared to the 10 mM glucose- 
containing aCSF plot, indicating that neurones recorded in the lower glucose 
concentration generally expressed lower input resistances. 
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Membrane Time-Constant 
The average membrane time-constant of neurones recorded in 10 mM and 
2 mM glucose-containing aCSF was 39.3 ± 2.0 ms (n=241) and 36.6 ± 1.7 ms 
(n=170), respectively, a non-significant difference (P=0.9). 11-20 ms was the most 
common membrane time-constant range (20 %) in 10 MM glucose-containing aCSF 
and 21-30 ms (23 %) in 2 mM glucose-containing aCSF (see figure 3.3). The median 
value was 31 ms in both cases. There was a very similar distribution pattern in both 
10 mM and 2 mM glucose-containing aCSF indicating that we were recording from 
a population of neurones of similar size in both conditions. 
Spontaneous Firing Rate 
234 neurones were recorded in 10 mM glucose-containing aCSF of which 75 
(32 %) were spontaneously active at rest and 159 (68 %) were silent (data could not 
be obtained ftom 7 neurones as no recording of the trace was made). The average 
firing frequency of the spontaneously active cells was 1.1 ± 0.1 Hz. 158 neurones 
were recorded in 2 mM glucose-containing aCSF, 79 (50 %) of which were 
spontaneously active and 79 (50 %) were silent (data could not be obtained from 12 
neurones as no recording of the trace was made). The average firing frequency of 
these cells was 1.0 ± 0.1 Hz. There was no significant difference between the 
average firing frequencies of the two populations (P=0.9). 0-0.5 Hz was the range 
with the highest percentage of active neurones in both 2 mM and 10 mM glucose- 
containing aCSF (see figure 3.4Ai). The median values were 0 and 0.03 Hz in 
10 mM and 2 mM glucose-containing aCSF, respectively. There was a significant 
increase in the percentage of active neurones recorded in 2 mM glucose-containing 
aCSF (50 %) compared to neurones recorded in 10 mM glucose-containing aCSF 
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(32 %) and hence an increase in the proportion of spontaneously active cells 
recorded in 2 mM glucose-containing aCSF (P<0.01; see figure 3.4Aii). 
Table 3.1 General membrane properties of all neurones 
10 mM Glucose 2 mM Glucose P values 
In' value 241 170 
Resting membrane potential 
(MV) 
-47.6 ± 0.5 -46.7 ± 0.5 0.3 
Input resistance (Mfl) 1602 ± 53 1387 ± 53 P<O. 01 
Membrane time-constant 
(ms) 
39.3 ± 2.0 36.6 ± 1.7 0.9 
Spontaneous activity 32 50 P<O. 01 
Spontaneous firing rate of 
active neurones (Hz) 
1.1 ± 0.1 1.0 ± 0.1 0.9 
These data show that the resting membrane potential and membrane time- 
constant did not significantly change in the two different glucose concentrations. 
However there was a significant increase in input resistance in 10 mM glucose- 
containing aCSF and there was a significant increase in the number of spontaneously 
active neurones in 2 mM glucose-containing aCSF. The expression of subthreshold 
active conductances was also investigated to see whether expression was altered 
between euglycaernic and hyperglycaernic conditions. Neurones were grouped into 
subdivisions based on their differential expression of subthreshold active 
conductances in an attempt to characterise the neurones into potential functional 
subgroups. These groups are termed clusters. Properties of action potentials and 
active conductances were calculated as shown in figure 3.5. 
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3.2.2 Expression of anomalous inward rectification (Cluster 1) 
The first group of neurones was identified as having a decrease in input 
resistance at more negative membrane potentials, indicated by a decrease in the slope 
in the plot of the IN (see figure 3.6A and Q. This decrease was instantaneous and 
non-inactivating. This conductance is similar to that described previously in other 
neurones as an anomalous inward rectifier (I.; for example see Constanti & Galvan, 
1983; Pickering et al., 1991). Table 3.2 gives an overview of this data. 
10 mMglucose-containing aCSF 
15 neurones were recorded in 10 mM glucose-containing aCSF that 
expressed only the anomalous inward rectifier (6 % of the population). Spontaneous 
activity was recorded in 4 of these neurones (27 %), with an average firing frequency 
of 1.6 0.4 Hz. These neurones had an average resting membrane potential of 
-50.1 2.0 MV 
(range -40 to -64 mV) and an average input resistance of 
1827 274 Mn (range 745 to 4664 MQ; n= 15). The membrane time-constant was 
48.1 ± 8.3 ms (range 13.2 to 139.2 ms). The threshold for spike firing was 
-30.7 =L 1.1 mV 
(n=15), at which point action potentials were generated with an 
amplitude of 91.4 ± 3.6 mV (range 70 to III mV) and a duration at half-height and 
threshold of 1.5 ± 0.1 ms and 3.0 ± 0.2 ms, respectively. The ratio of the duration 
(threshold/half-height) was 2.0 :E0.1. 
induced a 35 % reduction in input resistance at a membrane potential of 
-102.6 ± 0.7 mV relative to 
input resistance at rest. The activation threshold 
calculated from the IN for lan was estimated around -84.2 ± 1.7 mV (n= 15). 
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2 mMglucose-containing aCSF 
16 neurones were recorded in 2 mM glucose-containing aCSF that expressed 
only the anomalous inward rectifier (9 % of the population). Spontaneous activity 
was recorded in 4 out of these 16 neurones (25 %), with an average firing frequency 
of 1.4 ± 0.4 Hz. These neurones had an average resting membrane potential of 
-50.5 ± 2.0 mV (range -35 to -62 mV) and an average input resistance of 
1521 ± 108 M92 (range 754 to 2350 MD; n=16). The membrane time-constant was 
41.0 ± 5.6 ms (range 13.1 to 86.6 ins). The threshold for spike firing was 
-30.1 ± 1.3 mV (n=16), at which point action potentials were generated with an 
amplitude of 78.1 ± 5.8 mV and a duration at half-height and threshold of 
1.7 ± 0.1 ms and 3.6 ± 0.3 ms, respectively. The ratio of the duration (threshold/half- 
height) was 2.2 ± 0.1. 
induced a 44 % reduction in input resistance at a membrane potential of 
-102.2 ± 0.9 mV relative to input resistance at rest. The activation threshold 
calculated from the IN for Ia,, was estimated around -86.9 ±1 .0 mV (n= 16). 
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Table 3.2 Electrophysiological properties of cluster 1 neurones 
Cluster 1 Properties 
10 mM Glucose 2 mM Glucose P values 
In' value 15 16 
Spontaneous activity (%) 27 25 0.9 
Spontaneous firing rate (Hz) 1.6 0.4 1.4 ± 0.4 0.8 
Membrane potential (mV) -50.1 2.0 -50.5 2.0 0.9 
Input resistance (M11) 1827 274 1521 108 0.7 
Membrane time-constant (ms) 48.1 8.3 41.0 5.6 0.6 
Thr. -shold for action potential 
(AP) firing (mV) 
-30.7 1.1 -30.1 1.3 0.8 
AP amplitude (mV) 91.4 3.6 78.1 5.8 0.1 
AP duration half-height (ms) 1.5 ± 0.1 1.7 0.1 0.2 
AP duration threshold (ms) 3.0 ± 0.2 3.6 0.3 0.06 
Ratio of AP duration: 
threshold/ half-height 
2.0 ± 0.1 2.2 0.1 0.2 
Activation threshold I.., (mV) -84.2 1.7 -86.9 1.0 0.2 
1,,, induced reduction in input 
resistance (%) 
35.5 4.1 43.8 3.4 0.09 
There were no significant differences between any of the membrane 
properties of cluster I neurones recorded in the presence of 10 mM and 2 mM 
glucose-containing aCSF. 
3. Z3 Expression of transient outward rectylication with Im (Cluster 2) 
The second cluster of neurones identified contained two subthreshold active 
conductances: lang like cluster I neurones and a second conductance, IA. This second 
conductance resembled the A-like transient outward rectifier noted in other neurones 
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(for example see Connor & Stevens, 1971a, b; Miyazaki ef al., 1996; see figure 
3.6B). This conductance is characterised by a delayed return to resting membrane 
potential upon termination of injection of negative current. The amplitude of the 
membrane response was calculated at half-decay time and the average inactivation 
time of this active conductance was measured from the termination of the negative 
current injection until the return of the membrane potential to baseline. This cluster 
of neurones is like the ARC neurones described by van den Top et al., (2004). A 
characteristic of these neurones is their ability to exhibit burst-like firing patterns of 
activity. Table 3.3 gives an overview of this data. 
10 mMglucose-containing aCSF 
Whole-cell recordings were obtained from 8 neurones in 10 mM glucose- 
containing aCSF (3 % of the population). 4/8 of these neurones were active at rest 
(50 %), with an average firing frequency of 2.2 ± 0.7 Hz, one of which exhibited 
spontaneous burst-like patterns of firing. The average resting membrane potential 
and input resistance were -49.0 ± 2.1 mV (range -40 to -56 mV) and 
1782 : 1: 458 M (range 714 to 4682 MQ ) respectively, with a time-constant of 
33.5 4.9 ms (range 17.4 to 54.2 ms; n=8). Threshold for action potential firing was 
-30.5 1.9 mV, leading to action potentials of amplitude 85.6 ± 5.7 MV. Duration of 
the action potential at half-height and threshold was 1.7 ± 0.2 ms and 3.4 ± 0.5 ms, 
respectively, giving a ratio of 2.0 ± 0.1. 
1,,, induced a 39 % reduction in input resistance at a membrane potential of 
-98.1 : ±: 2.1 mV relative to input resistance at rest. The activation threshold calculated 
from the IN for 1. was estimated at -82.3 ± 2.7 mV (n=8). 
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The expression of the A-like conductance caused a slow return to baseline 
after termination of hyperpolarising current pulses. The mean decay-time of the 
conductance in these neurones was 1111 ± 212 ms (range 507 to 2353 ms) and the 
amplitude of the response at half-decay time was 5.1 ± 0.9 mV (range 1.4 to 8.5 mV; 
n=8) following negative current injection to an average membrane potential of 
-95.4 ± 3.0 mV. 
2 mMglucose-containing aCSF 
8 neurones were recorded in 2 mM glucose-containing aCSF that were 
classified as cluster 2 neurones (5 % of the population). 5/8 of these neurones were 
spontaneously active (63 %) with an average firing frequency of 0.2 ± 0.0 Flz and 3 
of these neurones exhibited a burst-like firing pattern of activity. The average resting 
membrane potential and input resistance were -45.9 ± 2.3 mV (range -34 to -58 mV) 
and 1243 ± 206 MO (range 548 to 2068 MK2) respectively, with a time-constant of 
31.2 ± 6.4 ms (range 13.2 to 64.7 ms; n=8). Threshold for action potential firing was 
-31.6 ± 2.4 mV, 
leading to action potentials of amplitude 81.8 ± 6.8 mV. Duration of 
the action potential at half-height and threshold was 1.7 ± 0.2 ms and 3.5 ± 0.4 ms, 
respectively, giving a ratio of 2.0 ± 0.9. 
induced a 35 % reduction in input resistance at a membrane potential of 
-99.6 ± 0.3 mV relative to 
input resistance at rest. The activation threshold calculated 
from the IN for 1. was estimated at -80.4 ± 2.9 mV (n=8). 
The mean decay time of the A-like conductance was 838 ± 174 ms (range 
201 to 1648 ms) and the amplitude of the response at half-decay-time was 
4.7 ± 0.6 mV (range 2.6 to 7.7 mV; n=8) following negative current injection to an 
average membrane potential of -98.9 ± 0.5 mV. 
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Table 3.3 Electrophysiological properties of cluster 2 neurones 
Cluster 2 Properties 
10 mM Glucose 2 mM Glucose P values 
'n' value 8 8 
Spontaneous activity 50 63 0.6 
Spontaneous firing rate (Hz) 2.2 ± 0.7 0.2 ± 0.0 P<0.05 
Membrane potential (mV) -49.0 2.1 -45.9 2.3 0.3 
input resistance (M92) 1782 458 1243 206 0.6 
Membrane time-constant (ms) 33.5 4.9 31.2 6.4 0.6 
Threshold for action potential 
(AP) firing (mV) 
-30.5 1.9 -31.6 2.4 1.0 
AP amplitude (mV) 85.6 5.7 81.8 6.8 0.6 
AP duration half-height (ms) 1.7 ± 0.2 1.7 ± 0.2 0.9 
AP duration threshold (ms) 3.4 ± 0.5 3.5 ± 0.4 0.9 
Ratio of AP duration: 
threshold/ half-height 
2.0 ± 0.1 2.0 ± 0.9 0.3 
Activation threshold I.. (mV) -82.3 2.7 -80.4 ±2.9 0.6 
I.. induced reduction in input 
resistance (%) 
39.3 7.1 35.2 7.8 0.9 
Decay time 1A (MS) IIH 212 838 174 0.4 
Amplitude IA (MV) 5.1 0.9 4.7 0.6 0.6 
There was a significant difference between the spontaneous firing rate of 
cluster 2 neurones recorded in 2 mM and 10 mM glucose-containing aCSF with an 
increase in firing in 10 mM glucose (P<0.05). There were no significant differences 
between any other membrane properties of cluster 2 neurones recorded in 10 mM or 
2 mM glucose-containing aCSF. However there appeared to be clear differences in 
some of the properties which did not reach statistical significance. These include the 
percentage of spontaneously active neurones (50 % in 10 mM and 63 % in 2 mM), 
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input resistance and the decay time of the A-like conductance. The reason they may 
not have reached statistical significance maybe due to the low 'n' numbers. 
3.2.4 Expression of no obvious subthreshold active conductances (Cluster 3) 
Cluster 3 neurones were characterised by the absence of any of the 
subthreshold active conductances expressed in the other neuronal clusters. The I-Vs 
of cluster 3 neurones were therefore linear, showing a directly proportional 
relationship between injected current and membrane response (see figure 3.7A). 
Table 3.4 gives an overview of this data. 
10 mMglucose-containing aCSF 
23 neurones were recorded in 10 mM glucose-containing aCSF that 
expressed no obvious subthreshold active conductances (10 % of the population). 6 
of these neurones were active at rest (26 %) with an average firing frequency of 
1.4 ± 0.4 Hz. The average resting membrane potential and input resistance were 
-49.1 ± 2.1 mV (range -30 to -63 mV) and 1857 ± 215 Mfl (range 490 to 4030 MQ), 
respectively, with a membrane time-constant of 37.4 ± 5.6 ms (n=23). Spike firing 
was induced at -31.5 ± 1.9 mV at which point action potentials were generated of 
amplitude 86.0 ± 2.9 mV and duration of 1.6 ± 0.1 ms and 3.2 ± 0.2 ms at half-height 
and threshold, respectively. The ratio between duration at threshold and half-height 
was 2.0 ± 0.0. 
2 mMglucose-containing aCSF 
In 2 mM glucose-containing aCSF, 17 neurones that expressed no obvious 
subthreshold active conductances were obtained (10 % of the population). 8 of these 
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neurones were active at rest (47 %) with an average firing frequency of 1.3 ± 0.5 Hz. 
The average resting membrane potential and input resistance were -46.4 ± 2.0 mV 
(range -37 to -64 mV) and 1418 ± 169 MQ (range 497 to 3038 MQ), respectively, 
with a membrane time-constant of 27.0 ± 4.2 ms (n= 17). Spike firing was induced at 
-29.4 ± 1.4 mV at which point action potentials were generated of amplitude 
81.8 ± 2.2 mV and a duration of 1.7 ± 0.1 ms and 3.5 ± 0.3 ms at half-height and 
threshold, respectively. The ratio between duration at threshold and half-height was 
2.1 ± 0.1. 
Table 3.4 Electrophysiological properties of cluster 3 neurones 
Cluster 3 Properties 
10 mM Glucose 2 mM Glucose P values 
in' value 23 17 
Spontaneous activity (%) 26 47 0.2 
Spontaneous firing rate (Hz) 1.4 ± 0.4 1.3 ± 0.5 0.9 
Membrane potential (mV) -49.1 2.1 -46.4 2.0 0.3 
Input resistance (Mil) 1857 215 1418 169 0.3 
Membrane time-constant (ms) 37.4 5.6 27.0 4.2 0.3 
Threshold for action potential 
(AP) firing (mV) 
-31.5 1.9 -29.4 1.4 0.5 
AP amplitude (mV) 86.0 2.9 81.8 2.2 0.4 
AP duration half-height (ms) 1.6 0.1 1.7 0.1 0.7 
AP duration threshold (ms) 3.2 A: 0.2 3.5 :: L 0.3 0.5 
Ratio of AP duration: 
threshold/ half-height 
2.0 ± 0.0 2.1 ± 0.1 0.8 
There were no significant differences between any membrane properties of 
cluster 3 neurones recorded in 2 mM and 10 MM glucose-containing aCSF. 
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3.25 Expression of time- and voltage-dependent inward rectification (Cluster 4) 
Another subthreshold active conductance expressed by a subset of ARC 
neurones was seen as a depolarising 'sag' in the membrane response to 
hyperpolarising current steps at more negative membrane potentials (see figure 
3.713). It is a time- and voltage-dependent inward rectification, which is similar to the 
hyperpolarisation-activated non-selective cation conductance (1h) reported in other 
neurones (for example see Halliwell & Adams, 1982; McCormick & Pape, 1990b; 
Pape, 1996). The threshold for the activation point Of lh was calculated by averaging 
the membrane potentials at which lh was first visible in the IN relationship. The 
change in membrane potential between instantaneous and steady-state was used as a 
measure of the magnitude of this conductance. Table 3.5 gives an overview of this 
data. 
10 mM glucose-containing aCSF 
23 neurones expressed Ih in the presence of 10 mM glucose-containing aCSF 
(10 % of the population) of which 6 were active at rest (26 %) with an average firing 
frequency of 1.7 ± 0.5 Hz. The average resting membrane potential of these cells 
was -51.5 ± 1.9 mV (range -37 to -67 mV), input resistance was 1134 ± 128 Mn 
(range 294 to 2877 M) and membrane time-constant was 26.6 ± 3.7 ms (range 6.6 
to 88.3ms; n=23). Spike firing was induced at -31.4 ± 1.5 mV, giving rise to action 
potentials of amplitude, duration at half-height, and threshold duration of 
79.2 ± 3.3 mV, 1.6 ± 0.1 ms and 3.4 ± 0.2 ms, respectively. The ratio between the 
two durations was 2.0 :E0.1. 
The average threshold for activation Of lh was -87.2 ± 1.5 mV, giving rise to a 
hyperpolarising sag of amplitude 6.6 ± 0.6 mV at a membrane potential of 
-82- 
Cha ter Three p 
- 104.8 ±1 .1 mV. This 
is equivalent to a decrease in input resistance of 12.9 % upon 
activation Of Ih. 
2 mMglucose-containing aCSF 
10 neurones were obtained in the presence of 2 mM glucose-containing aCSF 
that expressed Ih (6 % of the population). 6 of these neurones were active at rest 
(60 %) with an average firing frequency of 1.1 ± 0.3 Hz. The average resting 
membrane potential of these cells was -49.9 ± 2.4 mV (range -40 to -60 mV), input 
resistance was 1285 ± 252 MO (range 507 to 2452 MQ) and membrane time- 
constant was 37.5 ± 7.6 ms (range 5.2 to 93.6 ms; n=10). Spike firing was induced at 
-32.6 ± 1.7 mV, generating action potentials of amplitude, duration at half-height, 
and threshold duration of 88.2 ± 4.7 mV, 1.5 ± 0.0 ms and 3.5 ± 0.3 ms, respectively. 
The ratio between the two durations was 2.3 ± 0.1. 
The mean threshold for activation Of Ih was -81.4 ± 2.5 mV, giving rise to a 
hyperpolarising sag of amplitude 8.8 ± 0.9 mV at a membrane potential of 
- 106.1 ± 2.1 mV. This is equivalent to a decrease in input resistance of 15.7 % upon 
activation Of Ih- 
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Table 3.5 Electrophysiological properties of cluster 4 neurones 
Cluster 4 Properties 
10 mM Glucose 2 mM Glucose P values 
'n' value 23 10 
Spontaneous activity 26 60 0.06 
Spontaneous firing rate (Hz) 1.7 ± 0.5 1.1 ± 0.3 0.5 
Membrane potential (mV) -51.5 1.9 -49.9 2.4 0.6 
Input resistance (Mfl) 1134 128 1285 252 1.0 
Membrane time-constant (ms) 26.6 3.7 37.5 7.6 0.1 
Threshold for action potential 
(AP) firing (mV) 
-31.4 1.5 -32.6 1.7 0.4 
AP amplitude (mV) 79.2 3.3 88.2 4.7 0.06 
AP duration half-height (ms) 1.6 ± 0.1 1.5 ± 0.0 0.1 
AP duration threshold (ms) 3.4 ± 0.2 3.5 ± 0.3 0.9 
Ratio of AP duration: 
threshold/ half-height 
2.0 ± 0.1 2.3 ± 0.1 0.2 
Activation threshold Ih (MV) -87.2 1.5 -81.4 2.5 0.1 
Ih induced reduction in input 
resistance (%) 
12.9 1.2 15.7 1.0 0.2 
There were no significant differences between neurones recorded in the 
presence of 2 mM and 10 mM glucose-containing aCSF. However, it is important to 
note that the number of cluster 4 neurones recorded in both conditions was quite 
different and therefore this may have affected the significance values of these results. 
it is again apparent that there is a clear difference in the spontaneous activity of 
neurones recorded under both conditions (26 % in 10 mM and 60 % in 2 mM). 
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3.2.6 Expression of T-type conductance and Ih (Cluster 5) 
Cluster 5 neurones were characterised by expression of two subthreshold 
active conductances: lh as seen in cluster 4 neurones and a conductance resembling 
the T-type calcium conductance (see figure 3.8A). This conductance is characterised 
by a rebound depolarisation upon termination of negative current injection. This 
rebound depolarisation is similar to that described before in cells mediated by T-type 
calcium channels (for example see Llinas & Yarom, 1981). In order to be able to 
quantify the T-type conductance, the amplitude of the rebound depolarisation was 
calculated as the difference between the rebound plateau and the resting membrane 
potential. This value is only an estimate of the amplitude of the T-type conductance 
as there may be a contribution from Ih towards the rebound depolarisation. Table 3.6 
gives an overview of this data. 
10 mMglucose-containing aCSF 
41 neurones were characterised as having Ih and a T-type calcium 
conductance in 10 mM glucose-containing aCSF (17 % of the population). 14 
neurones were spontaneously active at rest (31 %) with an average firing frequency 
of 0.4 ± 0.1 Hz- The average resting membrane potential of these neurones was 
-48.7 ± 1.1 mV (range -30 to -60 mV) and they had an input resistance of 
1606 ± 124 MQ (range 498 to 3582 MQ). The membrane time-constant was 
43.6 ± 4.9 ins (n=41). The threshold for spike firing was -29.3 ± 0.9 mV and the 
amplitude of the generated action potentials were 78.6 ± 2.4 mV, with duration at 
half-height of 1.6 ±: 0.1 ms and at threshold of 3.4 ± 0.1 Ms. 2.1 ± 0.0 was the ratio 
between the two durations. 
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The mean threshold for activation Of lh was -86.5 ± 1.4 mV, giving rise to a 
hyperpolarising sag of amplitude 11.6 ± 4.8 mV at a membrane potential of 
-105 ± 0.9 mV. This is equivalent to a decrease in input resistance of 21.2 % upon 
activation Of Ih. 
Activation of the T-type calcium conductance gave an average membrane 
depolarisation of 11.9 ± 1.1 mV from a membrane potential of -48.5 ± 1.2 mV 
(n=38). 
2 mMglucose-containing aCSF 
25 neurones were characterised as having lh and a T-type calcium 
conductance when recorded in 2 mM glucose-containing aCSF 05% of the 
population), of which 12 were spontaneously firing at rest (48 %) with an average 
firing frequency of 1.0 ± 0.2 Hz.. The average resting membrane potential of these 
neurones was -49.3 ± 1.1 mV (range -42 to -64 mV) and they had a mean input 
resistance of 1213 ± 106 MKI (range 572 to 2868 Mn). The membrane time-constant 
was 33.0 ± 2.6 ms (n=25). The threshold for spike firing was -31.7 ± 0.8 mV and the 
amplitude of the generated action potentials were 83.8 ± 2.4 mV, with duration at 
half-height of 1.4 ± 0.0 ms and at threshold of 2.9 ± 0.1 ms. 2.0 ± 0.1 was the ratio 
between the two durations. 
The mean threshold for activation Of lh was -82.7 ± 7.1 mV, giving rise to a 
hyperpolarising sag of amplitude 8.1 ± 0.8 mV at a membrane potential of 
-106.2 ± 0.9 mV. This is equivalent to a decrease in input resistance of 15 % upon 
activation Of 
Ih- 
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Activation of the T-type calcium conductance gave an average membrane 
depolarisation of 13.8 ± 1.9 mV from a membrane potential of -51.2 ± 1.7 mV 
(n14). 
Table 3.6 Electrophysiological properties of cluster 5 neurones 
Cluster 5 Properties 
10 mM Glucose 2 mM Glucose P values 
tn' value 41 25 
Spontaneous activity 31 48 0.3 
Spontaneous firing rate (Hz) 0.4 ± 0.1 1.0 ± 0.2 
Membrane potential (mV) -48.7 1.1 -49.3 1.1 0.8 
input resistance (M91) 1606 124 1213 106 P<0.05 
Membrane time-constant (ms) 43.6 4.9 33.0 2.6 0.6 
Threshold for action potential 
(AP) firing (mV) 
-29.3 0.9 -31.7: L 0.8 P<0.05 
AP amplitude (mV) 78.6 2.4 83.8 2.4 0.09 
AP duration half-height (ms) 1.6 ± 0.1 1.4 0.0 P<0.05 
AP duration threshold (ms) 3.4 ± 0.1 2.9 0.1 P<0.01 
Ratio of AP duration: 
threshold/ half-height 
2.1 ± 0.0 2.0 0.1 0.2 
Activation threshold Ih (MV) -86.5 1.4 -82.7 7.1 0.3 
Ih induced reduction in input 
resistance 
21.2 9.0 15.0 1.8 0.2 
T-type amplitude (mV) 11.9 1.1 13.8 1.9 0.3 
There were significant differences between the input resistance (greater in 
10 mM glucose-containing aCSF; P<0.05), threshold for action potential firing 
(P<0.05) and both spike durations (longer in 10 MM glucose-containing aCSF; 
P<0.05 and P<0.01) of cluster 5 neurones recorded in 2 mM and 10 MM glucose- 
containing aCSF. Again it must be noted that there is a large difference in the 
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number of cluster 5 neurones recorded under both conditions which may have 
affected the significance of these results. 
3.2.7 Expression of T-type conductance (Cluster 6) 
Cluster 6 neurones expressed only the T-type calcium conductance (see 
figure 3.8B). Table 3.7 gives an overview of this data. 
10 mMglacose-containing aCSF 
69 neurons were obtained in 10 mM glucose-containing aCSF that expressed 
a T-type calcium conductance (29 % of the population), of which 20 were active at 
rest (29 %) with an average firing frequency of 1.2 ± 0.3 Hz. The average resting 
membrane potential, input resistance and membrane time-constant were 
-44.7: L 0.8 mV (range -33 to -64 mV), 1466 ± 78 MQ (range 508 to 3228 MQ) and 
30.4 ± 3.1 ms (range 2.4 to 126.9 ms), respectively (n=69). Spike firing threshold 
was -27.2 ± 0.6 mV, generating action potentials of amplitude 77.7 ± 1.7 mV and 
duration at half-height and threshold of 1.7 ± 0.1 ms and 3.5 ± 0.1 ms, respectively. 
This gave a ratio between the durations of 2.1 =L 0.0. 
Activation of the T-type calcium conductance gave an average membrane 
depolarisation of 9.1 ± 0.8 mV from a membrane potential of -45.7 ± 0.9 mV (n=60). 
2 mMglucose-containing aCSF 
56 neurons were obtained in 2 mM glucose-containing aCSF that expressed a 
T-type calcium conductance (33 % of the population), of which 31 were active at 
rest (55 %) with an average firing frequency of 0.7 ± 0.2 Hz. The average resting 
membrane potential, input resistance and membrane time-constant were 
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-45.1 ± 0.9 mV (range -30 to -61 mV), 1427 ± 111 MQ (range 355 to 4050 MQ) and 
34.0 ± 3.1 ms (range 9.8 to 130.1 ms), respectively (n=56). Spike firing threshold 
was -29.5 ± 0.8 mV, generating action potentials of amplitude 79.9 ± 1.8 mV and 
duration at half-height and threshold of 1.7 ± 0.1 ms and 3.4 ± 0.1 ms, respectively. 
This gave a ratio between the durations of 2.0 ± 0.0. 
Activation of the T-type calcium conductance gave an average membrane 
depolarisation. of 9.6 ± 0.9 mV from a membrane potential of -46.8 ± 1.1 mV (n=37). 
Table 3.7 Electrophysiological properties of cluster 6 neurones 
Cluster 6 Properties 
10 mM Glucose 2 mM Glucose P values 
In' value 69 56 
Spontaneous activity 29 55 P<O. 01 
Spontaneous firing rate (Rz) 1.2 =L 0.3 0.7 J: 0.2 0.9 
Membrane potential (mV) -44.7 ± 0.8 -45.1 0.9 0.3 
Input resistance (Mfl) 1466 ± 78 1427 111 0.3 
Membrane time-constant (ms) 30.4 ± 3.1 34.0 3.1 0.09 
Threshold for action potential 
(AP) firing (mV) 
-27.2 ± 0.6 -29.5 0.8 0.06 
AP amplitude (mV) 77.7 1.7 79.9 ± 1.8 
AP duration half-height (ms) 1.7 0.1 1.7 ± 0.1 1.0 
AP duration threshold (ms) 3.5 0.1 3.4 ± 0.1 0.9 
Ratio of AP duration: 
threshold/ half-height 
2.1 0.0 2.0 ± 0.0 0.7 
T-type amplitude (mV) 9.1 0.8 9.6 ± 0.9 0.4 
There was a significant increase in the level of spontaneous activity of 
neurones recorded in 2 mM compared to 10 mM glucose-containing aCSF (29 % in 
10 mM and 55 % in 2 mM). There were no significant differences between any of 
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the other membrane properties of cluster 6 neurones obtained in 2 mM and 10 mM 
glucose-containing aCSF. 
3. Z8 Expression Of Ian and T-type conductances (Cluster 7) 
Cluster 7 neurones were characterised as having an anomalous inward 
rectifier, as seen in cluster I neurones and a T-type calcium conductance as seen in 
clusters 5 and 6 (see figure 3.9A). Table 3.8 gives an overview of this data. 
10 mMglucose-containing aCSF 
37 neurones were recorded in 10 mM glucose-containing aCSF that 
expressed both 1,, and a T-type calcium conductance (15 % of the population). 16 of 
these were active at rest (43 %) with an average firing frequency of 1.1 ± 0.3 Hz. 
-46.7 ± 1.1 mV (range -34 to -64mV) was the average resting membrane potential of 
these neurones, and the input resistance and time-constant were 1741 ± 131 MQ 
(range 574 to 3406 MQ) and 42.1 ± 4.4 ms (range 8.6 to 132.6 ms), respectively 
(n=37). The threshold for spike firing was -30.2 ± 1.0 mV at which point action 
potentials of amplitude 88.3 : ý: 1.9 mV and duration at half-height and threshold of 
1.5 ± 0.0 rns and 3.2 ± 0.1 ms, respectively were recorded. This gave a ratio of 
2.1 ± 0.0. 
activation accounted for a 25 % reduction in input resistance at a 
membrane potential of -99.7 ± 0.7 mV relative to input resistance at rest. The 
activation threshold calculated from the IN for la,, was estimated around 
-87.0 ± 1.3 mV (n=37). 
Activation of the T-type calcium conductance gave an average membrane 
depolarisation of 8.7 ± 1.0 mV from a membrane potential of -47.6 ± 1.2 mV (n=30). 
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2 mMglucose-containing aCSF 
26 neurones were recorded in 2 mM glucose-containing aCSF that expressed 
both 1,,. and a T-type calcium conductance (15 % of the population). 18 of these were 
active at rest (69 %) with an average firing frequency of 1.8 ± 0.3 Hz. 
-44.8 ± 1.3 mV (range -34 to -60 mV) was the average resting membrane potential of 
these neurones, and the input resistance and time-constant were 1471 ± 133 Mn 
(range 495 to 2974 MQ) and 42.4 ± 5.2 ms (range 12 to 92.3 ms), respectively 
(n=26). The threshold for spike firing was -30.1 ± 1.2 mV at which point action 
potentials of amplitude 85.2 ± 2.3 mV and duration at half-height and threshold of 
1.6 ± 0.1 ms and 3.5 ± 0.2 ms, respectively, were recorded. This gave a ratio of 
2.1 ± 0.1. 
la,, induced a 34 % reduction in input resistance at a membrane potential of 
-104.3 ± 3.9 mV relative to input resistance at rest. The activation threshold 
calculated from the IN for 1. was estimated around -83.6 ±1 .0 mV (n=26). 
Activation of the T-type calcium conductance gave an average membrane 
depolarisation of 8.7 ± 1.5 mV from a membrane potential of -46.6 ± 2.1 mV (n= 15). 
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Table 3.8 Electrophysiological properties of cluster 7 neurones 
Cluster 7 Properties 
10 mM Glucose 2 mM Glucose P values 
'n'values 37 26 
Spontaneous activity 43 69 P<0.05 
Spontaneous firing rate (Hz) 1.1 :: L 0.3 1.810.3 P<0.05 
Membrane potential (mV) -46.7 1.1 -44.8 1.3 0.3 
Input resistance (Mfl) 1741 131 1471 133 0.3 
Membrane time-constant (ms) 42.1 4.4 42.4 5.2 0.9 
Threshold for action potential 
(AP) firing (mV) 
-30.2 1.0 -30.1 1.2 1.0 
AP amplitude (mV) 88.3 1.9 85.2 2.3 0.5 
AP duration half-height (ms) 1.5 ± 0.0 1.6 ± 0.1 0.7 
AP luration threshold (ms) 3.2 ± 0.1 3.5 ± 0.2 0.8 
Ratio of AP duration: 
threshold/ half-height 
2.1 ± 0.0 2.1 ± 0.1 1.0 
Activation threshold I.,, (mV) -87.0 1.3 -83.6 1.0 P<0.05 
I.,, induced reduction in input 
resistance (%) 
24.8 2.6 34.1 3.1 P<0.05 
T-type amplitude (mV) 8.7 1.0 8.7 1.5 0.9 
The significant differences between the two glucose concentrations were the 
percentage reduction in input resistance upon activation Of Ian, with a larger 
reduction in 2 MM glucose-containing aCSF (P< 0.05), the activation threshold for 
(P<0.05), the increase in spontaneous firing rate in 2 mM glucose (P<0.05) and 
the increase in the spontaneous activity of neurones recorded in 2 mM glucose- 
containing aCSF (43 % in 10 mM and 69 % in 2 mM; P<0.05). 
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3.2.9 Expression of Ia,,, Ih, and T-type conductances (Cluster 8) 
The final group of neurones was characterised as having I., like clusters I 
and 7, Ih, like clusters 4 and 5, and a T-type conductance, like clusters 6 and 7 (see 
figure 3.913). It is important to note that because there are multiple subthreshold 
active conductances expressed in these neurones, values for properties of each 
specific each conductance can only be estimated without fully knowing the 
contribution made by other conductances. Table 3.9 gives an overview of this data. 
10 mMglucose-containing aCSF 
In 10 mM glucose-containing aCSF, 25 neurones were recorded which 
expressed lang lh and T-type conductances (10 % of the population). 12 of these 
neurones were active at rest (48 %) with an average firing frequency of 1.3 ± 0.5 Hz. 
The average resting membrane potential, input resistance and membrane time- 
constant were -48.6 ± 1.3 mV (range -34 to -60 mV), 1771 ± 165 MQ (range 500 to 
4272 MQ) and 61.9 ± 8.9 ms (range 8.2 to 198.4 ms), respectively (n=25). Spike 
firing was induced at -29.4 ± 0.9 mV at which point action potentials were generated 
of amplitude, duration at half-height and threshold of 88.0 ± 2.3 mV, 1.5 ± 0.1 ms 
and 3.2 ± 0.1 ms, respectively, giving a ratio of 2.2 ± 0.1. 
1,,, induced a 29 % reduction in input resistance at a membrane potential of 
-103.5 ± 1.1 mV relative to input resistance at rest. The activation threshold 
calculated from the IN for la,, was estimated around -85.7 ± 1.3 mV (n=25). 
Activation of the T-type calcium conductance gave an average membrane 
depolarisation. of 9.5 EL 1.6 mV from a membrane potential of -49.9 ± 1.6 mV (n= 19). 
The mean threshold for activation Of lh was -86.1 ± 1.5 MV, giving rise to a 
hyperpolarising sag of amplitude 4.2 ± 0.5 mV at a membrane potential of 
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-103.4 ± 1.0 mV. This is equivalent to a decrease in input resistance of 8% upon 
activation Of Ih. 
2 mMglucose-containing aCSF 
In 2 mM glucose-containing aCSF, 12 neurones were recorded which 
expressed laný lh and T-type conductances (7 % of the population). 7 of these were 
active at rest (58 %) with an average firing frequency of 0.4 ± 0.1 Hz. The average 
resting membrane potential, input resistance and membrane time-constant were 
-46.3 ± 1.8 mV (range -37 to -55 mV), 1341 ± 200 MO (range 644 to 3183 MQ) and 
53.7 ± 7.4 ms (range 24.9 to 107 ms), respectively (n=12). Spike firing was induced 
at -28.9 :L1.9 mV at which point action potentials were generated of amplitude, 
duration at half-height and threshold of 91.6 ± 3.3 mV, 1.4 ± 0.1 ms and 
2.9 ± 0.2 ms, respectively, giving a ratio of 2.0 ± 0.1. 
1,,, induced a 28 % reduction in input resistance at a membrane potential of 
-97.2 ± 5.3 mV relative to input resistance at rest. The activation threshold calculated 
from the IN for Ian was estimated around -85.3 ± 2.1 mV (n=12). 
Activation of the T-type calcium conductance gave an average membrane 
depolarisation of 9.5 ± 2.8 mV from a membrane potential of -49.9 ± 2.8 mV (n=5). 
The mean threshold for activation Of lh was -87.7 ± 2.0 mV, giving rise to a 
hyperpolarising sag of amplitude 5.8 ± 0.5 mV at a membrane potential of 
-102.5 ± 0.9 mV. This is equivalent to a decrease in input resistance of 10 % upon 
activation Of 
Ih- 
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Table 3.9 Electrophysiological properties of cluster 8 neurones 
Cluster 8 Properties 
10 mM Glucose 2 mM Glucose P values 
tn' value 25 12 
Spontaneous activity (%) 48 58 0.6 
Spontaneous firing rate (Hz) 1.3 ± 0.5 OA ± 0.1 0.2 
Membrane potential (mV) -48.6 1.3 -46.3 1.8 0.3 
input resistance (Mil) 1771 165 1341 200 0.1 
Membrane time-constant (ms) 61.9 8.9 53.7 7.4 0.8 
Threshold for action potential 
(AP) firing (mV) 
-29.4 0.9 -28.9 1.9 0.7 
AP amplitude (mV) 88.0 2.3 91.6 3.3 0.4 
AP duration half-heig 1.5 ± 0.1 1.4 ± 0.1 0.8 
AP duration threshold (ms) 3.2 ± 0.1 2.9 ± 0.2 0.5 
Ratio of AP duration: 
threshold/ half-height 
2.2 ± 0.1 2.0 ± 0.1 0.4 
Activation threshold I.,, (mV) -85.7 1.3 -85.3 2.1 0.8 
1,,,, induced reduction in input 
resistance 
29.3 2.8 28.1 3.3 0.5 
Activation threshold Ih -86.1 1.5 -87.7 2.0 0.5 
Ih induced reduction in input 
resistance (%) 
8.0 ± 1.0 10.510.8 P<0.05 
T-type amplitude (mV) 9.5 ± 1.6 9.5 ± 2.8 0.9 
The only significant difference between cluster 8 neurones recorded in 2 mM 
and 10 mM glucose-containing aCSF was the reduction in input resistance induced 
by Ih (greater in 2mM; P<0.05). 
Tables 3.10 and 3.11 show a summary of the electrophysiological properties 
and properties of the active conductances of each cluster. 
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3.2.10 Comparison of percentage of neurones in each cluster recorded in 2 mM 
and 10 mM glucose-containing aCSF 
The percentage of neurones in each cluster did not vary considerably between 
neurones recorded in 2 mM and 10 mM glucose-containing aCSF (see figure 3.10). 
There were a higher percentage of neurones that fell into the clusters 1,2 and 6 in 
2 mM glucose-containing aCSF than in 10 mM glucose-containing aCSF (ranging 
between 2-4 % higher). There were a higher percentage of neurones that fell into the 
clusters 4,5 and 8, in 10 mM glucose-containing aCSF compared to 2 mM glucose- 
containing aCSF (2-4 % difference). Clusters 3 and 7 expressed the same percentage 
of neurones in both glucose concentrations. There were no significant differences 
between the proportion of neurones in each cluster (chi square test: cluster 1: P=0.2; 
cluster 2: P=0.5; cluster 3: P=0.9; cluster 4: P--0.2; cluster 5: P=0.5; cluster 6: 
P=0.3; cluster 7: P=1.0; cluster 8: P=0.2). 
3. ZlI Comparison ofpercentage of spontaneously active neurones in each cluster 
recorded in 2 mM and 10 mM glucose-containing aCSF 
There was a distinct difference in the spontaneous activity of neurones in 
each cluster recorded in 2 mM and 10 mM glucose-containing aCSF (see table 3.12 
and figure 3.11). In every cluster except cluster 1, there was an increase in the 
spontaneous firing of neurones recorded in 2 mM glucose-containing aCSF 
compared to 10 mM glucose-containing aCSF. However significance was only 
reached in clusters 6 and 7 (chi square test: P<0.01 and P<0.05, respectively). 
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Table 3.12 Comparison of spontaneous activity 
Spontaneous Activity (%) 
Cluster 10 mm 
Glucose 
2 mM 
Glucose 
P 
values 
1 27 25 0.9 
2 50 63 0.6 
3 26 47 0.2 
4 26 60 0.06 
5 31 48 0.3 
6 29 55 P<0.01 
7 43 69 P<0.05 
8 48 58 0.6 
3.3 Discussion 
in this study electrophysiological properties of ARC neurones were 
compared between neurones recorded in the presence of two different extracellular 
glucose concentrations; 2 mM and 10 mM. The aim of the present study was to 
investigate the effects of hyperglycaernic and euglycaernic glucose levels on ARC 
neurones by observing how their electrophysiological properties change under these 
respective recording conditions. In particular, the expression of subthreshold active 
conductances was investigated and also used as the basis upon which to classify 
neurones into groups. 
3.3.1 Effect of glucose on membrane properties ofARC neurones 
As well as being dependent on glucose for energy, the brain also contains 
glucose-sensing neurones that can alter their electrical properties in response to 
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changes in glucose levels (Anand et al., 1964; Oornura et al., 1964). The ARC has 
been shown to contain these glucose-sensing neurones (Spanswick et al., 1997; 
Muroya et al., 1999; Spanswick et al., 2000; Ibrahim et al., 2003). It is important 
that the levels of glucose within the brain and body are maintained around set limits 
otherwise conditions such as diabetes arise. Thus, as for many other nutrients and 
physiological processes, complex and often multiple interacting homeostatic systems 
are in place and organised to maintain for example, glucose within tight limits. 
Diabetes arises due to problems with insulin production or insulin resistance leading 
to high blood sugar levels. Euglycaemia is around 4-6 mM in the plasma whereas 
the physiological level of glucose in the brain is unclear, although it is reported to be 
between 1 and 2.5 mM (Silver & Erecinska, 1994). Classical electrophysiological 
studies which looked at glucose-sensing neurones in the hypothalamus used glucose 
at concentrations between 0 and 20 mM (for example see Ashford et al., 1990a; 
Spanswick et al., 1997) but recent studies have suggested that this level is too high 
and that neurones within the ARC are never exposed to such high levels. This study 
therefore aimed to compare the effects of both hyperglycaernic (10 mM) and 
euglycaernic (2 mM) glucose levels on the electrophysio logical properties of ARC 
neurones. In this study, properties used to compare the effects of 10 mM and 2 mM 
glucose-containing aCSF on ARC neurones centred on the resting membrane 
potential, input resistance, membrane time-constant and spontaneous firing rates. A 
more detailed comparison of other electrophysiological properties such as spike 
threshold, spike duration and activation points of active conductances were also 
considered. The proportion of neurones expressing particular active conductances 
was also looked at and these will all be discussed further now. 
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The major findings of this study were that there were clear differences 
between the input resistance, the percentage of active neurones and the expression of 
the active conductance Ih in neurones recorded in 2 mM compared to 10 mM 
glucose-containing aCSF. laý, also appeared stronger in 2 mM glucose-containing 
aCSF in a population of neurones. Perhaps the most interesting finding is that of the 
change in the activity of neurones. Although the spontaneous firing rate of active 
neurones did not show a significant difference between 2 mM and 10 mM glucose- 
containing aCSF, there was a significant change in the percentage of active versus 
silent neurones in the two conditions in the overall population. Within individual 
clusters, there was an increase in the percentage of active neurones recorded in 
2 mM glucose-containing aCSF compared to 10 mM glucose-containing aCSF in 
every cluster except cluster 1, with a significant increase in clusters 6 and 7. This 
indicates that neurones with similar electrophysiological properties have very 
different patterns of activity under different extracellular glucose concentrations, 
with neurones being more active under physiological conditions. Previous studies 
which were carried out in 10 mM glucose-containing aCSF, which is non- 
physiological, may therefore have produced very different results if they were 
carried out in physiological glucose. The expression of receptors, neuropeptides, and 
transmitters within neurones and their associated networks may also be affected by 
this change in glucose. These data therefore provide compelling evidence for a 
change in the activity of ARC neurones under different extracellular glucose 
concentrations and may force us to re-evaluate previous glucose-sensing studies 
which were carried out in non-physiological glucose levels. Furthermore, if such 
changes are paralleled at the signalling level, previous studies undertaken in these 
glucose and energy status-sensing networks may require a major re-evaluation. 
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Another important property that changed in the two recording conditions was 
input resistance. Input resistance showed a significant increase in neurones recorded 
in 10 mM glucose-containing aCSF compared to 2 mM glucose-containing aCSF, 
indicating that upon increasing glucose concentrations, ion channels are most likely 
closing within the membrane. The KATP channel is an important ion channel thought 
to be involved in glucose homeostasis and glucose-sensing (Ashford et al., 1990a, b; 
Rowe et al., 1996; Spanswick et al., 1997; Lee et al., 1999; Spanswick et al., 2000; 
Miki et al., 2001; Zhang et al., 2004). In 10 mM glucose-containing aCSF, more 
KATP channels may be closed, whilst in 2 mM glucose-containing aCSF, more may 
be open. Different glucose concentrations between 0 and 10 mM would need to be 
tested to see if the resistance continued to change over this range of concentrations. 
The point where resistance no longer changes would indicate when the KATP 
channels are likely to be fully closed. This point regarding KATP may be relevant to 
the observed increase in neuronal input resistance. However it is unlikely to account 
for the decrease in activity observed here in 10 mM glucose-containing aCSF. 
The other major finding of this study was the difference in expression of the 
active conductance 1h. Ih is a time- and voltage-dependent inward rectification, as 
seen in other neurones (Halliwell & Adams, 1982; Pape, 1996) and is characterised 
by a 'sag' in the membrane response during negative current injection. Ih was 
expressed in 33 % of neurones in this study. There were a greater percentage of 
neurones expressing Ih (neurones in clusters 4,5 and 8) in 10 mM glucose- 
containing aCSF compared to 2 mM glucose-containing aCSF although this did not 
reach significance. These data imply that there was greater expression of ion 
channels mediating the Ih conductance in 10 mM glucose. This is important as Ih Can 
contribute to the patterning of activity of neurones (Pape, 1996). In particular, it has 
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been shown to contribute to burst-like patterns of firing (van Welie et al., 2006) 
therefore Ih could contribute to pacemaker activity. It is also thought to contribute to 
the resting membrane potential of neurones as it prevents neurones from becoming 
too hyperpolarised. In addition the role Of Ih in thalamic burst firing can be 
modulated by extrinsic factors including 5-HT and noradrenaline (Pape & 
McCormick, 1989; McCormick & Pape, 1990a). Ih could therefore potentially act as 
a switch to alter the functional output of these neurones under different glucose 
conditions and in response to extrinsic factors. It would be interesting for future 
studies to look more closely at the expression Of Ih under different recording 
conditions to see how it affects the activity of these neurones. An important point to 
note is that if the expression of active conductances is altered by different glucose 
concentrations, neurones may be able to switch between clusters, for example a 
cluster 7 neurone could become a cluster 8 neurone if Ih becomes activated. The 
proportion of neurones in each cluster in 2 mM and 10 mM glucose may therefore 
change, although in this study no significant difference was found. 
The fact that electrophysiological properties of neurones have changed under 
these different recording conditions indicates that 10 mM and 2 mM glucose 
represent quite different physiological and/or pathophysiological states. 2 mM is 
thought to be more like the physiological concentration of glucose in the ARC and 
under these conditions there was an increase in the activity of neurones. This may be 
the resting activity of neurones in a normal euglycaernic state. 10 mM glucose may 
represent a hyperglycaernic state and therefore the properties of neurones in this 
level of glucose may represent those which more likely reflect a diabetic state. 
Previous studies which were carried out in 10 mM glucose or higher may therefore 
have been carried out in too high a glucose level and the results from these studies 
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must be considered in light of this fact. lh was observed to be altered in 10 mM 
glucose indicating that the expression of ion channels or their biophysical properties 
may change in different physiological states and it may be that many other factors, 
such as receptors and peptides, may also change their expression in high glucose 
levels. 
Aside from these properties that did change in neurones recorded in the two 
different glucose concentrations, there were also properties which did not show a 
significant change. Overall the resting membrane potential of neurones recorded in 
10 mM and 2 mM glucose-containing aCSF did not significantly change. These 
results are in accordance with a previous study that looked at the activity of neurones 
in 10 mM and 2 mM glucose-containing aCSF. In this study, membrane potential did 
not alter when reducing glucose concentration from 10 mM to 2 mM (Claret et al., 
2007). Cluster 2 neurones are the only neurones that have been functionally 
identified, as orexigenic NPY neurones (van den Top et al., 2004). Some NPY 
neurones within the ARC have been identified as GI neurones, although not all NPY 
neurones are believed to function in this way (Muroya et al., 1999). If these 
orexigenic cluster 2 neurones fonn part of the glucose-sensing population then they 
may be expected to be more active in lower glucose conditions, as was observed 
here. Cluster 2 neurones had a more depolarised membrane potential in 2 mM as 
opposed to 10 MM glucose-containing aCSF indicating that they are likely to be 
glucose-sensing neurones. None of the other clusters were identified as either 
orexigenic or anorexigenic and as we know that both GE and GI neurones are 
present within the ARC (Muroya et al., 1999; Ibrahim el al., 2003), there may have 
been an equal proportion of neurones which were hyperpolarised or depolarised by 
glucose. Alternatively, it might be possible that some of the neurones in other 
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clusters are not glucose-sensing at all and so did not detect any changes in glucose 
and alter their membrane properties. 
A further point to consider is that many of the cells we recorded from had a 
membrane potential very close to or at the threshold for action potential firing and 
the membrane potential rarely becomes more depolarised than this threshold value. 
There may not appear to be a significant difference between the membrane potentials 
of the two populations, as the difference between the threshold values and values just 
beneath threshold are very small, but the activity of the neurones may be very 
different which has been shown in this study. 
The membrane time-constant gives an indication of the size of the neurone 
being recorded from, which would not be expected to change in 10 mM or 2 mM 
glucose-containing aCSF. The results indicate this to be the case as there was no 
significant change in membrane time-constant between the two different glucose 
concentrations. This indicates that we were recording from a similar population of 
neurones. 
Overall there were few significant differences between the other 
electrophysiological properties investigated in this study. The possible reason for this 
could simply be that the ARC neurones from which we were recording were not 
glucose-sensing and so did not alter their membrane properties as they were not 
detecting these changes in glucose. Alternatively, if they were glucose-sensing 
neurones it may be that they were not sensing this change in glucose due to the fact 
that it was not significant enough to bring about any changes. One property which 
did appear different but did not reach statistical significance, probably due to low 'n' 
numbers, was the decay time of the A-current in cluster 2 neurones. The A-like 
transient outward rectifier was expressed by 4% of ARC neurones. This 
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conductance is characterised by a delayed return to resting membrane potential upon 
tennination of injection of negative current and resembles the activation of A-like 
potassium conductances (Connor & Stevens, 1971a, b). The decay time of the 
A-current was smaller in 2 mM glucose-containing aCSF. A-currents are thought to 
be involved in the regulation of repetitive firing (Rogawski, 1985) therefore any 
change in the properties of the A-current may lead to differences in the firing 
properties of neurones. Indeed, in this study the proportion of cells which exhibited 
burst-like firing patterns was different between the two recording conditions and has 
also been shown to be different in fasted animals (personal communication, 
D. Spanswick) indicating that glucose levels are important for controlling firing 
patterns. It has been shown that firing patterns are important for the release of 
neuropeptides from neurones; for example, the release of vasopressin from 
magnocellular neurones in the posterior pituitary depends on burst-like patterns of 
action potentials (Dutton & Dyball, 1979). A recent study showed that ARC 
neurones expressing an A-like current produced membrane potential oscillations in 
the presence of orexigens and were hence termed conditional pacemaker neurones. 
These neurones were sensitive to orexin and ghrelin and were NPY/AgRP containing 
neurones (van den Top et al., 2004). The size of the A-current is important for burst- 
firing: a shorter A-current leads to an increase in the frequency of bursts and may 
function to signal an increase in neuropeptide release, as would be expected in lower 
glucose conditions and fasted conditions. Conversely, a longer A-current decreases 
the frequency of bursts and may signal to reduce neuropeptide release, as expected in 
high glucose conditions. Cluster 2 neurones in this study might therefore be 
important in the generation of pacemaker activity in the ARC, which may lead to the 
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release of specific orexigenic neuropeptides and this pacemaker activity is likely to 
be different depending on the extracellular glucose concentration. 
Another active conductance investigated in this study was Ian. la", similar to 
the anomalous inward rectifier conductance described in other neurones (Constanti 
& Galvan, 1983), was expressed by 36 % of neurones in this study. I., is 
characterised by a decrease in input resistance at more negative membrane 
potentials. In this study there was a greater decrease in input resistance associated 
with 1. in 2 mM glucose-containing aCSF compared to 10 mM glucose-containing 
aCSF although these values did not reach significance in most cases, probably 
reflecting the low 'n' numbers. There were also a greater number of neurones in 
clusters I and 2, which both express I., in 2 mM compared to 10 mM glucose- 
containing aCSF, although this did not reach significance. These results indicate that 
the expression of 1. may be greater in physiological glucose. These data add to the 
evidence that the expression of ion channels is altered under different glucose 
concentrations. The function of Ian within neurones is unclear though it could help to 
maintain the membrane potential of neurones within a functional range (van den Top 
& Spanswick, 2006). However its role within the ARC and elsewhere still remains to 
be fully elucidated. Potentially the KATP channel may be responsible for the increase 
in 1. in 2 mM glucose as this channel is an inward rectifier. Therefore it may 
contribute to 1. but further studies utilising blockers of this channel (such as 
tolbutamide) are needed to clarify this. 
The final subthreshold active conductance investigated in this study was the 
T-type calcium like conductance, which was expressed by 71 % of neurones making 
it the most abundant conductance in ARC neurones. This conductance is 
characterised by a rebound depolarisation upon termination of negative current 
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injection. This rebound depolarisation is similar to that described before in cells 
activated by T-type calcium channels (Llinas & Yarom, 1981). T-type conductance 
is a low-voltage activated and rapidly inactivating current. In this study, this 
conductance was not seen to change between the two recording conditions. T-type 
conductances are involved in the generation of burst like firing patterns in the CNS, 
alongside Ih (Huguenard, 1996) and have also been shown to be involved in the 
generation of pacemaker activity in the ARC (van den Top et al., 2004). In particular 
the T-type conductance has been identified as an essential component of thalamic 
oscillations (Suzuki & Rogawski, 1989; Huguenard & Prince, 1994). Recently, 
T-type channels have also been shown to be important in the vesicular release of 
neurotransmitters from neurones (Pan et al., 2001; Carbone et al., 2006). Neurones 
in this study expressing the T-type conductance may therefore be important in 
generating specific patterns of activity in neurones and in generating the release of 
neuropeptides within the ARC. 
In addition to comparing the electrophysiological properties of ARC 
neurones, this study also classified neurones into groups or clusters based upon the 
subthreshold active conductances they expressed. 
3.3.2 Electrophysiological characterisation qfARC neurones 
The ARC within the hypothalamus plays an important role in the control of 
energy homeostasis (Williams et al., 2000; Cone et al., 2001; Williams el al., 2001). 
As it is located above the median eminence which is lacking a complete BBB 
(Ganong, 2000), it is able to receive information from circulating metabolites which 
signal the energy status of the body and produce an appropriate response. The ARC 
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receives information from a diverse range of signals and itself contains a diverse 
population of neurones. Within the ARC there is a complex network of neurones that 
differ in their intrinsic properties, neuronal inputs and outputs. However, how these 
neuronal networks function to integrate and produce appropriate responses is still 
largely unknown. An electrophysiological classification of ARC neurones could help 
to provide an understanding of their functional roles, as neurones with different 
properties such as the differential expression of active conductances could indicate a 
functional heterogeneity between ARC neurones. This classification is important as 
it means in the future the function of neurones could be identified just by looking at 
the electrophysiological properties of the neurone and any future experiments could 
then be placed into a functional context. The classification of ARC neurones in this 
study is based upon previous work carried out by van den Top (2002), who classified 
ARC neurones into 6 clusters. This classification has in recent years been extended 
and now comprises 8 neuronal clusters (unpublished data). The characterisation of 
neurones in this study builds upon this classification. 
A total of 411 ARC neurones were recorded from and these neurones were 
divided into 8 groups or clusters based upon subthreshold active membrane 
conductances expressed. These included la,,, lhq the A-like transient outward rectifier 
and the T-type calcium conductance. Active conductances are important for shaping 
the electrophysiological. properties of individual neurones as they integrate synaptic 
inputs and help to control the output of neurones by altering their patterns of activity 
(Huguenard, 1996; Pape, 1996; van den Top el al., 2004). Dividing neurones into 
groups that contain different active conductances might help to functionally separate 
ARC neurones, as neurones with different electrophysiological properties could also 
have different functions within the ARC. These active conductances have previously 
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been identified in neurones as described before and are easily identifiable from the 
IN relationship. 
Cluster I neurones were identified by the expression of 1,,,; cluster 2 neurones 
expressed 1. and IA; cluster 3 neurones were identified on the basis that they did not 
express any of the subthreshold active conductances used to characterise the other 
neurones; cluster 4 neurones expressed lh; cluster 5 neurones expressed lh and 
T-type; cluster 6 neurones expressed T-type; cluster 7 neurones expressed 1,,,, and 
T-type and cluster 8 neurones expressed Ia,, lh and T-type. 
Characterising ARC neurones based upon subthreshold active conductances 
represents one way in which to classify ARC neurones into potential functional 
groups. However this is by no means a definitive classification and there are many 
ways in which this classification can be built upon. For example, this classification 
only looks at subthreshold conductances but there are important suprathreshold 
conductances, such as the action potential and afterhyperpolarisation which could be 
used to classify the neurones further into groups. In addition to these intrinsic 
factors, responses to extrinsic factors such as neuropeptides and hormones could be 
used to classify neurones into potential functional groups. There are also many ways 
in which this classification could be improved, for example, deten-nining what 
receptors or transmitters are expressed within the neurone and determining the inputs 
to and outputs from the neurones could help to further subdivide ARC neurones into 
functional groups. As the classification is extended it may become a more useful 
tool in which to identify functional groups within the ARC based upon their 
electrophysiological properties. Further studies are therefore needed to extend the 
classification and divide neurones into even more specific functional groups. 
Electrophysiological studies need to be combined with studies identifying the 
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chemical phenotype, the projections, membrane receptors and synaptic physiology 
and pharmacology in order to fully identify functional groups within the ARC. 
In conclusion, recording from neurones in physiological and non- 
physiological glucose produced several notable differences in the 
electrophysiological. properties of ARC neurones. In particular there was an increase 
in activity, a decrease in input resistance and a change in the expression of some 
subthreshold active conductances in neurones recorded in physiological compared to 
non-physiological glucose. These results are important in showing that neurones 
under different physiological or pathophysiological states, such as diabetes, have 
very different properties. In addition, ARC neurones were subdivided into groups 
based upon the subthreshold active conductances they expressed. These clusters may 
represent different functional groups within the ARC, as the electrical properties of 
neurones may represent one way of separating neurones into functional groups, and 
so have helped us to further understand and characterise ARC neurones. 
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Figure 3.1 Comparison of resting membrane potentials of neurones recorded in 
10 mM and 2 mM glucose-containing aCSF 
A: Bar-chart comparing the membrane potentials of neurones recorded in 10 MM 
glucose-containing aCSF and 2 mM glucose-containing aCSF. A total of 241 neurones 
were recorded in 10 mM glucose-containing aCSF and a total of 170 neurones were 
recorded in 2 mM glucose-containing aCSF. The numbers of neurones in each 5 mV bin 
were plotted as a percentage of these totals. 
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Figure 3.2 Comparison of input resistances of neurones recorded in 10 mM and 
2 mM glucose-containing aCSF 
A: Bar-chart comparing the input resistances of neurones recorded in 10 mM glucose- 
containing aCSF and 2 mM glucose-containing aCSF. A total of 241 neurones were 
recorded in 10 mM glucose-containing aCSF, and a total of 170 neurones were recorded 
in 2 mM glucose-containing aCSF. The numbers of neurones in each 500 MKI bin were 
plotted as a percentage of these totals. 
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Figure 3.3 Comparison of membrane time-constants of neurones recorded in 
10 mM and 2 mM glucose-containing aCSF 
A: Bar-chart comparing the membrane time-constants of neurones recorded in 10 mM 
glucose-containing aCSF and 2 mM glucose-containing aCSF. A total of 241 neurones 
were recorded in 10 mM glucose-containing aCSF, and a total of 170 neurones were 
recorded in 2 mM glucose-containing aCSF. The numbers of neurones in each 10 ms bin 
were plotted as a percentage of these totals. 
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Figure 3.4 Comparison of spontaneous firing rates of neurones recorded in 10 mM 
and 2 mM glucose-containing aCSF 
Ai: Bar-chart comparing the spontaneous firing rates of neurones recorded in 10 mM 
glucose-containing aCSF and 2 mM glucose-containing aCSF. Data is included from 
234 neurones (75 active cells and 159 silent cells) in 10 mM glucose-containing aCSF 
and 158 neurones (79 active cells and 79 silent cells) in 2 mM glucose-containing aCSF. 
The numbers of neurones in each 0.5 Hz bin were plotted as a percentage of these totals. 
AH: Bar-chart comparing the proportion of active and silent neurones recorded in 10 
mM glucose-containing aCSF and 2 mM glucose-containing aCSF. Note the increase in 
the proportion of spontaneously active cells from 10 mM glucose-containing aCSF to 
2 mM glucose-containing aCSF. 
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Figure 3.5 Characteristics and analysis of electrical properties of arcuate nucleus 
neurones 
A: Example of an action potential of an arcuate nucleus (ARC) neurone recorded in 
current clamp and shown on an expanded time-scale. The amplitude of the spike was 
calculated as the difference between the membrane potential at the peak of the action 
potential (upper dashed line) and the membrane potential at the threshold of spike firing 
(lower dashed line). The duration at half-height was calculated as the difference in time 
between the rising and falling phase of the action potential at the point of half-amplitude 
of the action potential (arrow 1). The duration at threshold was calculated as the 
difference in time between the rising and failing phase of the action potential at the point 
of threshold (arrow 2). 
Bi: Activation of the anomalous inward rectifier (Ian) leads to a decrease in input 
resistance at more negative membrane potentials. The arrows indicate the decreased 
membrane response at more hyperpolarised membrane potentials (downward arrow) 
relative to membrane potential responses close to rest (upward arrow) as a result of the 
activation Of Ian. Note the fast activation and the lack of inactivation of this conductance. 
Bii: Activation of an A-like conductance resulted in a delayed return to baseline 
following negative current injection. In the absence of the A-like conductance, the 
membrane would be expected to discharge at the same rate as it was charged at the 
beginning of the negative current injection. The duration of the activation of the A-like 
conductance was measured as the time between the end of current injection (marked by 
the first vertical dotted line) and the return of the membrane potential to the level prior 
to the current injection (marked by the second vertical dotted line). The amplitude of 
the current was measured at half-duration (line marked *). 
Bifi: The hyperpo I ari sat ion-activated non-selective cation conductance 0h) is 
characterized by a time- and voltage-dependent sag in the membrane response to 
negative current injection. At negative membrane potentials, there was no inactivation 
Of lh. The amplitude Of lh was measured by subtracting the membrane potential at the 
end of the negative current injection (upper dotted line) from the membrane potential 
following steady-state charging of the cellular membrane (lower dotted line). 
Biv: The activation of the T-type calcium conductance close to the resting membrane 
potential resulted in a rebound depolarisation at the break of the response to negative 
current injection. Generally one or more action potentials were generated during the 
membrane depolarisation. The lower dotted line marks the resting membrane potential 
and the upper dotted line marks the peak of the rebound depolarisation as observed as a 
plateau following the action potential. To quantify the amplitude of the T-type 
conductance, the difference in membrane potential between resting membrane potential 
and the peak of the membrane depolarisation was taken. Cells in which the plateau was 
masked due to prolonged action potential firing were not used for analysis. 
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Figure 3.6 Electrophysiological properties of cluster 1 and 2 neurones 
A: Superimposed traces from a continuous whole-cell current clamp recording of a 
cluster I neurone, showing membrane responses to a range of hyperpolarising and 
depolarising rectangular-wave current steps of constant increment (illustrated 
beneath). The membrane potential of the neurone is shown to the left in all figures. 
Anomalous inward rectification (Ian) can be seen as a relative reduction in the 
increase of the membrane voltage responses to the linearly increased hyperpolarising 
current pulses, as indicated by the arrows. 
B: Superimposed traces from a continuous whole-cell current clamp recording of a 
cluster 2 neurone, showing membrane responses to a range of hyperpolarising and 
depolarising rectangular-wave current steps of constant increment (illustrated 
beneath). Anomalous inward rectification (I. ) can be seen as a relative reduction in 
the increase of the membrane voltage responses to the linearly increased 
hyperpolarising current pulses, as indicated by the arrows. The second arrow 
indicates the delayed return to baseline following negative current injection as a 
result of the activation of an A-like conductance. 
C: Plot of the current-voltage relationship (I-V) of the neurone shown in B as 
obtained by plotting the current injected into the cell (X-axis) against the resulting 
membrane potential (Y-axis). Note the reduction in the slope of the plot towards 
more negative membrane potentials as a result of the activation Of Ian. The arrow 
shows the point in the I-V at which the slope of the plot decreased and the mean 
activation threshold for Ian was estimated by averaging the membrane potential of 
this point in the I-V plots of cluster I or cluster 2 neurones. 
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Figure 3.7 Electrophysiological properties of cluster 3 and 4 neurones 
Ai: Superimposed traces from a continuous whole-cell current clamp recording of a 
cluster 3 neurone, showing membrane responses to a range of hyperpolarising and 
depolarising rectangular-wave current steps of constant increment (illustrated 
beneath). Note the lack of any distinctive subthreshold active membrane 
conductances. 
Afi: Plot of the current-voltage relationship of the neurone shown in Ai. Note the 
constant slope of the plot as a result of the constant membrane resistance over the 
range of membrane potentials tested. 
Bi: Superimposed traces from a continuous whole-cell current clamp recording of a 
cluster 4 neurone, showing membrane responses to a range of hyperpolarising and 
depolarising rectangular-wave current steps of constant increment (illustrated 
beneath). Note the sag in the membrane response during negative current injection as 
a result of the activation Of lh. The amplitude of the lh conductance was measured as 
the difference in membrane potential between the two dotted lines. The arrow heads 
inserted in the I-V plot mark the activation Of Ih at different membrane potentials as 
the kinetics of activation are different at different holding potentials. Note the 
decrease in activation latency (time difference between the two arrowheads) and 
increased amplitude of the sag at more negative membrane potentials. Square and 
circle mark the position of the traces used to measure the instantaneous and steady- 
state membrane responses, respectively (see Bii). 
Bfi: Plot of the instantaneous (square) and steady-state (circle) membrane responses 
of the neurone shown in Bi. The difference between the lines is indicative of the 
activation Of lh, which decreases the steady-state membrane response at negative 
holding potentials resulting in a non-linear current-voltage relationship. The arrow 
marks the point used to estimate the activation threshold Of lh in ARC neurones, 
which in the neurone shown amounts to approximately -88 mV. 
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Figure 3.8 Electrophysiological properties of cluster 5 and 6 neurones 
Ai: Superimposed traces from a continuous whole-cell current clamp recording of a 
cluster 5 neurone, showing membrane responses to a range of hyperpolarising and 
depolarising rectangular-wave current steps of constant increment (illustrated 
beneath). Note the sag in the membrane response during negative current injection as 
a result of the activation Of lh. Note also the rebound depolarisation upon release of 
the holding current due to the activation of a T-type calcium conductance (arrow 1), 
although there may also be some contribution from lh. 
Aii: Plot of the instantaneous (square) and steady-state (circle) membrane responses 
of the neurone shown in Ai. Note the decrease in the steady-state membrane 
response at negative holding potentials as a result of the activation Of Ih. Arrow 2 
marks the point used to estimate the activation threshold Of Ih in ARC neurones, 
which in the neurone shown amounts to approximately -91 mV. 
Bi: Superimposed traces from a continuous whole-cell current clamp recording of a 
cluster 6 neurone, showing membrane responses to a range of hyperpolarising and 
depolarising rectangular-wave current steps of constant increment (illustrated 
beneath). Note the rebound depolarisation upon release of the holding current due to 
the activation of a T-type calcium conductance (arrow 3) and the absence of any 
other subthreshold active conductances. 
Bfi: Plot of the current-voltage relationship of the neurone shown in Bi. Note the 
linear relationship between injected current and the resulting membrane response. 
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Figure 3.9 Electrophysiological properties of cluster 7 and 8 neurones 
Ai: Superimposed traces from a continuous whole-cell current clamp recording of a 
cluster 7 neurone, showing membrane responses to a range of hyperpolarising and 
depolarising rectangular-wave current steps of constant increment (illustrated 
beneath). Anomalous inward rectification (1,, ) can be seen as a relative reduction in 
the increase of the membrane voltage responses to the linearly increased 
hyperpolarising current pulses, as indicated by the arrows. Note also the rebound 
depolarisation upon release of the holding current due to the activation of a T-type 
calcium conductance (arrow 1). 
Afi: Plot of the current-voltage relationship (I-V) of the neurone shown in Ai. Note 
the reduction in the slope of the plot towards more negative membrane potentials as 
a result of the activation of 1. (arrow 2). 
Bi: Superimposed traces from a continuous whole-cell current clamp recording of a 
cluster 8 neurone, showing membrane responses to a range of hyperpolarising and 
depolarising rectangular-wave current steps of constant increment (illustrated 
beneath). Note the sag in the membrane response during negative current injection as 
a result of the activation Of lh. Anomalous inward rectification (la,, ) can be seen as a 
relative reduction in the increase of the membrane voltage responses to the linearly 
increased hyperpolarising current pulses, as indicated by the arrows. Note the 
rebound depolarisation upon release of the holding current due to the activation of a 
T-type calcium conductance (arrow 3). Note also that the active conductances may 
be contributing towards each other therefore values can only be estimated. 
Bfi: Plot of the instantaneous (square) and steady-state (circle) membrane responses 
of the neurone shown in Bi. Note the decrease in the steady-state membrane response 
at negative holding potentials as a result of the activation of Ih. Note also the 
reduction in the slope of the instantaneous Plot towards more negative membrane 
potentials as a result of the activation of 1,,,. Arrow 4 marks both the activation point 
Of Ih and Ian in this case, at about -93 mV. 
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Figure 3.10 Relative proportion of neurones in each cluster recorded in 10 mM 
and 2 mM glucose-containing aCSF 
A: Bar-chart showing the percentage of neurones classified into each cluster 
recorded in 10 mM and 2 mM glucose-containing aCSF. Note the percentage of 
neurones in clusters 1,2 and 6 is higher in 2 mM glucose-containing aCSF but in 
clusters 4,5 and 8, the percentage of neurones is higher in 10 mM glucose- 
containing aCSF. Clusters 3 and 7 expressed the same percentage of neurones in 
both glucose concentrations. 
- 130- 
Figure 3.10 
A 
35 
30 
25 
cu u -)0 
15 Z 
10 
-0 
z 
0 
Cluster 
2 mM glucose 
10 mM glucose 
1 
Chapter Three 
Figure 3.11 Comparison of neurones displaying spontaneous suprathreshold 
activity in each cluster recorded in 10 mM and 2 mM glucose-containing aCSF 
A: Bar-chart showing the percentage of spontaneously active neurones in each 
cluster recorded in 10 mM and 2 mM glucose-containing aCSF. Note the percentage 
of active neurones is higher in all clusters, except cluster 1, in 2 mM glucose 
compared to 10 mM glucose. 
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4.1 Introduction 
The arcuate nucleus (ARC) of the hypothalamus is involved in the regulation 
of feeding and energy homeostasis. It contains two principal neuronal subtypes 
involved in this process: orexigenic NPY/AgRP neurones and anorexigenic 
POMC/CART neurones (Cone, 2005). In addition the ARC expresses a variety of 
other neuronal subtypes including neuromedin U, neurotensin, somatostatin, 
dopamine and galanin-like peptide (GALP; Chronwall, 1985; Cone et al., 2001). The 
neurotransmitter 5-HT has been extensively implicated in the control of feeding and 
energy homeostasis, alongside its regulation of many biological, behavioural and 
physiological processes such as then-noregulation, stress responses, reproductive 
behaviour and circadian rhythms (Blundell, 1977; Bonate, 1991; Wilkinson & 
Dourish, 1991; Lowry, 2002). It is also associated with psychiatric disorders such as 
depression and anxiety (Baldwin & Rudge, 1995; Graeff et al., 1996), as well as 
neurodegenerative conditions including Alzheimer's and Parkinson's disease (Cross, 
1990). 5-HT is synthesised from tryptophan by tryptophan hydroxylase (Fuller, 
1980). It is predominantly produced in the gut but it is also produced in the brain, 
primarily from the raph6 nuclei in the brainstern (Azmitia & Segal, 1978; 
Sawchenko et al., 1983). 5-HT exerts its actions through multiple receptor subtypes, 
which have been pharmacologically classified into seven families: 5-HTI-7 (Hoyer et 
al, 1994; Bames & Sharp, 1999). The 5-HT3 receptor is a ligand-gated ion channel 
but all the other receptors are G-protein coupled (for review of 5-HT signalling, see 
general introduction and Raymond et al., 2001 and Adayev et al., 2005). 
In the control of feeding specifically, 5-HT acts to suppress food intake 
whereas depletion of 5-HT increases food intake (Blundell, 1977,1984; Curzon, 
1990; Leibowitz et al., 1990; Curzon, 1991; Samanin & Grignaschi, 1996; 
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Simansky, 1996). 5-HT levels have been shown to increase in the lateral 
hypothalamus upon feeding (Schwartz et aL, 1989) and direct injection of 5-HT into 
the PVN suppresses food intake (Currie & Coscina, 1996). As it is a strong candidate 
for the inhibition of feeding, several serotonergie agents have been used in the 
pharmacological treatment of obesity. These include d-fenfluramine (d-fen), a 
serotonin releaser and re-uptake inhibitor (Guy-Grand, 1992) and sibutramine, a 
combined noradrenaline and serotonin reuptake inhibitor (Luque & Rey, 2002). Both 
agents have been shown to reduce feeding upon application. d-Fen however was 
withdrawn ftom use due to severe cardiopulmonary side-effects (valvular heart 
disease and pulmonary hypertension; Connolly et al., 1997; Mark et al., 1997). 
Studies to-date indicate that the 5-HT receptors likely to be involved in the 
regulation of feeding are either the 5-HTI or 5-HT2 subtypes (De Vry & Schreiber, 
2000). Metergoline, a non-selective 5-HTI/2 receptor antagonist blocked the 
inhibitory effect of 5-HT on feeding when injected into the paraventricular nucleus 
(PVN; Currie & Coscina, 1996) and the 5-HTIB/2c agonist mCPP decreased food 
intake in rats (Dryden et al., 1996b) suggesting evidence of an interaction between 
the 5-HT, and 5-HT2 receptors in the control of feeding. 
More specific evidence for the involvement of the 5-HTI receptor is that 
d-fen has been suggested to exert its inhibitory effects on feeding through the 5-HTI 
receptor, particularly the 5-HTIB subtype (Neill & Cooper, 1989; Grignaschi & 
Samanin, 1992; Grignaschi et al., 1995) but not the 5-HTIA subtype (Vickers et al., 
1996). Further evidence for a role for the 5-HTIB receptor in feeding is shown by the 
fact that 5-HTIB knockout mice did not display hypophagia after fenfluramine 
administration (Lucas et al., 1998); the 5-HTIB/2c agonist mCPP decreased food 
intake when injected into rats (Dryden el al., 1996b) and the 5-HTIB agonists 
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RU24969, TFMPP and mCPP all induced a dose-dependent reduction in food intake 
which was blocked by 5-HTIB antagonists (Bendotti & Samanin, 1987; Kennett et 
al., 1987; Kennett & Curzon, 1988). Furthermore, a more selective 5-HTIB agonist, 
CP94253 also induced hypophagia (Halford & Blundell, 1996; Lee & Simansky, 
1997; Lee et al., 2002). The 5-HTIB receptor is widely expressed throughout the 
hypothalamus, with particularly strong expression in the magnocellular nuclei, the 
supraoptic nucleus, and the PVN (Makarenko et al., 2002). Studies have shown 
5-HT neurones to interact with neuropeptide Y (NPY) neurones (Guy et al., 1988) 
and that 5-HT inhibits feeding partly by blocking NPY release in the PVN, as the 
5-HT synthesis inhibitor, p-chlorophenylalanine was able to increase the level of 
NPY available for release (Dryden et al., 1996c). The 5-HTIB receptor is expressed 
on NPY neurones and 5-HT induces a hyperpolarisation in these neurones (Heisler et 
al., 2006). Collectively these data indicate a key role for the 5-HTIB receptor in the 
control of energy homeostasis. 
In contrast to the inhibitory effects of 5-HT on feeding, the 5-HTIA receptor 
agonist flesinoxan increased feeding (Dryden et al., 1996a). Studies showed that the 
5-HTIA/7 agonist 8-OH-DPAT elicited feeding in rats (Dourish et al., 1985,1986) 
and later showed that 8-OH-DPAT induced hyperphagia through the 5-HTIA 
receptor (Hutson et al., 1988). In contrast to its usual hypophagic effects, this 5-HT 
agonist causes hyperphagia due to the fact that the 5-HTIA receptor is an auto- 
receptor and so 5-HT and its agonists act upon presynaptic 5-HTIA receptors to 
inhibit 5-HT release and hence increase feeding. In situ hybridisation techniques 
have been used to show the expression of 5-HTIA receptors all over the brain, 
including within the hypothalamus, particularly the ventromedial nucleus (VMN) 
and dorsomedial hypothalamus (DMH; Chalmers & Watson, 199 1; Pompeiano et al., 
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1992; Wright et al., 1995), as have studies using immunohistochernistry which 
showed expression of 5-HTIA receptors over a large proportion of the brain, 
including the hypothalamus (Aznar et al., 2003). 
Evidence for the role of the 5-HT2 receptor in feeding is suggested by the 
observation that 5-HT affects the activity of POMC neurones through the 5-HT2C 
receptor, as they are expressed on PONIC neurones (Heisler et al., 2002). Further 
evidence for a role for this receptor in the control of feeding was shown by Tecott 
who demonstrated that 5-HT2C knockout mice develop hyperphagia (Tecott et al., 
1995), whilst mice with a mutated form of the 5-HT2C receptor also showed signs of 
hyperphagia (Nonogaki et al., 1998). Vickers reported that the effects of d-fen were 
reduced in 5-HT2c knockout mice, and that the 5-HT2c receptor antagonist 
SB242084 inhibited d-fen-induced hypophagia (Vickers et al., 1999,2001). The 
non-specific 5-HT2 receptor antagonist ketanserin also inhibited d-fen-induced 
hypophagia (Hewson et al., 1988), adding to the evidence indicating that this 
receptor plays an important role in mediating the effects of the appetite suppressant 
d-fen. 5-HT2C receptors have been localised within the ARC, PVN, and DMH 
(Wright et al., 1995). Further studies utilised in situ hybridisation to show the 
expression of 5-HT2c receptors within the hypothalamus, particularly, in the DMH, 
lateral hypothalamus (LH) and PVN (Hoffman & Mezey, 1989; Molineaux et al., 
1989). 
Although most of the literature leans towards a role for the 5-HT2c receptor 
subtype in the control of feeding, some studies have looked at the 5-HT2A and 
5-HT2B receptor subtypes. 5-HT has been shown to reduce hyperphagia in mice 
over-expressing NPY by acting at 5-HT2A receptors (Hsiao et al., 2005). A 5-HT2A 
receptor antagonist was able to block the action of NPY in the PVN, indicating an 
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interaction between NPY and 5-HT2A receptors (Currie et al., 2002). The 5-HT2B 
receptor agonist BW 723C86 induced hyperphagia, in contrast to the effect of other 
5-HT2 agonists (Kennett et al., 1997a). 5-HT2B receptors have been reported within 
the hypothalamus, particularly in the DMH (Duxon et al., 1997a). 5-HT2A receptors 
have not been widely found in the hypothalamus, but are instead predominantly 
expressed in the amygdala, hippocampus and cortex (Xu & Pandey, 2000). However, 
there was a study which did find 5-HT2A receptors in the PVN using 
immunohistochernistry (Zhang et al., 2002). 
Despite this extensive literature supporting a role for 5-HT receptors in 
controlling energy balance, the receptors and cellular mechanisms underlying the 
effects of 5-HT at the level of the ARC are still not completely known. Therefore, 
the aims of this study, shown in this chapter and the next, were to investigate the 
cellular mechanisms by which 5-HT regulates key hypothalamic neurones in the 
ARC involved in regulating energy homeostasis and to elucidate which 5-HT 
receptor subtypes were mediating these effects by using a range of selective agonists 
and antagonists. In addition, the phenotype of neurones that are regulated by 5-HT 
will be investigated using markers for orexigenic (ghrelin) and anorexigenic (CART) 
neurones. 
4.2 Results 
In this study, 5-HT (50 gM) was applied to 122 ARC neurones obtained with 
the whole-cell patch clamp technique. This concentration of 5-HT was chosen to 
ensure there was an adequate supply of 5-HT at the synapse to produce a response, 
as 5-HT is subject to re-uptake. 5-HT was bath applied to the slice by superfusion 
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for between 45-75 seconds. Results were obtained in 2 mM glucose-containing aCSF 
unless otherwise stated. These neurones responded to 5-HT either with a 
depolarisation of the membrane (30 %), a hyperpolarisation of the membrane (37 %) 
or did not respond (33 %; see figure 4.1). This chapter will describe the excitatory 
effects of 5-HT on rat ARC neurones whilst the inhibitory effects will be shown in 
the following chapter. Statistical significance in these chapters was determined using 
student's two tailed t-test, paired or unpaired as appropriate or chi-square test where 
stated. 
4.2.1 The e-xcitatory effects of 5-HT on ARC neurones 
Bath application of 5-HT (50 ýiM) to the slice by superfusion for 45-75 s 
induced a membrane depolarisation in 37 ARC neurones. The depolarisation of the 
membrane was slow in onset and could reach threshold for action potential firing, 
resulting in an increase in the activity of these neurones. This response was 
characterised by depolarisation of the membrane from a mean resting membrane 
potential of -50.2 ± 1.1 mV to -43.8 ± 0.9 mV, a mean peak membrane 
depolarisation of 6.4 ± 0.7 mV (n=37; see figure 4.1C). The response partially 
recovered upon washout of 5-HT from the bath, returning the mean membrane 
potential to -48.8 ± 1.5 mV (n=25). The 5-HT-induced depolarisation was 
maintained in the presence of 500 nM tetrodotoxin (TTX), indicating a direct effect 
on ARC neurones (n=6; see figure 4.2Ai). 
The depolarisation induced by 5-HT was associated with either an increase in 
input resistance, a decrease in input resistance or no measurable change. 
Increase in Input Resistance: 5-HT-induced depolarisation in a sub- 
population of neurones was associated with a significant 33.1 ± 4.2 % increase in 
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neuronal input resistance from a mean of 939 ± 140 MO at rest to 1225 ± 160 MO in 
the presence of 5-HT, an increase of 286 ± 40 MO (P<0.01; n=9; see figure 4.2). 
Decrease in Input Resistance: The 5-HT-induced membrane depolarisation 
was also associated with a significant 25.8 ± 2.7 % decrease in neuronal input 
resistance in a sub-population of neurones, from a mean of 1669 ± 212 MO at rest to 
1235 ± 165 MQ in the presence of 5-HT, a decrease of 434 ± 86 MO (P<0.0 1; n= 15; 
see figure 4.3). 
No change in Input resistance: In a further subset of neurones, the 5-HT- 
induced membrane depolarisation was associated with a non-significant 1.0 ± 2.1 % 
change in neuronal input resistance from a mean of 1413 ± 161 MO at rest to 
1424 ± 162 MQ in the presence of 5-HT, a change of 11 ± 34 MO. (No change in 
resistance was considered to be a value of 10 % or less; P=O. 8; n= 13; see figure 4.4). 
In a sub-population of neurones, to confinn that the change in resistance was 
due to 5-HT and not due to an indirect effect through voltage-dependent 
conductances being engaged, a period of constant negative current injection was 
applied during the 5-HT response to eliminate any voltage-dependent effects (for 
example see figure 4.2Ai). 
The effect of 5-HT on ARC neurones was also studied in voltage-clamp. 
5-HT induced an inward current (see figure 4.5A), with a mean peak current of 
23.2 ± 6.6 pA at a holding potential of -40 mV (n=6) and a mean peak current of 
16.6 ± 5.0 pA at a holding potential of -50 mV (n=6). The current was fast in onset 
with a slow gradual decay after reaching its peak. 
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4.2.2 Ionic mechanism underlying the 5-HT-induced depolarisation 
The 5-HT-induced depolarisation was associated with an increase, a decrease 
or no change in input resistance. Current-voltage relationships were obtained in 
control conditions and at the peak of the 5-HT-induced depolarisation to further 
investigate the underlying ionic mechanism. In neurones which responded to 5-HT 
with an increase in input resistance, there was an average reversal potential of 
-91.5 ± 3.0 mV (n=4; see figure 4.2Aiii). This is close to the reversal potential for 
potassium ions under our recording conditions. In neurones which responded to 
5-HT with a decrease in input resistance, extrapolation of the IN resulted in an 
average reversal potential of -39.5 ± 0.8 mV (n=6; see figure 4.3Aiii), indicating 
activation of a non-selective cation conductance. In neurones that responded to 
5-HT with no change in resistance, the plots showed a parallel shift (n=7; see figure 
4.4Aiii) indicating either the activation of an electrogenic pump in the membrane or 
the concurrent activation/inhibition of more than one conductance. The reversal 
potential was taken from the point at which the plots of the two current-voltage 
relations intersected. 
Voltage-clamp ramps were also performed in the presence of TTX to identify 
the ionic mechanism underlying the 5-HT-induced inward current (see figure 4.5B). 
The currents were obtained from ramp protocols that drove the holding potential 
from -130 mV to -30 mV, at a rate of 10 mV per second. The current responses in 
the presence and absence of 5-HT showed a parallel shift indicating no change in 
input resistance (n=2). 
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4.2 3 5-HT-induced membrane potential oscillations 
In three of the neurones exposed to 5-HT, regular bursts of action potentials 
were generated, corresponding with underlying membrane potential oscillations (see 
figure 4.6). These oscillations consisted of a biphasic wavefonn, with a slow 
depolarising phase followed by a rapid hyperpolarising component. The mean 
amplitude of the membrane potential oscillations, measured from the peak of the 
hyperpolarising to the peak of the depolarising phase, amounted to 17.1 ± 2.9 mV 
(n=3). The depolarisation of the membrane reached threshold for action potential 
firing leading to the generation of bursts of action potentials. The average number of 
action potentials generated per-burst superimposed upon these membrane potential 
oscillations was 17.0 ± 4.6 and the peak frequency amounted to 2.3 ± 0.7 Hz. 
4. Z4.5-HT-induced indirect effects on ARC neurones 
As well as inducing a direct membrane depolarisation, 5-HT exerted indirect 
effects on ARC neurones by inducing a change in synaptic activity, either increasing 
or decreasing the number of spontaneous excitatory post-synaptic potentials (EPSPs) 
or inhibitory post-synaptic potentials (IPSPs). EPSPs increased in ftequency ftom 
0.9 ± 0.2 Hz to 1.7 ± 0.3 Hz in the presence of 5-HT (n=3). IPSPs increased in 
frequency from 0.4 ± 0.1 Hz to 1.1 ± 0.4 Hz in the presence of 5 -HT (n=2; see figure 
4.7A). 5-HT also caused a decrease in the number of spontaneous EPSPs or IPSPs in 
some neurones from a mean frequency of 1.4 ± 0.4 Hz to 0.3 ± 0.3 Hz in the 
presence of 5-HT (n=2; see figure 4.7B). 
To identify which 5-HT receptor subtypes are involved in the 5-HT-induced 
depolarisation, a range of 5-HT agonists and antagonists were used. 
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4.2.5 The effects of 5-HT receptor agonists on ARC neurones 
To determine the nature of the 5-HT receptor subtypes that mediate the 
depolarisation induced by 5-HT, the effects of selective agonists were first 
investigated. All agonists were bath applied to the slice by superfusion for 60-120 s. 
(x-methyl 5-HT (25 [M), a 5-HT2 receptor preferential agonist depolarised ARC 
neurones, from a membrane potential of -46.8 ± 1.8 mV to -41,0 ± 2.1 mV, a mean 
peak depolarisation of 6.0 ± 0.8 mV (n=17; see figure 4.8A). (x-methyl 5-HT induced 
depolarisation of neurones to threshold, inducing action potential firing and 
increasing excitability. Input resistance decreased by 21.3 ± 5.0 % in a sub- 
population of these neurones, from 1102 ± 173 MO to 842 ± 129 MO in the presence 
of (x-methyl 5-HT. Input resistance increased by 22.8 ± 4.2 % in a further subset of 
neurones, from 1263 ± 266 MO to 1552 ± 326 MO in the presence of (x-methyl 
5-11T. (x-methyl 5-HT also induced a burst-like pattern of firing in a sub-population 
of ARC neurones, similar to that observed with 5-HT (n=2). 
Agonists for the 5-HTI receptor were next tested for their ability to mimic the 
5-HT-induced depolarisation. The 5-HTI/5/7 receptor agonist 5-CT (10 ýN) induced 
a membrane depolarisation, which reached threshold for action potential firing, from 
a membrane potential of -42.9 ± 3.3 mV to -37.7 ± 4.3 mV, with an associated 
4.2 ± 6.2 % increase in membrane resistance from 961 ±8 MO to 1002 ± 63 MO 
(n=3; see figure 4.8B). 
However, the 5-HTIA/7 receptor agonist 8-OH-DPAT (10 ýM; n=3) and the 
5-HT3 receptor agonist mCPBG (10 [tM; n=3) did not mimic the 5-HT-induced 
excitation (see figure 4.9) and had no effect on the membrane potential or input 
resistance of neurones that had responded to 5-HT with depolarisation. 
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Collectively these data suggest that there maybe different receptors mediating 
the 5-HT-induced depolarisation, through different mechanisms. It may be that 
different subtypes of the 5-HT2 receptor may mediate the increase and decrease in 
input resistance associated with the 5-HT-induced depolarisation and also the 
5-HTI/5 receptors may be partly responsible for mediating the 5-HT-induced 
depolarisation associated with either no change or a small increase in input 
resistance. 
4.2.6 The effects of 5-HT receptor antagonists on 5-HT-induced responses in ARC 
neurones 
To clarify further the potential role of 5-HT2 receptors in the 5-HT-induced 
depolarisation, the effects of a selective 5-HT2 receptor antagonist were tested. All 
antagonists were bath applied to the slice by superfusion for approximately 
5 minutes, this time of application ensuring saturation of the bath at the required 
concentration. The 5-HT2 receptor antagonist altanserin inhibited the 5-HT-induced 
depolarisation in a concentration-dependent manner (see figure 4. IOAiii). 
Application of the antagonist alone had no effect on the recorded neurones. 200 nM 
altanserin partially reduced the 5-HT-induced depolarisation with a 21.4% ± 24.1 % 
reduction in mean peak depolarisation compared to control in the absence of 
antagonist (n=3). 400 nM altanserin partially suppressed the 5-HT-induced 
depolarisation with a 30.5 ± 16.6 % reduction in mean peak depolarisation (n=3). 
800 nM altanserin further inhibited the depolarisation with a 58.1 ± 23.3 % reduction 
in mean peak depolarisation (n=2). In the presence of I ýM altanserin the 5-HT- 
induced mean peak depolarisation was reduced from 6.2 ± 0.7 mV to 2.2 ± 1.3 mV, a 
57.6 ± 12.4 % reduction (n=5; see figure 4.10A). l vM altanserin partially reduced 
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the decrease in input resistance seen in the presence of 5-HT, from a mean peak 
decrease of 213 ± 50 M in 5-HT alone to 125 ± 180 MQ in the presence of the 
antagonist. 
In order to more specifically identify which subtypes of the 5-HT2 receptor 
were mediating the depolarisation, subtype-specific antagonists were tested. Firstly, 
the 5 -HT2c receptor antagonist RS 102221 was shown to partially suppress the 5-HT- 
induced depolarisation. In the presence of I ýM RS102221, the mean peak 
membrane depolarisation. induced by 5-HT was reduced from 7.4 ± 1.7 mV to 
4.8 ± 2. OmV in the presence of the antagonist, a 36.2 ± 21.5% reduction (n=4; see 
figure 4.10B) whilst mean peak decrease in membrane resistance induced by 5-HT 
was reduced from 273 ± 185 MQ to 96 ± 92 MO. In the presence of 2 ýtM 
RS102221, mean peak membrane depolarisation induced by 5-HT was reduced by 
37.9 ± 21.6 % in the presence of the antagonist (n=3). At 3 [tM, RS10221 only 
partially inhibited the 5-HT-induced depolarisation, as the mean peak depolarisation 
reduced by 6.8 ± 15.6 % (n=3). The antagonist alone had no effect on membrane 
potential or input resistance. 
Next, in order to investigate the involvement of the 5-HT2A receptor subtype, 
a selective 5-HT2A antagonist was tested. The 5-HT2A receptor antagonist R-96544 
had no effect on the 5-HT-induced depolarisation at I ýLM (n=6). However in the 
presence of 10 ýM R-96544, there was a reduction in the peak membrane 
depolarisation induced by 5-HT from 13.8 ± 2.8 mV to 7.0 ± 2.3 mV in the presence 
of the antagonist, a 53.1 ± 6.7 % reduction and a reduction in the 5-HT-induced 
increase in neuronal input resistance from 249 ± 26 MO in 5-HT alone to 
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106 ± 110 MO in the presence of the antagonist (n=4; see figure 4.11A). This 
antagonist alone had no effect on activity of neurones. 
Finally, the role of the 5-HT2B receptor subtype was investigated. The 5-HT2B 
receptor antagonist SB 204741 partially suppressed the 5-HT-induced depolarisation 
at I pM (n=3; see figure 4.11 B), with a reduction in mean peak depolarisation of 
85.0 ± 32.5 % compared to control in the absence of the antagonist. SB 204741 
induced a slight depolarisation of the membrane when applied alone suggesting that 
this antagonist acted in part as an agonist. 
To clarify whether the 5-HTI receptor is involved in mediating part of the 
5-HT-induced depolarisation, the 5-HTI receptor antagonist cyanopindolol was 
tested on ARC neurones. This antagonist had no effect on activity of neurones by 
itself and had no effect on the 5-HT-induced depolarisation (10 ýN; n=3) suggesting 
that this receptor is not involved in the 5-HT-induced depolarisation. 
These data suggest that the principal receptor subtypes involved in mediating 
the 5-HT-induced depolarisation are the 5-HT2A, 5-HT2B and 5-HT2C receptors. 
These results suggest that 5-HT is able to excite a population of ARC 
neurones but the identity of ARC neurones that are excited by 5-HT remains 
unknown. In order to try to identify the types of ARC neurones that were excited by 
5-HT, two methods were used. Firstly ghrelin, a marker of orexigenic neurones, was 
applied to neurones that had been exposed to 5-HT and responded with reversible 
depolarisation. Secondly, a double-labelling protocol was perfon-ned with CART, a 
marker for anorexigenic POMC neurones with which it co-localises (Elias el al., 
1998a). 
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4.2.7 The effects of ghrelin on ARC neurones 
Ghrelin is a 28 amino acid peptide, first identified as the endogenous ligand 
for the growth hormone secretagogue receptor (GHS-R; Kojima et al., 1999). It is an 
orexigenic hormone that is released from the stomach, and both central and 
peripheral injections of ghrelin cause an increase in food intake and body-weight in 
rats and humans (Tschop et al., 2000; Wren et al., 2001a, b; Wang et al., 2002; 
Faulconbridge et al., 2003; Currie et al., 2005). Ghrelin is reported to exert its effects 
in the arcuate nucleus via NPY/AgRP neurones, as NPY neurones in the ARC 
express the GHS-R (Willesen et al., 1999) and ghrelin increases NPY and AgRP 
mRNA expression (Kamegai et al., 2000,2001). Antibodies and antagonists of NPY 
and AgRP abolish the orexigenic effects of ghrelin (Nakazato et al., 2001). A 
population of hypothalamic neurones that express ghrelin and project to NPY 
neurones have also been discovered (Cowley et al., 2003; Mondal et al., 2005). 
Thus, in this study, ghrelin was used as a marker to identify orexigenic neurones as it 
is known to selectively target orexigenic neurones. 
All ghrelin and associated 5-HT-induced responses were obtained in 10 mM 
glucose. Ghrelin (100-200 nM) was applied to 24 ARC neurones that responded to 
5-HT with depolarisation. 58 % of these neurones did not respond to ghrelin. 42 % 
of these neurones responded with a depolarisation of the membrane upon ghrelin 
application, from a mean membrane potential of -50.5 ± 2.4 mV to -45.2 ± 2.6, a 
mean peak depolarisation of 5.3 ± 0.9 mV (n=10; see figure 4.12). The ghrelin- 
induced depolarisation was slow in onset and caused an increase in the activity of 
these neurones. In a sub-population of neurones ghrelin was able to induce a burst- 
like pattern of firing (se figure 4.12AH). Input resistance did not change in the 
presence of ghrelin, from 1000 ± 177 MO to 990 ± 191 MO, a reduction of 
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10 ± 70 MO. These data suggest that 5-HT is able to excite a sub-population of both 
orexigenic neurones and other un-identified neurones. 
4.2.8 5-HT excites CAR T-expressing neurones 
CART is a neuropeptide that has been shown to be involved in the regulation 
of feeding and energy homeostasis. CART was first identified as a mRNA that 
increased in the rat striaturn after acute administration of cocaine or amphetamine 
(Douglass et al., 1995). The administration of CART pepticle fragments into the 
cerebral ventricles inhibits feeding whereas administration of CART antiserurn 
increases feeding (Kristensen et al., 1998; Lambert et al., 1998). However injection 
of CART into the hypothalamic nuclei directly increases food intake (Abbott el al., 
2001). CART neurones have been shown to express the long form of the leptin 
receptor (Elias el al., 2001) and in leptin deficient obese mice (oblob), there is a 
reduction in CART mRNA and upon repletion of leptin, CART expression is 
stimulated (Kristensen et al., 1998). Taken together, these data suggest a key role at 
the level of the ARC for CART signalling in pathways regulating food intake and 
energy balance. 
CART is expressed within the ARC in the hypothalamus (Douglass et al., 
1995; Koylu et al., 1998; Elias et al., 2001) and is co-localised in anorexigenic 
POMC neurones within the ARC (Elias et al., 1998a). Therefore in this study, CART 
was used as a marker of anorexigenic neurones. 
Alexa 633 (50 pM) was added to the intracellular recording solution in order 
to be able to identify the neurones from which we recorded. 5-HT was applied to 
these neurones and then slices were subsequently stained for CART to identify if 
these neurones were CART-expressing or non-CART-expressing neurones. 5-HT 
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excited CART-expressing neurones (n=7; see figure 4.13A), or gave no response 
(n 1). 
Non-CART positive neurones (see figure 4.13B) were excited by 5-HT 
(n= 11), inhibited by 5-HT (n= 10) or did not respond (n=6). 
These data suggest that 5-HT is able to excite a population of CART- 
expressing neurones and hence excites anorexigenic neurones. 
As well as being the primary metabolic fuel for neurones, a population of 
neurones within the ARC are able to sense glucose and alter their activity 
accordingly (Levin et al., 2004). How such a key substrate affects the ability of ARC 
neurones to integrate extrinsic inputs and formulate responses was explored in this 
study. Neurones were recorded in both 10 mM and 2 mM glucose-containing aCSF 
and the response to 5-HT was recorded. 
4.2 9 5-HT-induced responses in 10 mM and 2 mM glucose-containing aCSF 
Neurones were recorded in both 10 mM and 2 mM glucose-containing aCSF. 
5-HT induced a depolarisation in 39 % (32/82) of neurones in 10 MM glucose- 
containing aCSF and 30 % (37/122) of neurones to which it was applied in 2 mM 
glucose-containing aCSF, a non-significant difference (chi-square test: P=0.2). In 
10 mM glucose-containing aCSF, 5-HT induced a peak membrane depolarisation of 
8.9 ± 0.7 mV (from a mean of -49.3 ± 1.3 mV to -40.4 ± 1.3 mV) and in 2 mM 
glucose-containing aCSF, 5-HT induced a peak membrane depolarisation of 
6.4 ± 0.7 mV, (from a mean of -50.2 ± 1.1 mV to -43.8 ± 0.9 mV), a significant 
difference between the two conditions (P<0.05). Peak change in input resistance did 
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not significantly differ between both recording conditions (from 1401 ± 116 MO to 
1299 ± 95 MK2 in 2 mM glucose and from 1384 ± 90 MQ to 1365 ± 103 M92 in 
10 mM glucose; P=0.4). 
5-HT induced a hyperpolarisation in 17 % (14/82) of neurones to which it 
was applied in 10 mM glucose-containing aCSF and 37 % (45/122) in 2 mM 
glucose-containing aCSF, a significant difference between the two conditions (chi- 
square test: P<0.01). In 10 mM glucose-containing aCSF, 5-HT induced a peak 
membrane hyperpolarisation of 14.8 ± 1.7 mV (from an average of -44.2 ± 2.4 mV 
to -59.0 ± 2.5 mV) and in 2 mM glucose-containing aCSF, 5-HT induced a peak 
membrane hyperpolarisation of 12.7 ± 0.9 mV (from an average of -49.0 ± 1.0 mV 
to 61.6 ± 1.2 mV), a non-significant difference between the two conditions (P=0.2). 
The peak change in input resistance induced by 5-HT did not significantly alter 
between the two recording conditions (from an average of 1608 ± 264 MQ to 
836 ± 90 MKI in 10 mM glucose and from 1438 ± 76 MO to 915 ± 67 M92 in 2 mM 
glucose; P=O. 1). 
5-HT induced no response in 44 % (36/82) of neurones to which it was 
applied in 10 mM glucose-containing aCSF and 33 % (40/122) in 2 mM glucose- 
containing aCSF, a non-significant difference (chi-square test: P=0.1; see figure 
4.14). 
4. ZIO 5-HT-induced responses in neurones classified into electrophysiological 
clusters 
in chapter three of this thesis, eight neuronal clusters were identified within 
the ARC based upon their electrophysiological properties. These clusters are 
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proposed to represent different functional groups within the ARC. The response to 
5-HT would thus be expected to produce differential effects across these functional 
groups. Figure 4.15 shows a histogram showing the responsiveness of each cluster to 
5-HT. 
Cluster I neurones responded to 5-HT with inhibition in 54 % of neurones, 
excitation in 15 % of neurones and no response in 31 % of neurones (n= 13). 
Cluster 2 neurones responded to 5-HT with inhibition in all neurones tested 
(n=4). As these neurones have previously been characterised as NPY/AgRP 
neurones (van den Top et al., 2004), this suggests that 5-HT is acting as an 
anorexigenic signal at the level of the ARC. 
Neurones in cluster 3 responded to 5-HT with inhibition in 15 % of neurones, 
excitation in 46 % of neurones and did not respond in 39 % of neurones (n=13). 
Cluster 4 neurones responded to 5-HT with inhibition in 42 % of neurones, 
excitation in 29 % of neurones and no response in 29 % of neurones (n=7). 
Neurones classified as cluster 5 responded to 5-HT with inhibition in 20 % of 
neurones, excitation in 45 % of neurones and no response in 35 % of neurones 
(n=20). 
Cluster 6 neurones responded to 5-HT with inhibition in 24 % of neurones, 
excitation in 37 % of neurones and no response in 39 % of neurones (n=41). 
Neurones in cluster 7 responded to 5-HT with inhibition in 56 % of neurones, 
excitation in 6% of neurones and no response in 38 % of neurones (n=16). 
Cluster 8 neurones responded to 5-HT with inhibition in 75 % of neurones 
and excitation in 25 % of neurones (n=8). No neurones in this cluster failed to 
respond to 5-HT, 
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4.3 Discussion 
In the present study, the effects of 5-HT on ARC neurones were investigated 
using the whole-cell patch-clamp technique. ARC neurones responded to 5-HT 
either with a depolarisation of the membrane, a hyperpolarisation of the membrane 
or they did not respond. This chapter focused on the excitatory effects of 5-HT. 
5-HT produced an excitatory effect in 37 % of the ARC neurones it was 
applied to, resulting in a depolarisation of the membrane with either a concomitant 
increase, decrease or no change in input resistance. The 5-HT-induced depolarisation 
persisted in the presence of TTX, indicating a direct effect of 5-HT on the recorded 
neurone. In addition, 5-HT produced indirect effects on ARC neurones by altering 
synaptic activity. 
24 % of neurones that were excited by 5-HT responded with an increase in 
neuronal input resistance. Current-voltage relationships showed a reversal potential 
around -91.5 mV indicating that the ionic mechanism most likely involves the 
closure of one or more resting potassium conductances. 41 % neurones responded 
with a decrease in input resistance with a reversal potential indicated around 
-39.5 mV, suggesting activation of a non-selective cation conductance mediating part 
of the 5-HT-induced depolarisation. 35 % neurones had no change in resistance 
associated with the 5-HT-induced excitation, with the current-voltage relationship 
showing a parallel shift indicating activation of an electrogenic pump in the 
membrane or activation/inhibition of a combination of potassium and non-selective 
cation conductances. This mechanism was also confirmed by performing voltage- 
clamp ramps, whereby a parallel shift was obtained. A previous study has reported 
that 5-HT excites tuberomammillary neurones via a Na+/Ca2+ exchanger and 
therefore it is possible that this exchanger may be mediating the effects seen here 
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(Eriksson et al., 2001). This would need further investigation using specific blockers 
for this pump. Overall, these data suggest that multiple conductances and 
mechanisms are responsible for mediating the 5-HT-induced depolarisation. This is 
in agreement with a study in subthalamic neurones which showed that a combination 
of conductances are involved in the 5-HT-induced excitation (Shen et al., 2007). 
As well as inducing a membrane depolarisation, 5-HT was also able to 
induce membrane potential oscillations in a sub-population of ARC neurones, which 
were associated with a pattern of bursts of action potential firing. The significance of 
these membrane potential oscillations and burst-like pattern of firing is unclear but 
maybe related to the release of neuropeptides from ARC neurones. This is suggested 
by previous studies that have shown that the pattern of action potential discharge is 
an important factor for the rate of neuropeptide release from neurones. Studies have 
shown that burst-like patterns of action potential discharge facilitate the release of 
vasopressin from nerve terminals of magnocellular neurones located in the posterior 
pituitary (Dutton & Dyball, 1979; Bicknell & Leng, 1981). Therefore if this also 
applies to neurones within the ARC, burst-like firing patterns induced by 5-HT may 
be important for the release of neuropeptides. Within the ARC, a burst-like pattern of 
firing has been shown in orexigenic NPY neurones (van den Top et al., 2004). 
Therefore 5-HT may facilitate the release of peptides related to energy homeostasis, 
for example a-MSH. 
In order to determine which receptors were mediating the 5-HT-induced 
depolarisation of the membrane, a range of agonists and antagonists for 5-HT 
receptors were used. The 5-HT-induced depolarisation was mimicked by the 5-HT2 
preferential receptor agonist ct-methyl 5-HT, suggesting that the 5-HT2 receptor is 
involved in the excitatory effects of 5-HT on ARC neurones. The a-methyl 5-HT- 
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induced depolarisation was associated with both an increase and decrease in input 
resistance. The 
5-HTI/5/7 receptor agonist 5-CT also mimicked the depolarisation 
with a minimal increase in input resistance, yet the 5-HTIA/7 receptor agonist 
8-OH-DPAT and the 5-HT3 receptor agonist mCPBG did not mimic the 5-HT- 
induced excitation. These results indicate that the 5-HT-induced depolarisation may 
be mediated by several receptors through different mechanisms. Different subtypes 
of the 5-HT2 receptor may be responsible for at least two different mechanisms; one 
may be responsible for an increase in input resistance and another may be 
responsible for a decrease in input resistance. The 5-HTI/5 receptors may be 
responsible for the 5-HT-induced depolarisation associated with either no change or 
a small increase in input resistance. Further work looking at the mechanisms 
underlying the agonist responses and 5-HT responses in the presence of antagonists 
would help clarify this. 
A range of antagonists were then tested to determine further which receptors 
were involved in the 5-HT-induced depolarisation. The 5-HT2 receptor antagonist 
altanserin attenuated the 5-HT-induced depolarisation in a concentration-dependent 
manner, providing further evidence for a 5-HT2 receptor mediating this response. in 
order to clarify further the subtypes involved, specific antagonists for the 
5-HT2A/B/C 
subtypes were then tested. The 5-HT2c receptor antagonist RS102221 partially 
inhibited the 5-HT-induced depolarisation, as did the 5-HT2A receptor antagonist 
R-96544 and the 5-HT2B receptor antagonist SB 204741. The 5-HT2A receptor 
antagonist R-96544 also reduced the 5-HT-induced increase in neuronal input 
resistance and the 5-HT2c receptor antagonist RS102221 reduced the 5-HT-induced 
decrease in neuronal input resistance. Further studies need to be carried out to 
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elucidate if the specific subtypes are specifically associated with either an increase or 
decrease in input resistance and are hence responsible for different mechanisms. 
These results indicate that the 5-HT2A/2B/2c receptors all play an important 
role in mediating the 5-HT-induced depolarisation and are in accordance with 
previous studies that have suggested the involvement of the 5-HT2C receptor in 
mediating the excitatory effects of 5-HT on ARC neurones (Heisler et al., 2002). The 
5-HT2c receptor has been shown to play an important role in energy homeostasis as 
5-HT2c knockout mice develop hyperphagia (Tecott et al., 1995), whilst mice with a 
mutated form of the 5-HT2c receptor also show signs of hyperphagia (Nonogaki et 
al., 1998). Therefore these data suggest that the excitatory effects of 5-HT through 
the 5-HT2 receptor subtypes may play an essential role in controlling energy 
homeostasis. The 5-HT, receptor antagonist cyanopindolol did not block the 5-HT- 
induced depolarisation, suggesting that the 5-HT, receptor is not involved. It has 
previously been shown that 5-HT hyperpolarises ARC neurones through the 5-HTIB 
receptor and therefore it seems likely that the 5-HT, receptor may be responsible for 
mediating 5-HT-induced hyperpolarisations, not depolarisations (Heisler et al., 
2006). 
Studies in neurones outside the ARC have also suggested a role for the 5-HT2 
or 5-HT2c receptor in mediating 5-HT-induced depolarisations These include 
prefrontal cortex neurones (Araneda & Andrade, 1991), sympathetic preganglionic 
neurones (SPNs; Lewis et al., 1993; Pickering et al., 1994), inferior olivary neurones 
(Placantonakis et al., 2000), striatal cholinergic interneurones (Blomeley & Bracci, 
2005), subthalarnic nucleus neurones (Stanford et al., 2005; Xiang et al., 2005; Shen 
et al., 2007) and PVN neurones (Heisler et al., 2007). However an additional study 
in the PVN showed that 5-HT-induced depolarisation was not due to 5-HT2A/2C 
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receptors but instead was due to 5-HT4 and 5-HT7 receptors (Ho et aL, 2007). 
Results shown here however also provide novel evidence for the involvement of 
5-HT2A and 5-HT2B receptors mediating the 5-HT-induced depolarisation of ARC 
neurones. 
The study then went on to try to identify types of neurones in the ARC that 
responded to 5-HT with depolarisation. One way in which this was done was by 
testing the effects of ghrelin. Ghrelin is an orexigenic hormone produced from the 
stomach and in a small population of neurones within the brain, and is known to 
potently increase food intake and body-weight in rodents (Kojima et al., 1999; 
Tschop et al., 2000). Ghrelin was applied to a number of ARC neurones that had 
been depolarised by 5-HT. Ghrelin caused a depolarisation of the membrane in 42 % 
of these neurones but 58 % did not respond to ghrelin. As ghrelin is known to 
selectively activate orexigenic neurones, these results imply that there is a population 
of orexigenic neurones that are depolarised by 5-HT, with a larger population of non- 
orexigenic neurones that are depolarised by 5-HT. It has been shown that a small 
population of POMC neurones do contain the ghrelin receptor, the GHS-R, 
(Willesen et al., 1999) and so ghrelin appears able to excite a small population of 
anorexigenic neurones as well as orexigenic neurones. However, it is unlikely that 
5-HT depolarises orexigenic neurones as 5-HT functions to inhibit feeding and is 
therefore more likely to target anorexigenic neurones. This was investigated using 
immunohistochernistry, by processing alexa-labelled neurones for CART. 
CART is an anorexigenic peptide that is co-expressed with POMC neurones 
(Elias et al., 1998a). 5-HT excited CART-expressing neurones indicating that 5-HT 
excites anorexigenic neurones. However, 5-HT also excited non-CART expressing 
neurones, as well as inhibiting or having no effect on them. This indicates that 5-HT 
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is able to excite both anorexigenic neurones as well as a population of unidentified 
ARC neurones. These neurones could potentially be orexigenic neurones such as 
NPY or other unidentified anorexigenic neurones such as neuromedin U or GALP. 
Alternatively these ARC neurones could have functions unrelated to feeding and 
energy homeostasis, for example they may be involved in pain responses or 
reproduction. Further double-labelling experiments would need to be performed in 
order to characterise the other types of neurones in the ARC that are excited by 
5-HT. 
As well as being critically dependent on glucose for their fuel, specialised 
groups of neurones use glucose to alter their activity. Glucose-sensing neurones are 
specialised neurones that change their electrical activity in response to changes in 
extracellular glucose concentration (Anand et al., 1964; Oomura et al., 1964; Levin 
et al., 2004). The ability of ARC neurones to respond to extrinsic factors such as 
5-HT may be altered under different glucose concentrations therefore in this study 
the effects of 5-HT on neurones recorded in 10 mM and 2 mM glucose-containing 
aCSF was investigated. There was an increase in the percentage of neurones 
responding with depolarisation or no response in 10 mM compared to 2 mM 
glucose-containing aCSF although this did not reach statistical significance. In 
10 mM glucose-containing aCSF there was also a significant increase in the 
amplitude of the peak depolarisation. There was a significant reduction in the 
percentage of neurones responding with hyperpolarisation in 10 mM compared to 
2 mM glucose-containing aCSF, although there was no significant difference in the 
amplitude of the hyperpolarisation. Input resistance did not significantly change in 
neurones recorded in both conditions. 
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These data indicate that glucose affects the ability of ARC neurones to respond 
to extrinsic factors. In this case, under higher glucose conditions, ARC neurones 
responded to 5-HT with an increased number of depolarisations and a reduction in 
hyperpolarisations. These results correlate with the glucose-sensing functions of 
NPY and POMC neurones within the ARC. NPY neurones are inhibited by increases 
in glucose (Muroya et al., 1999) whereas POMC neurones are excited by increases in 
glucose (Ibrahim et al., 2003). Therefore in 10 mM glucose, which represents a 
hyperglycaemic state, NPY neurones should respond with inhibition and POMC 
neurones should respond with excitation. As 5-HT is known to potently inhibit 
feeding (Blundell, 1984), one way in which this may occur is through the inhibition 
of NPY neurones and excitation of POMC neurones. In 10 mM glucose there was a 
decrease in the percentage of inhibitions and an increase in the percentage of 
excitations by 5-HT. This could indicate that 5-HT acting at high glucose 
concentrations has a preferential role of exciting POMC neurones rather than 
inhibiting NPY neurones. 
The ability of ARC neurones to integrate inputs and produce responses is 
therefore altered under different glucose states. It may be that glucose affects the 
expression of 5-HT receptors and in different glucose concentrations different levels 
of 5-HT receptors may be expressed. In higher glucose, more 5-HT2 receptors may 
be expressed leading to more depolarisations and in lower glucose more 5-HT, 
receptors, which are thought to mediate the 5-HT-induced hyperpolarisation, may be 
expressed. Overall these data indicate glucose as a key signalling molecule affecting 
the ability of ARC neurones to respond to extrinsic factors. 
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In conclusion, this study has demonstrated that 5-HT directly excites a 
population of ARC neurones, including identified CART neurones, via 5-HT2A, 
5-HT2B and 5-HT2C receptors. Several mechanisms are involved in this 
depolarisation, namely the activation of a potassium channel, a non-selective cation 
channel or a mixture of the two, or possibly through activation of an electrogenic 
pump in the membrane. 
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Figure 4.1 5-HT differentially regulates ARC neurones 
A: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone with a resting membrane potential of -45 mV (shown to the left of the trace 
in this and subsequent figures). Application of 5-HT (50 piM), as indicated by the 
line above the trace, induced a membrane hyperpolarisation and associated decrease 
in neuronal input resistance, indicated by the decrease in amplitude of electrotonic 
potentials (downward deflections of the trace) evoked in response to hyperpolarising 
rectangular-wave current pulses (5-30 pA, I s, 0.2 Hz; not shown). The large 
sequential downward and upward deflections in the middle of the response indicate 
where an IN was taken. 
B: A pie chart showing the membrane responses of 122 ARC neurones to application 
of 5-HT. Neurones responded either with a membrane hyperpolarisation (45/122; 
example shown in A), depolarisation (37/122; example shown in Q, or they did not 
respond (40/122). 
C: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone showing 5-HT-induced depolarisation and an increase in action potential 
firing. 
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Figure 4.2 5-HT directly excites a population of ARC neurones with a 
concomitant increase in input resistance 
Ai: Samples of a continuous whole-cell cuffent-clamP recording from an ARC 
neurone in the presence of TTX (500 nM). Application of 5-HT (50 ýM) induced a 
membrane depolarisation and associated increase in neuronal input resistance, 
indicated by the increase in amplitude of electrotonic potentials (downward 
deflections of the trace) evoked in response to hyperpolarising rectangular-wave 
current pulses (not shown), seen during a period of constant negative current 
injection to eliminate any voltage-dependent effects (as shown by arrows). Note the 
5-HT-induced depolarisation persists in the presence of TTX 
AH: Superimposed samples from a continuous whole-cell current-clamp recording 
showing membrane potential responses of an ARC neurone to a series of depolarising 
and hyperpolarising rectangular-wave current pulses of constant increment (-35 to 
+3 5 pA, I s, 0.1 Hz) before and in the presence of 5 -HT. 
Aiii: Plot of the current-voltage (I-V) relationships before (o) and in the presence of 
5-HT (9), shown in Aii. Note the increase in the slope of the I-V in the presence of 
5-HT indicating an increase in neuronal resistance, with a reversal potential around 
-88 mV. 
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Figure 4.3 5-HT excites a sub-population of ARC neurones with a concomitant 
decrease in input resistance 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone showing 5-HT-induced (50 [M) depolarisation and increase in firing 
frequency. 
Aft: Superimposed samples of a continuous whole-cell current-clamp recording 
showing membrane potential responses of the ARC neurone shown in Ai to a series 
of depolarising and hyperpolarising rectangular-wave current pulses, before (-80 to 
+ 16 pA, I s, 0.1 Hz) and in the presence of 5-HT (-100 to +20 pA, I s, 0.1 Hz). 
Aiii: Plot of the current-voltage (I-V) relationships before (o) and in the presence of 
5-HT (e), shown in Aii. Note the decrease in the slope of the I-V in the presence of 
5-HT indicating a decrease in neuronal resistance, tending towards a reversal 
potential, when extrapolated, of -42 mV. 
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Figure 4.4 5-HT excites a sub-population of ARC neurones: a response 
associated with no change in input resistance 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone showing 5-HT-induced depolarisation (50 pM). 
Afl: Superimposed samples from a continuous whole-cell current-clamp recording 
showing membrane potential responses of the ARC neurone, shown in Ai, to a series 
of depolarising and hyperpolarising rectangular wave current pulses, before and in the 
presence of 5-HT (-25 to +10 pA, I s, 0.1 Hz). 
Aiii: Plot of the current-voltage (I-V) relationships before (o) and in the presence of 
5-HT (e), shown in Aii. Note the parallel shift between the plots indicating no 
change in input resistance. 
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Figure 4.5 5-HT induces an inward current in ARC neurones 
A: Application of 5-HT (50 pM) to an ARC neurone clamped at a holding potential 
of -40 mV (in voltage-clamp mode) induced an inward current and increased the 
frequency and amplitude of IPSCs (upward deflections) and EPSCs (downward 
deflections). The IPSCs were reversed in direction by changing the holding potential 
to -80 mV. 
B: Current responses obtained in voltage-clamp in the presence (green trace) and 
absence (black trace) of 5-HT (50 VM). The currents were obtained from ramp 
protocols that drove the holding potential from -130 mV to -30 mV, at a rate of 
10 mV Per second. These responses are parallel indicating that there was no change 
in conductance in this neurone. 
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Figure 4.6 5-HT induces a burst-like pattern of firing in some ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone showing 5-HT-induced (50 gM) depolarisation and induction of a burst-like 
pattern of firing. 
Aft: ExPanded region, as indicated by the arrow, from the neurone shown in Ai, 
showing membrane potential oscillations with associated bursts of action potentials. 
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Figure 4.7 5-HT-induced changes in spontaneous synaptic activity 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone showing 5-HT-induced (50 pM) depolarisation and induction of 
spontaneous IPSPs. 
Afi: Expanded regions from the neurone shown in Ai, showing few spontaneous 
IPSPs in the control and upon application of 5-HT, the induction of IPSPs. 
Bi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone showing 5-HT-induced depolarisation and a reduction in spontaneous 
EPSPs. 
Bfi: Expanded regions from the neurone shown in Bi, showing spontaneous EPSPs 
in the control period and their subsequent reduction or loss in the presence of 5-HT. 
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Figure 4.8 The effects of the 5-HT receptor agonists (x-methyl 5-HT and 5-CT 
on ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ýM) induced membrane depolarisation. 
Afi: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HT2 receptor agonist oc-methyl 5-HT 
(25 ýLM) induced membrane depolarisation, mimicking the effect of 5-HT. In this 
neurone, (x-methyl 5-HT was able to induce a burst-like pattern of firing. 
Bi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT induced a membrane depolarisation 
Bii: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Bi. Application of the 5-HTI/5/7 receptor agonist 5-CT (10 VtM) 
induced a membrane depolarisation, partly mimicking the effect of 5-HT. 
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Figure 4.9 The effects of the 5-HT receptor agonists 8-OH-DPAT and mCPBG 
on ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 [M) induced a membrane depolarisation. 
Afi: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HTIA/7 receptor agonist 8-OH-DPAT 
(10 ýM) had no effect. 
Bi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT induced a membrane depolarisation and increase in 
action potential firing. 
Bfi: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Bi. Application of the 5-HT3 receptor agonist mCPBG (10 ýM) 
had no effect. 
- 177- 
Figure 4.9 
Ai 5-HT 
-47 
49 ___ 
Bi 
5-HT 
-40 
Bii MCPBG 
-45 
20 mV 
60s 
20 mV 
50s 
20 mV 
50s 
Aii 8-OH-DPAT 
Chapter Four 
Figure 4.10 The effects of the 5-HT receptor antagonists altanserin and 
RS102221 on ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ýM) induced a membrane depolarisation. The 
large downward and upward deflections in the middle of the response indicate where 
an IN was taken. 
Afl: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HT2 receptor antagonist altanserin 
(I ýtM) inhibited the 5-HT-induced depolarisation. 
AW: Plot showing the reduction in the amplitude of the 5-HT-induced depolarisation 
in the presence of increasing concentrations of altanserin. The control response was 
set as 100% and upon increasing doses of altanserin there was a reduction in the 
amplitude of the response compared to control. 
Bi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT induced a membrane depolarisation and increase in 
action potential firing. 
Bii: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Bi. Application of the 5-HT2c receptor antagonist RS102221 
(I ýM) inhibited the 5-HT-induced depolarisation. 
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Figure 4.11 The effects of the 5-HT receptor antagonists R-96544 and 
SB 204741 on ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ýtM) induced a membrane depolarisation. The 
dashed lines indicate the time where an IN was taken. 
Afi: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HT2A receptor antagonist R-96544 
(10 pM) partially reduced the 5-HT-induced depolarisation. 
Bi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT induced a membrane depolarisation 
Bii: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Bi. Application of the 5-HT2B receptor antagonist SB 204741 
(I ýLM) partially inhibited the 5-HT induced depolarisation. 
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Figure 4.12 The effects of ghrelin on 5-HT-excited ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ýM) induced a membrane depolarisation and 
subsequent induction of a burst-like pattern of firing. 
AH: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone in Ai. Application of ghrelin (100 nM) induced a membrane 
depolarisation and induction of membrane potential oscillations and burst firing 
pattern of action potential discharge. 
- 183- 
-52 
-46 
Figure 4.12 
Ai 
5-HT 
Aii 
Ghrelin 
-) V 
Chapter Four 
Figure 4.13 5-HT excites CART-expressing neurones 
Ai: Confocal images showing that a single ARC neurone, labelled with Alexa 633 
(red) during recording, was CART positive (green, visualised using Cy2). CART 
positive neurones were either excited by 5-HT or showed no response. 
Afi: Samples of a continuous whole-cell current-clamp recording from a CART 
positive ARC neurone showing the 5-HT (50 ýM) induced excitation in this neurone. 
B: Confocal images showing that a single ARC neurone labelled with Alexa 633 
(red) during recording was not CART positive (green, visualised using Cy2). Non- 
CART positive neurones were either excited, inhibited or showed no response to 
5-HT. 
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Figure 4.14 A comparison of the effects of 5-HT on ARC neurones under 
normo- (2 mM glucose) and hyper-glycacmic (10 mM glucose) conditions 
A: Bar-chart comparing the response to 5-HT of ARC neurones recorded in 10 mM 
and 2 mM glucose-containing aCSF. In 10 mM glucose-containing aCSF, there were 
a higher proportion of 5-HT-induced excitations and no responses than in 2 mM 
glucose-containing aCSF, but there were a higher proportion of 5-HT-induced 
inhibitions in 2 mM compared to 10 mM glucose-containing aCSF. 
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Figure 4.15 Electrophysiological classification of ARC neurones and their 
responsiveness to 5-HT 
A: A histogram showing the responsiveness of the electrophysiologically classified 
clusters to 5-HT within the ARC. 
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5.1 Introduction 
5-HT is a neurotransmitter that has been implicated in many different 
behavioural, psychological and physiological functions and diseases. As well as 
having a role in the control of mood disorders it is also associated with reproduction, 
feeding and energy homeostasis and thennoregulation (Bonate, 1991; Wilkinson & 
Dourish, 1991; Baldwin & Rudge, 1995; Graeff et al., 1996). One of the areas of the 
brain that is responsible for controlling many of these functions is the arcuate 
nucleus (ARC) of the hypothalamus. In particular, in relation to the control of 
feeding and energy homeostasis, the 5-HT system and the ARC have been shown to 
be essential components for the central regulation of energy hornoeostasis (Blundell, 
1977,1984; Schwartz et al., 1999,2000). Of the 7 major subgroups of 5-HT 
receptors, the 5-HTI and 5-HT2 receptors have been predominantly shown to be 
involved in the control of feeding and energy homeostasis (see chapter 4 and De Vry 
& Schreiber, 2000). However, the effects of 5-HT acting at the level of the ARC are 
still poorly understood. In particular the neuronal subtypes of ARC neurones that are 
modulated by 5-HT are still not fully known. As 5-HT is known to inhibit feeding 
(Blundell, 1977,1984), it may be that 5-HT inhibits orexigenic neurones and excites 
anorexigenic neurones within the ARC to suppress feeding. 
Following on from the previous chapter that described the excitatory effects 
of 5-HT on rat hypothalamic ARC neurones, the aims of this study were to 
investigate the cellular mechanisms by which 5-HT inhibits ARC neurones and to 
elucidate which 5-HT receptor subtypes were mediating these effects. In addition, 
the neuronal subtypes involved in the regulation of energy homeostasis by 5-HT 
were investigated. 
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5.2 Results 
ZI The inhibitory effects of 5-HT on ARC neurones 
Results were obtained in 2 mM glucose-containing aCSF unless otherwise 
stated. Bath application of 5-HT (50 ýM) for between 45-75 seconds induced a 
membrane hyperpolarisation in 45/122 ARC neurones. The hyperpolarisation of the 
membrane was slow in onset and resulted in the cessation of action potential firing, 
inhibiting the activity of these neurones. The response was characterised by 
hyperpolarisation of the membrane from a mean resting membrane potential of 
-49.0 ± 1.0 mV to -61.6 ± 1.2 mV, a mean peak membrane hyperpolarisation of 
12.7 ± 0.9 mV (n=45; see figure 5.1 Ai). The response recovered upon washout of 
5-HT from the bath, returning the mean membrane potential to -47.9 ± 1.3 mV 
(n=37). The membrane hyperpolarisation was associated with a significant 
35.8 ± 3.2 % decrease in neuronal input resistance from a mean of 1438 ± 76 MQ at 
rest to 915 ± 67 MO in the presence of 5-HT, a decrease of 523 ± 54 MO (P<0.01). 
To confirm that the change in resistance was due to 5-HT and not due to a change in 
voltage, a period of constant positive current injection was applied during the 5-HT 
response to eliminate any voltage-dependent effects in a sub-population of neurones. 
The 5-HT-induced hyperpolarisation and reduction in input resistance was 
maintained in the presence of 500 nM TTX, indicating a direct effect on ARC 
neurones (n=4; see figure 5.1 Aii). 
The effect of 5-HT on ARC neurones was also studied in voltage-clamp. 
5-HT induced an outward current (n=7; see figure 5.2A), with a mean peak current 
of 9.1 ± 2.1 pA at a holding potential of -50 mV. The current induced by 5-HT was 
quick in onset but decayed at a relatively slower rate after reaching its peak. 
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5.22 Ionic mechanism underlying the 5-HT-induced hyperpolarisation 
The 5-HT-induced hyperpolarisation was associated with a decrease in 
neuronal input resistance (or an increase in conductance). Current-voltage 
relationships were obtained from 29 cells, in control conditions and at the peak of the 
5-HT-induced hyperpolarisation (see figure 5.1B). The 5-HT-induced conductance 
change had a reversal potential of -79.1 ± 1.8 mV, approaching the reversal potential 
for K+ ions under our recording conditions. In addition, in a sub-population of 
neurones, 5-HT activated or enhanced an inward rectifier, revealed from the current- 
voltage relationship in the presence of 5-HT (n=4; for example see figure 5.1 Bii). 
Inward rectification is identified as a decrease in input resistance at more negative 
membrane potentials, indicated by a decrease in the slope in the plot of the IN. 
Voltage-clamp ramps were also performed in the presence of TTX to study 
the mechanism underlying the 5-HT-induced outward current. The currents were 
obtained from ramp protocols that drove the holding potential from -130 mV to 
-30 mV, at a rate of 10 mV per second. Superimposition of currents obtained from 
ramps before and at the peak of the response revealed an average reversal potential 
of -87.7 ± 1.2 mV (n=3; figure 5.213), close to the reversal potential for K+ ions 
under our recording conditions. 
To identify which 5-HT receptor subtypes are involved in the 5-HT-induced 
hyperpolarisation, a range of 5-HT agonists and antagonists were used 
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5. Z3 The effects of 5-HT receptor agonists on ARC neurones 
To determine the nature of the 5-HT receptor subtypes that mediate the 
hyperpolarisation induced by 5-HT, the effects of selective agonists were first 
investigated. Firstly, the 5-HTIA agonist 8-OH-DPAT (10 ýM) was tested, and was 
shown to hyperpolarise ARC neurones from a membrane potential of -45.9 ± 3.6 mV 
to -50.3 ± 4.3 mV, a mean peak hyperpolarisation of 4.4 ± 0.8 mV, associated with a 
decrease in input resistance from 1213 ± 251 MO to 1052 ± 170 MO (n=7; see 
figure 5.3A). The 8-OH-DPAT-induced hyperpolarisation was smaller in amplitude 
than the 5-HT-induced hyperpolarisation, but still resulted in the cessation of action 
potential firing and inhibition of these neurones. The 8- OH-DPAT- induced 
hyperpolarisation did not completely mimic the 5-HT response and did not always 
wash off. 
The next agonist investigated was the 5-HTI/5/7 agonist 5-CT (10 4M). This 
induced a membrane hyperpolarisation from -41.9 ± 2.9 mV to -55.8 ± 4.2 mV, a 
mean peak hyperpolarisation of 13.9 ± 2.9 mV. There was a concurrent decrease in 
membrane resistance from 1223 ± 179 MO to 983 ± 146 MO (n=5; see figure 5.3B). 
The 5-CT-induced hyperpolarisation was of similar magnitude to the 5-HT response 
and inhibited the activity of neurones but often did not persist as long as the 5-HT- 
induced hyperpolarisation and was quicker to wash off. 
To further clarify the role of the 5-HTI receptor in the 5-HT-induced 
hyperpolarisation, more subtype-specific agonists were tested. Agonists were bath 
applied for 1-4 mins. The 5-HTIAiIB agonist RU24969 (20 ýM; n=5; see figure 
5.4A), and the specific 5-HTIB agonist CP93129 at I ýM (n=4; see figure 5.4B) and 
10ýLM (n=3) were without significant effect on neurones in which 5-HT induced a 
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membrane hyperpolarisation and they did not affect the membrane potential or input 
resistance of these neurones. 
In addition, the 5-HT3 receptor agonist mCPBG (10 ýM) did not mimic the 
5-HT-Induced hyperpolarisation (n=6) and induced no effect on membrane potential 
or input resistance of neurones to which it was applied. 
These data suggest a role for 5-HTI/7 receptors in the 5-HT-induced 
hyperpolarisation as agonists at these receptors (8-OH-DPAT and 5-CT) were able to 
induce a hyperpolarisation of neurones, mimicking the effects of 5-HT. 
5. Z4 The effects of 5-HT receptor antagonists on 5-HT-induced responses in ARC 
neurones 
To further identify the 5-HT receptors that mediate the 5-HT-induced 
hyperpolarisation, a range of selective antagonists were tested. Application of all 
antagonists alone had no effect on the recorded neurones. The 5-HT7 receptor 
antagonist SB269970 (10 ýM) only partially reduced the 5-HT-induced 
hyperpolarisation (n=8; see figure 5.5A), from a mean peak hyperpolarisation of 
11.7 ± 2.4 mV to 8.7 ±2 mV, a 27 ±7% reduction. SB269970 was without effect on 
5-HT-induced changes in input resistance as 5-HT induced a mean peak decrease in 
input resistance of 493 ± 134 M (from 1419 ± 202 MO to 964 ± 139 MQ) whilst it 
decreased to 438 ± 141 MO (1353 ± 251 MO to 860 ± 122 MO) in the presence of 
the antagonist. 
The role of 5-HTI receptors in the 5-HT-induced hyperpolarisation was next 
investigated. The 5-HTIA/IB receptor antagonist cyanopindolol (10 ýLM) reduced the 
5-HT-induced hyperpolarisation, from a mean peak of 6.2 ± 2.9 mV to 1.3 ± 0.4 mV 
in the presence of the antagonist, a 79.6 ± 6.8 % reduction (n=5; see figure 5.5B). 
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Cyanopindolol reduced the decrease in input resistance induced by 5-HT from 
323 ± 250 to 13 ± 59 MO in the presence of the antagonist. 
To further differentiate the effects of the 5-HTj subtypes mediating the 
inhibitory response, subtype-specific antagonists were tested. The 5-HTIA receptor 
antagonist WAY-100635 reduced the 5-HT-induced hyperpolarisation in a 
concentration-dependent manner (see table 5.1 and figure 5.6A). 
Table 5.1: Effects of WAY-100635 on 5-HT-induced hyperpolarisation 
Concentration Mean peak Mean peak % reduction Reduction Reduction 
of hyper- hyper- in mean peak in input in input 
WAY- 100635 polarisation polarisation in hyper- resistance resistance 
(nM) in 5-HT 5-HT and polarisation in 5-HT in 5-HT and 
(mv) antagonist (mV) (MCI) antagonist 
(Mn) 
30 11.1 2.5 2.3 ± 1.3 60.3 ± 14.8 346 ± 140 168 87 
(n=4) 
100 9.8 1.3 4.2 ± 3.4 59.8 ± 29.7 99 ± 40 18 62 
(n=3) 
300 9.7 2.7 4.3 ± 1.0 48.3 ± 18.8 361 ± 252 70 45 
(n=3) 
1000 17.4 3.6 3.2 ± 2.1 89.1 ± 11.6 910 ± 160 366 25 
(n=3) II I I 
Next the 5-HTIB receptor antagonist SB224289 was tested. At I ýM, it had 
no effect on the 5-HT-induced hyperpolarisation, as the mean peak hyperpolarisation 
induced by 5-HT was 12.0 ± 3.5 mV and 12.1 ± 5.8 mV in the presence of the 
antagonist (n=3). However at 2 [tM, SB224289 suppressed the hyperpolarisation 
induced by 5-HT from a mean peak of 12.4 ± 2.8 mV to 4.0 ± 1.4 mV in the 
presence of the antagonist, a 69.2 ± 3.3 % reduction (n=4; see figure 5.6B). 
As these data imply more than one receptor is involved in the 5-HT-induced 
hyperpolarisation, a combination of antagonists were tested on the 5-HT-induced 
response. The 5-HTIB antagonist SB224289 (2 ýM) and 5-HT7 antagonist SB269970 
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(10 pM) in combination only partially reduced the 5-HT-induced hyperpolarisation 
(n=3; see figure 5.7Aii). However upon addition of the 5-HTIA antagonist 
WAY-100635 (300 nM) there was a reduction in mean peak hyperpolarisation of 
82.3 ± 14.0 % (n=5, see figure 5.7Aiii). 
Finally, antagonists for other 5-HT receptors were tested to determine their 
role in the 5-HT-induced hyperpolarisation. The 5-HT3 receptor antagonist 
MDL72222 (100 nM) had no effect on the 5-HT-induced hyperpolarisation (n=4; see 
figure 5.8A), nor did the 5-HT2 receptor antagonist altanserin (200 nM; n=4; see 
figure 5.8B). 
The results from this study have shown that 5-HT is able to inhibit a 
population of ARC neurones most likely through 5-HTI (predominantly 5-HTIA) and 
5-HT7 receptors. However, the identity of these ARC neurones that are inhibited by 
5-HT is unknown. In order to try to identify the types of ARC neurones that were 
inhibited by 5-HT, several methods were used. Firstly ghrelin, a marker of 
orexigenic neurones, was applied to neurones that had been exposed to 5-HT and 
responded with a reversible hyperpolarisation. Secondly, the effects of 5-HT on 
identified neuropeptide Y (NPY) neurones were investigated. Thirdly, 
immunohistochernistry was used to identify 5-HT receptors and to see if they were 
co-localised with CART. 
5.2.5 The effects of ghrelin on ARC neurones 
Ghrelin is an orexigenic hormone produced from the stomach and in a small 
population of neurones within the brain, and is known to potently increase food 
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intake and body-weight in rodents (Kojima et aL, 1999; Tschop et aL, 2000). It 
selectively targets orexigenic neurones therefore in this study, ghrelin was used as a 
marker to identify orexigenic neurones. 
All ghrelin and associated 5-HT-induced responses were obtained in 10 mM 
glucose. Ghrelin (100-200 nM) was applied to 14 ARC neurones that responded to 
5-HT with hyperpolarisation. 21 % of these neurones were unaffected by ghrelin. 
79 % of these neurones responded with a depolarisation of the membrane upon 
ghrelin application, from an average membrane potential of -49.4 ± 1.9 mV to 
-41.1 ± 1.3, a mean peak depolarisation of 8.3 ± 1.3 mV (n=1 1; see figure 5.9). The 
ghrelin-induced depolarisation was slow in onset and reached threshold for action 
potential firing, increasing the activity of these neurones. Input resistance increased 
in the presence of ghrelin, from 1281 ± 226 MQ to 1410 ± 345 MO a change of 
130 ± 141 MQ. These results indicate that 5-HT acts at the level of orexigenic 
neurones and induced inhibition of these neurones. 
5.2.6 5-HT inhibits ore-xigenic NPY1AgRP neurones 
Some ARC neurones can be identified by their electrophysiological 
properties. A sub-population of ARC neurones which express the anomalous inward 
rectifier and an A-like conductance have been identified (cluster 2 neurones 
described in chapter 3) and these neurones have been shown to express NPY and 
agouti-related peptide (AgRP; van den Top et al., 2004). NPY and AgRP neurones 
are both orexigenic peptides and have been shown to co-localise in the ARC (Hahn 
et al., 1998). These neurones have also been shown to express pacemaker properties 
as orexigenic peptides such as orexin induce membrane potential oscillations and 
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burst-like firing patterns. In this study, NPY/AgRP pacemaker neurones in the ARC 
were inhibited by 5-HT (n=7; see figure 5.10). The response was characterised by 
hyperpolarisation of the membrane from a mean resting membrane potential of 
-54.0 6.1 mV to -65.5 ± 5.3 mV, a mean peak membrane hyperpolarisation of 
11.5 2.2 mV. The membrane hyperpolarisation was associated with a significant 
34.5 7.6 % decrease in neuronal input resistance from a mean of 1564 ± 250 MU 
at rest to 942 ± 127 MO in the presence of 5-HT, a decrease of 621 ± 201 MO 
(P<0.05). These data provide compelling evidence that 5-HT inhibits identified 
orexigenic NPY/AgRP neurones. 
5.2.7 Co-localisation of 5-HT receptors and CART 
CART is a neuropeptide that has been shown to be involved in the regulation 
of feeding and energy homeostasis (see chapter 4 and general introduction). There is 
a high level of CART expression within the hypothalamus, including in the ARC 
(Douglass et al., 1995; Koylu et al., 1998; Elias et al., 2001) and CART is co- 
expressed in POMC neurones within the ARC (Elias et al., 1998a). Therefore if 
5-HT receptors are found co-localised with CART in the ARC, this will be strong 
evidence to suggest a role for 5-HT receptors in catabolic or anorexigenic signalling 
pathways. 
The co-localisation of CART and the 5-HT receptor subtypes: 5-HTIA, IB, 
and 7 was investigated in this study. Negative controls, in the absence of primary 
and secondary antibodies, contained no staining in all cases. These results represent 
preliminary work as further positive and negative controls need to be perfon-ned in 
order to produce detailed results. 
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The 5-HTIB receptor was expressed in two distinct clusters within the ARC, 
predominantly in the ventromedial region of the ARC, with a smaller cluster present 
in the lateral ARC (data not shown, due to initial problems capturing pictures on the 
confocal microscope. Once these problems had been overcome however, the 
experiment could not be repeated as the 5-HTIB antibody was no longer available. ) 
When the double-labelling protocol was applied, in the majority of cases, neurones 
were identified that were positive only for the 5-HTIB receptor (see figure 5.11) or 
positive only for CART within the ARC (see figure 5.12), indicating no co- 
localisation between the two. 
A minority of neurones were positive for both CART and the 5-HTIB 
receptor, indicating co-localisation between the two (see figure 5.13). Compared to 
the number of positive 5-HTIB and CART neurones, there were fewer co-localised 
neurones. 
During the course of this study the primary antibody being used for the 
5-HTIB receptor went out of production. Other commercially available 5-HTIB 
primary antibodies could not be used as the species they were raised in would have 
led to a cross-reaction with the CART antibody. It was therefore not possible to 
develop these results further to identify the actual percentage of co-localised 
neurones in the ARC or to further characterise the expression pattern of this receptor 
within the ARC. 
No positive staining was obtained for the 5-HTIA or 5-HT7 receptor. After the 
initial negative results, the protocol was altered several times to try to achieve 
positive staining. These changes included either removing or altering the 
concentration of the blocking serum, doubling the concentration of the primary 
antibody, changing the time taken to fix the slices, and removing the anti-fade to see 
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if this was affecting the results. However none of these changes resulted in any 
positive staining which indicated that the problem was unlikely to be due to the 
protocol. Further studies need to be carried out using additional positive and negative 
controls in order to gain confidence from these results. 
5.3 Discussion 
In the present study, the effects of 5-HT on ARC neurones were investigated 
using the whole-cell patch clamp recording technique. 
5-HT hyperpolarised 45 % of ARC neurones with a concurrent decrease in 
input resistance. The 5-HT-induced hyperpolarisation still persisted in the presence 
of TTX indicating a direct effect of 5-HT on ARC neurones. The ionic mechanism 
by which the 5-HT-induced hyperpolarisation occuffed is likely to be due to 
activation of a potassium conductance, as a reversal potential of -88 mV was 
obtained in voltage clamp, approaching that of K+ ions under our recording 
conditions. Additionally, in this study, an inward rectifier was seen to be activated or 
enhanced in a population of ARC neurones, as revealed from the current-voltage 
relationship by the decrease in input resistance at more negative membrane 
potentials. Therefore it is possible that a G-protein coupled inwardly-rectifying 
potassium channel (GIRK) was activated by 5-HT in this study; this needs to be 
tested further using specific blockers for this channel, for example tertiapin Q and 
clozapine. These results are in accordance with other studies that have implicated a 
potassium conductance in the 5-HT-induced hyperpolarisation, particularly through a 
GIRK channel (Bayliss et al., 1997; Muraki et al., 2004; Shen et al., 2007). 
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To clarify the nature of the 5-HT receptors mediating the hyperpolarisation of 
the membrane, a range of agonists and antagonists were used. The 5-HT-induced 
hyperpolarisation was partially mimicked by the 5-HTIA agonist 8-OH-DPAT and 
the 5-HTI/5/7 agonist 5-CT. However neither the 5-HTIA/IB agonist RU24969, the 
5-HTIB agonist CP93129 nor the 5-HT3 receptor agonist mCPBG were able to mimic 
the 5-HT-induced hyperpolarisation. These results indicate that the 5-HT-induced 
hyperpolarisation involves 5-HT, receptors and possibly 5-HT5/7 receptors. 
The 5-HT7 receptor antagonist SB269970 and the 5-HTIA/IB receptor 
antagonist cyanopindolol partially inhibited the 5-HT-induced hyperpolarisation. The 
5-HTIA receptor antagonist WAY-100635 attenuated the 5-HT-induced 
hyperpolarisation in a concentration-dependent manner but the 5-HTIB receptor 
antagonist SB224289 only partially reduced the response. The 5-HT2 receptor 
antagonist altanserin and the 5-HT3 receptor antagonist MDL72222 were without 
effect on the 5-HT-induced hyperpolarisation. These results indicate that 
predominantly the 5-HTIA receptor, and the 5-HTIB and 5-HT7 subtypes are likely to 
be involved in mediating the 5-HT-induced hyperpolarisation. These results are in 
agreement with previous studies which have identified these receptors in 5-HT- 
induced hyperpolarisations both within the ARC (Heisler et al., 2006) and in other 
areas of the brain, such as the prefrontal cortex (Araneda & Andrade, 1991), 
subthalamic nucleus (Stanford et al., 2005; Shen et al., 2007), lateral hypothalamus 
(LH; Muraki et al., 2004) and caudal raphd nucleus (Bayliss et al., 1997). 
The study then went on to try to identify types of neurones in the ARC that 
were hyperpolarised by 5-11T. Ghrelin is an orexigenic hormone that is released from 
the stomach, and both central and peripheral injections of ghrelin cause an increase 
in food intake and body-weight in rats and humans (Tschop et al., 2000; Wren et al., 
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2001a, b; Wang et al., 2002; Faulconbridge et al., 2003; Currie et al., 2005). In this 
study, ghrelin was used as a marker to identify orexigenic neurones as is it known to 
selectively target such neurones. Ghrelin was applied to a number of ARC neurones 
that had responded to 5-HT with membrane hyperpolarisation. Ghrelin caused a 
depolarisation in 79 % of these neurones with only 21 % of these neurones not 
responding to ghrelin. As ghrelin is known to selectively activate orexigenic 
neurones, these results suggest that the neurones that are hyperpolarised by 5-HT are 
likely to be orexigenic neurones, such as NPY neurones within the ARC. Further 
evidence that 5-HT is likely to be inhibiting NPY neurones is shown by the fact that 
a population of neurones have been identified within the ARC that express NPY and 
AgRP (van den Top et al., 2004). These neurones express certain active 
conductances that identify them and are called cluster 2 neurones in this study (see 
chapter 3). 5-HT hyperpolarised cluster 2 neurones in this study, providing further 
evidence that 5-HT hyperpolarises orexigenic NPY neurones. 
The preliminary results from the immunohistochemistry study indicate that 
the 5-HTIB receptor was predominantly located on neurones in the ventromedial 
ARC with a smaller subset of neurones in the lateral ARC expressing this receptor. 
CART is an anorexigenic peptide, co-localised with POMC neurones in the ARC, 
which is known to be involved in the control of feeding (Elias et al., 1998a; Lambert 
et al., 1998). In this study, it was used in a double-labelling protocol alongside the 
5-HT receptors so that we could detennine if any of the 5-HT receptors were on the 
same neurones as CART and hence found on anorexigenic neurones. In the majority 
of cases, the 5-HTIB receptor was not found co-localised on CART neurones, 
indicating that the 5-HTIB receptor is not usually found on anorexigenic POMC 
neurones. It would be interesting to see what types of neurones 5-HTIB receptors do 
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co-localise with. One possibility is that they may co-localise with the functionally 
antagonistic population of orexigenic NPY neurones, which has been shown 
previously (Heisler et aL, 2006), but it is not possible to look for co-localisation with 
NPY using immunohistochemistry as NPY is rapidly transported out of the cell 
body. In a small number of cases, the 5-HTIB receptor did co-localise with CART 
and hence there may be a subset of anorexigenic neurones within the ARC that do 
express the 5-HTIB receptor. 
These results are in accordance with previous studies that have found the 
expression of 5-HTIB receptors in the hypothalamus (Makarenko et al., 2002; Heisler 
et al., 2006) and provide novel evidence of the expression of this receptor on a sub- 
population of anorexigenic CART positive neurones. Previous studies have only 
shown expression of this receptor on NPY neurones (Heisler et al., 2006) or in close 
proximity to NPY neurones (Makarenko et al., 2002). This study did find expression 
of 5-HTIB receptors on non-CART positive neurones also, which could have been 
NPY neurones. It was unfortunate that the results could not be developed further due 
to the problems obtaining the primary antibody for the 5-HTIB receptor. The 
majority of studies in the literature utilise the in situ hybridisation technique in order 
to locate the 5-HT receptors so this technique, or other techniques such as RT-PCR, 
will be worth considering for future work (for example see Pompeiano et al., 1992 
and Heisler et al., 2002). 
In conclusion, 5-HT directly inhibits a population of ARC neurones, 
including identified orexigenic NPY neurones, via the 5-HTIA, 5-HTIB and 5-HT7 
receptors, through a mechanism most likely involving a potassium conductance. 
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As 5-HT is recognised to be important in the regulation of energy 
homeostasis, the results from these studies (chapters 4 and 5) indicate that 5-HT 
acting upon NPY and POMC neurones within the ARC may contribute to this 
regulation of feeding and energy homeostasis. In the control of obesity specifically, 
drugs acting upon the serotonergic system (sibutramine and d-fen) have been used 
for the pharmacological treatment of obesity (Guy-Grand, 1992; Luque & Rey, 
2002). The data from these studies could offer an explanation as to how these drugs 
were effective. These drugs may have been acting at the level of the ARC by 
inhibiting NPY neurones and exciting POMC neurones to reduce feeding and 
increase energy expenditure, In addition these data provide an insight into how 
selective agonists at 5-HT receptors might be able to produce a decrease in feeding. 
For example, the inhibitory actions upon feeding by 5-HTIB receptor agonists may 
have been partially due to 5-HT inhibiting orexigenic NPY neurones in the ARC 
(Bendotti & Samanin, 1987; Kennett et al., 1987; Kennett & Curzon, 1988; Dryden 
et al., 1996b). The down-regulation of feeding by 5-HT2c receptors might have been 
due to the excitation of anorexigenic POMC neurones by 5-HT within the ARC 
(Vickers et al., 1999,2001). 
In conclusion these studies have provided further evidence of the 
involvement of 5-HT in the central control of energy homeostasis and specifically 
identified mechanisms by which 5-HT acts to regulate neuronal excitability at the 
level of the ARC. 
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Figure 5.1 5-HT directly inhibits ARC neurones through activation of a 
potassium conductance 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone with a resting membrane potential of -45 mV (shown to the left of the trace 
in this and subsequent figures). Application of 5-HT (50 ýLM) for approximately 60 s, 
as indicated by the line above the trace, induced a membrane hyperpolarisation and 
associated decrease in neuronal input resistance, indicated by the decrease in 
amplitude of electrotonic potentials (downward deflections of the trace) evoked in 
response to hyperpolarising rectangular wave current pulses (5-30 pA, I s, 0.2 Hz; 
not shown). 
Afi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone in the presence of TTX (500 nM). Application of 5-HT (50 ýM) for 
approximately 90 s induced a membrane hyperpolarisation and associated decrease 
in neuronal input resistance. Note the 5-HT-induced hyperpolarisation persists in the 
presence of TTX 
Bi: Superimposed samples from a continuous whole-cell current-clamp recording 
showing membrane potential responses of an ARC neurone to a series of depolarising 
and hyperpolarising rectangular-wave current Pulses of constant increment, before 
(-130 to+ I OpA, Is, 0.1 Hz) and in the presence of 5-HT(-150 to 30pA, Is, 0.1 Hz). 
Bfi: Plot of the current-voltage (I-V) relationships before (o) and in the presence of 
5-HT (o), shown in Bi. Note the decrease in the slope of the I-V in the presence of 
5-HT indicating a decrease in neuronal resistance, with a reversal potential around 
-78 mV, close to that for potassium ions under our recording conditions. 
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Figure 5.2 5-HT induces an outward current in ARC neurones 
A: Application of 5-HT (50 ýiM) for approximately 60 s, as indicated by the line 
above the trace, to an ARC neurone voltage-clamped at a holding potential of 
-40 mV induced an outward current. 
B: Current responses obtained in voltage-clamp in the presence (green trace) and 
absence (black trace) of 5-HT. The currents were obtained from ramp protocols that 
drove the holding potential from - 13 0 mV to -20 mV, at a rate of 10 mV per second. 
Note the reversal potential of about -84 mV. 
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Figure 5.3 The effects of the 5-HT receptor agonists 8-OH-DPAT and 5-CT on 
ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ýM) for approximately 60 s induced a membrane 
hyperpolarisation and associated decrease in neuronal input resistance. 
Aft: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HTIA/7 receptor agonist 8-OH-DPAT 
(10 ýM) for approximately 60 s induced a small membrane hyperpolarisation. 
Bi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ptM) for approximately 75 s induced a membrane 
hyperpolarisation and associated decrease in neuronal input resistance. 
Bfi: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Bi. Application of the 5-HTI/5/7 receptor agonist 5-CT (10 ýLM) 
for approximately 75 s induced a membrane hyperpolarisation, mimicking the effect 
of 5-HT. 
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Figure 5.4 The effects of the 5-HT receptor agonists RU 24969 and CP 93129 on 
ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ptM) for approximately 30 s induced a membrane 
hyperpolarisation and decrease in neuronal input resistance. The parallel lines 
indicate a break in the trace during the wash off of 5-HT. 
AH: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HTIA/IB receptor agonist RU 24969 
(20 4M) had no effect on membrane potential or input resistance. 
Bi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT induced a membrane hyperpolarisation. The parallel 
lines indicate the time, approximately 60 s, where an I-V was taken. 
Bfi: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Bi. Application of the 5-HTIB receptor agonist CP 93129 (1 ptM) 
had no effect on membrane potential or input resistance. 
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Figure 5.5 The effects of the 5-HT receptor antagonists SB 269970 and 
cyanopindolol on ARC neurones 
Ai: Samples of a continuous whole-cell current-clamP recording from an ARC 
neurone. Application of 5-HT (50 ýM) for approximately 50 s induced a membrane 
hyperpolarisation and associated decrease in neuronal input resistance. The large 
deflections at the peak of the response indicate where an IN was taken. 
Afi: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HT7 receptor antagonist SB 269970 
(10 VM), as indicated by the line below the trace, had no effect on the 5-HT-induced 
hyperpolarisation in this neurone. The large deflections at the peak of the response 
indicate where an IN was taken. 
Bi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 [tM) for approximately 75 s induced a membrane 
hyperpolarisation and associated decrease in neuronal input resistance. 
BR: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Bi. Application of the 5-HTI receptor agonist cyanopindolol 
(10 ýtM) significantly attenuated the 5-HT-induced hyperpolarisation. 
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Figure 5.6 The effects of the 5-HT receptor antagonists WAY-100635 and SB 
224289 on ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 [tM) for approximately 30 s induced a membrane 
hyperpolarisation and associated decrease in neuronal input resistance. 
Afi: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HTIA receptor antagonist WAY-100635 
(I pM) inhibited the 5-HT-induced hyperpolarisation. 
AW: Plot showing the reduction in the amplitude of the 5-HT-induced depolarisation 
in the presence of increasing concentrations of WAY-100635. The control response 
was set as 100% and upon increasing concentrations of WAY-100635 there was a 
reduction in the amplitude of the response compared to control. 
Bi: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ptM) for approximately 40 s induced a membrane 
hyperpolarisation and associated decrease in neuronal input resistance. The 
deflections during the response correspond to the point where an IN was taken. 
Bfi: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Bi. Application of the 5-HTIB receptor antagonist SB 224289 
(2 VM) partially inhibited the 5-HT-induced hyperpolarisation and associated 
decrease in input resistance. 
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Figure 5.7 The effects of the 5-HT receptor antagonists WAY-100635, SB 
224289 and SB 269970 in combination on ARC neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 gM) for approximately 90 s induced a membrane 
hyperpolarisation and associated decrease in neuronal input resistance. The parallel 
lines indicate a period of time following washout of the drug. 
Aii: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HTIB receptor antagonist SB 224289 
(2 pM) and the 5-HT7 receptor antagonist SB 269970 (10 pM) partially reduced the 
5-HT-induced hyperpolarisation. 
Aiii: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone as in Ai. Application of the 5-HTIA receptor antagonist WAY-100635 
(300 nM), 5-HTIB receptor antagonist SB224289 (2 ýM) and the 5-HT7 receptor 
antagonist SB269970 (10 gM) suppressed the 5-HT-induced hyperpolarisation. 
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Figure 5.8 The effects of the 5-HT receptor antagonists MDL7222 and 
altanserin on ARC neurones 
A: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ýtM) for approximately 60 s induced a membrane 
hyperpolarisation; a response unaffected by the subsequent application of the 5-HT3 
receptor antagonist MDL7222 (100 nM). 
B: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT induced a membrane hyperpolarisation; a response 
unaffected by the application of the 5-HT2 receptor antagonist altanserin (200 nM). 
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Figure 5.9 The effects of ghrelin on 5-HT-inhibited neurones 
Ai: Samples of a continuous whole-cell current-clamp recording from an ARC 
neurone. Application of 5-HT (50 ýM) for approximately 50 s induced a membrane 
hyperpolarisation. 
Aft: Samples of a continuous whole-cell current-clamp recording from the same 
ARC neurone in Ai. Application of ghrelin (100 nM) induced a membrane 
depolarisation and increase in action potential firing. 
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Figure 5.10 The effects of 5-HT on orexigenic NPY/AgRP neurones 
A: Superimposed samples of a continuous whole-cell current-clamp recording 
showing membrane potential responses to a series of depolarising and 
hyperpolarising rectangular-wave current pulses of constant increment. This neurone 
was identified as an orexigenic ARC NPY/AgRP pacemaker neuron, by the presence 
of an anomalous inward rectifier (la,, ) and an A-like conductance UA; van den Top et 
al., 2004). 
Bi: Samples of a continuous whole-cell current-clamp recording from an orexigenic 
ARC NPY/AgRP pacemaker neurone, identified based upon its characteristic 
electrophysiological properties (see A). Application of 5-HT (50 gM) induced a 
membrane hyperpolarisation in these neurones. 
Bfi: Superimposed samples from a continuous whole-cell current-clamp recording 
showing membrane potential responses of an orexigenic ARC NPY/AgRP neurone to 
a series of depolarising and hyperpolarising rectangular-wave current pulses of 
constant increment, before (-60 to + 12 pA, I s, 0.1 Hz) and in the presence of 5-HT' 
(-90 to +36 pA, 1 s, 0.1 Hz). 
Bfii: Plot of the current-voltage (I-V) relationships before (o) and in the presence of 
5-HT (o), shown in BE Note the decrease in the slope of the I-V in the presence of 
5-HT indicating a decrease in neuronal resistance, with a reversal potential around 
-82mV, close to that for potassium ions under our recording conditions. 
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Figure 5.11 Immunohistochemical detection of a 5-HTIB receptor-expressing 
non-CART positive neurone within the ARC 
Ai: Confocal image of a single ARC neurone showing expression of the 5-HTIB 
receptor visualised using Cy5 (red). 
AH: Confocal image showing that the neurone in Ai does not express CART (green). 
Scale bar applies to both Ai and Aii. 
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Figure 5.12 Immunohistochemical detection of a CART positive neurone within 
the ARC 
Ai: Confocal image of a single ARC neurone showing expression of CART 
visualised using Cy2 (green). 
Aft: Confocal image showing that the neurone in Ai does not express 5-HTIB 
receptor(red). 
Scale bar applies to both Ai and Aii. 
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Figure 5.13 Co-localisation of 5-HTIB receptor and CART within the ARC 
Ai: Confocal image of a single ARC neurone showing expression of 5-HTIB receptor 
visualised using Cy5 (red). 
Afi: Confocal image of the same ARC neurone in Ai, showing the expression of 
CART visualised using Cy2 (green). 
Aiii: Superimposed image of Ai and Aii, showing the co-localisation (yellow) of the 
5-HTIB receptor and CART on a single ARC neurone 
Scale bar applies to Ai, Aii and Aiii. 
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6.1 Introduction 
Leptin is the hormonal product of the ob gene (Zhang et al., 1994) and acts as 
an adiposity factor, increasing in proportion to the amount of stored fat in the body 
and communicating this information to the brain. Leptin deficient mice (oblob) and 
leptin resistant mice (dbldb) and rats (falfa) have been shown to be hyperphagic and 
obese (Lee et al., 1996). Administration of leptin causes a decrease in body-weight 
and food intake in both oblob and wild-type mice and rats (Campfield et al., 1995; 
Halaas et al., 1995; Pelleymounter et al., 1995; Weigle et al., 1995; Schwartz et al., 
1996). These data therefore support a major role for leptin in regulating body-weight. 
Leptin receptors have been found within regions of the brain that are 
involved in feeding and energy homeostasis, including the arcuate nucleus (ARC), 
dorsomedial hypothalamus (DMH) and ventromedial nucleus (VMN; Schwartz et 
al., 1996). There are several splice variants of the leptin receptor (Ob-Ra - Ob-Rf) 
but the one that is thought to be involved in controlling energy homeostasis is the 
long form of the leptin receptor (Ob-Rb). Neuropeptide Y (NPY) and 
pre-pro-opiomelanocortin (POMC) neurones in the ARC have been shown to 
express this leptin receptor (Mercer et al., 1996; Cheung et al., 1997; Baskin et al., 
1999) and to be targets for leptin. Leptin down-regulates the expression of NPY in 
the ARC (Stephens et al., 1995; Schwartz et al., 1996), and up-regulates the 
expression of POMC (Schwartz et al., 1997; Thornton et al., 1997). POMC neurones 
release several melanocortin peptides, including a-MSH, which bind to and activate 
melanocortin receptors (Mountjoy et al., 1994). The fact that agonists and 
antagonists of these receptors inhibit and stimulate feeding respectively (Fan et al., 
1997), and MC4-R receptor knockout mice are obese (Huszar et al., 1997), provides 
compelling evidence that the melanocortin pathway is important in the control of 
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body-weight. Agouti-related peptide (AgRP) is a peptide that is co-expressed with 
NPY in the ARC and is an antagonist for MC3-R and MC4-R receptors (Ollmann et 
al., 1997; Shutter et al., 1997; Hahn et al., 1998). AgRP increases food intake and 
body-weight and like NPY is down-regulated by leptin (Ebihara et al., 1999). As 
leptin is able to increase the level of POMC and decrease the level of AgRP, it 
appears that leptin and the melanocortin pathway are closely linked in the control of 
feeding. 
Several studies have shown that fasting can increase NPY and AgRP and 
decrease POMC levels, and that leptin is able to reduce NPY and AgRP but increase 
POMC levels in fasted rats, therefore this study will also look at the effects of leptin 
on fasted animals. (Baskin et al., 1999; Mizuno & Mobbs, 1999; Komer et al., 2000, 
200 1; Bi et al., 2003; Perello et al., 2007). 
As well as regulating NPY/POMC neurones, leptin also targets other 
hypothalamic neurones, for example, melanin concentrating hormone (MCH), 
galanin, galanin-like peptide (GALP), orexin and corticotrophin releasing factor 
(CRF). Leptin increases the expression of the anorexigenic peptides CRF and GALP 
(Huang et al., 1998; Kumano et al., 2003) whereas it inhibits the expression of the 
orexigenic peptides MCH, orexin and galanin (Sahu, 1998; Lopez et al., 2000). 
In addition to regulating the expression of hypothalamic neuropeptides, leptin 
is also able to regulate the electrical excitability of neurones (Spanswick et al., 1997; 
Cowley et al., 2001). The ability of leptin to alter the activity of neurones is assumed 
to be independent of its ability to regulate gene expression. However numerous 
studies have shown activity-dependent gene regulation occurs, particularly in the 
hippocampus. In neurones, changes in the concentration of intracellular calcium have 
been shown to mediate important effects on gene expression (Ghosh & Greenberg, 
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1995). For example, the expression of immediate early genes (genes whose 
transcription is activated within minutes of stimulation) such as c-fos and c-jun, is 
associated with an increase in calcium and activation of subsequent second 
messenger pathways, which leads to the regulation of transcriptional activity of late 
response genes (Sheng & Greenberg, 1990; Ginty et al., 1992). The increase in 
calcium responsible for these changes in immediate early gene expression is 
controlled by activation of two types of calcium channel: the N-methyl-D-aspartate 
(NMDA) receptor and the voltage gated L-type calcium channel (Cole et al., 1989; 
Szekely et al., 1989; Murphy et al., 1991). Transcription of c-fos activated by 
calcium influx through the NMDA receptor and the L-type calcium channel has been 
studied in the hippocampus and in neuronal cell lines (Bading et al., 1993; Ghosh et 
al., 1994). Another study has identified the non-NMDA receptor as being important 
for activity-dependent regulation of brain derived neurotrophic factor (BDNF) and 
nerve growth factor (NGF) in the hippocampus (Zafra et al., 1990). Activity- 
dependent release of transforming growth factor beta (TGF-P) has also been 
demonstrated in the hippocampus (Lacmann el al., 2007). 
It is not just activity alone, but the pattern of activity that is important for 
regulating the expression of genes. For example, specific patterns of action potentials 
alter the expression of neural cell adhesion molecules (Itoh et al., 1995), 
neurotransmitters (Hodaie et al., 1995) and immediate early genes (Sheng et al., 
1993). These patterns of activity alter the calcium concentration, which leads to 
changes in gene expression; therefore calcium provides a key link between electrical 
activity and gene expression. 
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The aims of this study were to determine the effects of leptin on neuropeptide 
gene expression within the hypothalamus and to separate activity- versus non- 
activity-dependent gene regulation. A new technique was developed for this purpose. 
Hypothalamic explants were prepared from rat brains and were incubated with leptin 
for various lengths of time. Total RNA was extracted from the explants and 
quantitative real-time PCR was performed to detennine the expression levels of 
various neuropeptides within the hypothalamus (see section 2.3). Although several 
studies have used a hypothalamic explant incubation protocol previously, they have 
not measured the level of gene expression as we do here, but instead measure the 
release of peptides from the explants (King et al., 1999; Korbonits et al., 1999; Kim 
et al., 2000; Russell et al., 2001; Dhillo et al., 2002; Breen et al., 2005). This 
protocol also utilised a more detailed time-course over which to study gene 
expression that has been absent in previous studies. If our protocol proved effective, 
then it would be used to determine the effects of leptin on the levels of various 
peptides and neurotransmitters, such as 5-HT, within the hypothalamus. It would 
also be used to test whether the effects of leptin on gene regulation are activity- or 
non-activity-receptor-dependent. The hypothesis is that leptin acts on gene regulation 
in a non-aetivity-dependent manner. This would be tested by incubating the explants 
in antagonists for different ion channels that have been shown to be important in 
mediating the activity of neurones. These include TTX, which would block sodium 
channels and remove any action-potential dependent activity; AP5 to block NMDA 
receptors; NBQX to block non-NMDA receptors and nifedipine to block the L-type 
calcium channel to block calcium influx. EGTA, a calcium chelator could also be 
used to block the effects of calcium. If gene expression is affected by any of these 
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treatments then this would provide insight into the effects of leptin and the role of 
activity in regulating gene expression. 
6.2 Results 
The initial study aimed to check that our experimental protocols were 
effective. Briefly, the protocol used was as follows. Hypothalamic explants were 
prepared from age-matched (6 weeks old) male rats as described in section 2.3.1. 
The explants were immediately incubated in 2 mM glucose-containing aCSF at 350C 
for 60 minutes. After this time, the explants were removed and placed into small 
vials containing 2 mM glucose-containing aCSF at 35'C. For each experiment, four 
control animals were used and these four explants were incubated in aCSF for the 
same time as the challenge time for that experiment. Four explants were used as the 
test tissues for each experiment and incubated in aCSF containing either leptin, 
GABA, AMPA, or a specific concentration of glucose. The challenge time varied 
depending on the experiment. At the end of the incubation time, the explant was 
removed and placed into an eppendorf and immediately snap-frozen on dry ice. The 
samples were stored in a -800C freezer prior to molecular analysis. Statistical 
significance was determined using Mann Whitney or Kruskal-Wallis tests where 
stated. 
In the first experiment, the regulation of c-fos, a marker of neuronal activity, 
by the neurotransmitters GABA and AMPA was studied. 
6.2.1 The effects of GABA and AMPA on c-jos mRNA expression 
Hypothalamic explants from animals fed ad libitum were exposed to either 
I ýLM or I mM GABA, or I ýLM or 50 ttM AMPA for 10 mins. Explants were then 
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snap-frozen after 15 mins. Expression levels of c-fos mRNA were then examined 
relative to control utilising the real-time PCR protocol as described in chapter 2. 
GABA: At I ýM, there was an average 3.1 ± 10.0 % change in the level of 
c-fos mRNA (n=4). At I mM, there was an average 14.5 ± 32.5 % change in c-fos 
mRNA (n=4; see figure 6. lAi). Neither value was significant. The relative 
expression of c-fos for each of the 4 individual explants can be seen in figure 6.1 Aii. 
AMPA: At I ýM, there was an average 18.0 ± 15.7 % change in c-fos 
mRNA expression (n=4) and at 50 gM there was an average 27.0 ± 30.3 % change in 
c-fos mRNA (n=4; see figure 6.2Ai). Neither value was significant. The relative 
expression of c-f6s for each of the 4 individual explants can be seen in figure 6.2Aii. 
The next study aimed to determine the effect of leptin on NPY and POMC 
gene expression in the hypothalamus. 
6.2.2 The effects of leptin on NPY and POMCmRNA expression 
Hypothalamic explants from animals fed ad libitum were exposed to 100 nM 
leptin for either 15,30,45 or 60 minutes. ExPression levels of NPY and POMC 
mRNA were then examined relative to control. 
NPY: At 15 mins, leptin. caused an average 16.1 ± 4.0 % change in the level 
of NPY (n=8) and at 30 mins caused an average 22.1 ± 7.1 % change (n=6). At 
45 mins, NPY levels changed by 5.2 ± 4.4 % (n=8) and at 60 mins, expression 
changed by 3.9 ± 4.8 % (n=8). The peak time for leptin regulating NPY levels was 
30 mins (see figure 6.3Ai). None of these values were significant. The relative 
expression of NPY for each of the individual explants can be seen in figure 6.4Ai. 
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Comparing the expression of NPY mRNA at each time point using the Kruskal- 
Wallis test indicated no significant difference in expression between any time points. 
POMC: At 15 mins, the level of POMC changed by an average of 
14.0 ± 3.1 % (n=8) whilst it changed by 6.6 ± 5.6 % at 30 mins (n=6). At 45 mins, 
POMC expression changed by 12.7 ± 5.8 % (n=8) followed by a change at 60 mins 
of 0.8 ± 5.2 % (n=8); see figure 6.3Aii). Again, none of these values were 
significant. The relative expression of POMC for each of the individual explants can 
be seen in figure 6.4Aii. Comparing the expression of POMC mRNA at each time 
point using a Kruskal-Wallis test indicated a significant difference between 
expression at 15 and 45 mins (P<0.05) and no significant differences in expression 
between any other time points. 
When comparing the regulation of NPY and POMC by leptin, there was a 
significant difference between the two at 30 mins (P<0.05), but at 15,45 and 60 
mins the expression levels of NPY and POMC were not significantly different (see 
figure 6.3Aiii). 
The next experiment aimed to determine the effect of leptin on NPY and 
PONIC gene expression in the hypothalamus from fasted animals. 
6. Z3 The effects of leptin on NPY and POMCmRNA expression in fasted animals 
Hypothalamic explants from animals fasted for 24 hours were exposed to 
100 nM leptin for 15,30,45,60,120 or 240 minutes. Expression levels of NPY and 
POMC mRNA were then examined relative to control utilising the real-time PCR 
protocol. 
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NPY: At 15 mins leptin did not change the expression level of NPY, a 
0.4 ± 8.4% change but at 30 mins there was a significant 186.8 :L 96.9 % up- 
regulation (P,:: ý0.01). At 45 mins, NPY levels changed by 0.6 ± 18.9 % and at 
60 mins and 120 mins, expression changed by 3.9 ± 7.9 % and 3.2 ± 14.8 %, 
respectively. At 240 mins there was a significant 49.9 ± 32.9 % up-regulation of 
NPY (P<0.01; n=4; see figure 6.5Ai). The relative expression of NPY for each of the 
individual explants can be seen in figure 6.6Ai. Comparing the expression of NPY 
mRNA at each time point using a Kruskal-Wallis test indicated no significant 
difference in expression between any time points. 
POMC: At 15 mins, the level of POMC changed by 5.1 ± 5.1 % whilst at 
30 mins there was a significant 191.8 ± 98.2 % increase (P<0.01). At 45 mins, 
POMC changed by 1.7 ± 11.7 % followed by an 11.8 ± 6.2 % change at 60 mins. At 
120 and 240 mins there was a 21.2 ± 30.3 % and 20.1 ± 21.2 % change in the level 
of POMC, respectively (n=4). These results indicate that at a peak of 30 mins there 
was an up-regulation of POMC by leptin (see figure 6.5Aii). The relative expression 
of POMC for each of the individual explants can be seen in figure 6.6Aii. 
Comparing the expression of POMC mRNA at each time point using Kruskal-Wallis 
test indicated no significant difference in expression between any time points. 
When comparing the expression of NPY and POMC, there were no 
significant differences at any time points (see figure 6.5Aiii). 
The next study looked at the expression of another hypothalamic peptide, 
AgRP. 
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6.2.4 The effects of leptin on AgRP mRNA expression 
The effect of 100 nM leptin on the expression of AgRP mRNA in ad libilum 
fed animals was tested over the time-course 15,30,45 and 60 mins. At 15 mins there 
was an average 7.9 :L9.7 % change in AgRP, at 30 mins and 45 mins there was a 
significant 53.6 ± 1.9 % and 31 ± 6.7 % down-regulation, respectively (P<0.05), and 
at 60 mins there was a 9.5 ± 6.4 % change (n=3; see figure 6.7Ai). The relative 
expression of AgRP for each of the individual explants can be seen in figure 6.7Aii. 
Comparing the expression of AgRP mRNA at each time point using a Kruskal- 
Wallis test indicated no significant differences in expression between any time 
points. 
The experiment was repeated with fasted animals and the time course was 
extended to include 120 and 240 mins. At 15 mins, there was an average 
33.3 ± 2.3 % increase in AgRP levels. However, there was a 70.2 ± 8.5 % increase in 
AgRP at 30 mins. At 45,60 and 120 mins, there was a 45.4 ± 5.3 %, 3.3 ± 2.5 % and 
19.3 ± 2.4 % reduction, respectively. At 240 mins there was a 27.8 =L 0.3 % increase 
in AgRP. At all time points except 60 mins the values were significant (P<0.01; n=3; 
see figure 6.8Ai). The relative expression of AgRP for each of the individual 
explants can be seen in figure 6.8Aii. Comparing the expression of AgRP mRNA at 
each time point using Kruskal-Wallis test indicated a significant difference in 
expression between 30 and 45 mins but no significant differences between any other 
time points. 
We then went on to test whether changing the external glucose concentration 
could affect the expression of NPY and POMC. 
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6.2.5 The effect of changing glucose concentration on NPY and POMC mRNA 
expression 
Hypothalamic explants from animals fed ad libitum were incubated in 2 mM 
glucose for 60 mins. They were then exposed to either 0.2 mM or 5 mM glucose for 
15 mins, and the expression of NPY and POMC mRNA was compared to control 
animals that had not been exposed to a change in glucose concentration. 
NPY: From 2 to 0.2 mM, NPY was significantly down-regulated by 
49.5 ± 15.5 % (n=4; P<0.01) and from 2 to 5 mM, it was altered by 32.2 ± 39.6 % 
(n=4; see figure 6.9Ai). The relative expression of NPY for each of the individual 
explants can be seen in figure 6.9Aii. 
POMC: From 2 to 0.2 mM, POMC expression significantly decreased by 
61.3 ± 3.1 % (n=4; P<0.01) and from 2 to 5 mM it changed by 13.4 ± 19.3 % (n=4; 
see figure 6. lOAi). The relative expression of POW for each of the individual 
explants can be seen in figure 6.1 OAH. 
6.3 Discussion 
The initial aims of this study were to determine the effects of leptin on 
neuropeptide gene expression within a whole hypothalamic explant and to identify if 
these effects on gene expression were dependent on the activity of neurones. In order 
to achieve these aims a new protocol was developed whereby hypothalamic explants, 
prepared from rats fed ad libitum or fasted, were incubated with leptin and the 
expression levels of hypothalamic neuropeptide mRNA were subsequently measured 
over a time-course. Hypothalamic explants were used in this study as this enabled 
the circuitry within the hypothalamus to remain intact, thereby maintaining all 
contacts between the multiple nuclei within the hypothalamus in order to mimic the 
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conditions in vivo. However it has the advantage over in vivo studies of being able 
to control and manipulate the external environment and expose the explant only to 
the factors being studied at that time. 
Initially, in order to establish whether our experimental protocols were 
effective, we measured the level of c-fos gene expression, a marker of neuronal 
activity, after incubating the explants in different concentrations of GABA and 
AMPA. Both AMPA, a glutamate receptor agonist and GABA, an inhibitory 
neurotransmitter had no significant effect on the expression of c-fos mRNA. The 
incubation time might have been too short to see any significant changes in c-fos 
mRNA expression and further incubation times should have been investigated to see 
if significant changes would have occurred over a longer time scale. However due to 
time constraints these experiments were not performed. As this experiment did not 
prove that our experimental protocol was effective, a different experiment was 
performed to try to prove that it was working effectively. 
We therefore next decided to study the effect of leptin on hypothalamic 
neuropeptide gene expression. Leptin is produced from adipose tissue in proportion 
to the amount of fat stored and is the product of the ob gene (Zhang et al., 1994). It 
plays a highly significant role in the control of feeding and body-weight regulation, 
as it has been shown to inhibit food intake and body-weight (Campfield et al., 1995; 
Halaas et al., 1995; Pelleymounter et al., 1995; Weigle et al., 1995). Leptin inhibits 
the expression of orexigenic peptides such as NPY and stimulates expression of 
anorexigenic peptides, such as POMC, in the ARC (Stephens et al., 1995; Schwartz 
et al., 1996,1997; Thornton et al., 1997). 
The first experiment looked at the effect of leptin on NPY and POMC 
expression in hypothalamic explants prepared from rats fed ad libitum. Expression 
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levels of either NPY or PONIC were not affected by leptin in a significant way at any 
time point. In some instances, significance may have been reached with higher 'n' 
values. At both 30 mins, leptin significantly differentially regulated NPY and POMC 
mRNA levels. These results indicate that leptin is able to differentially regulate the 
level of both NPY and POMC in the hypothalamus. Leptin signalling is a complex 
process whereby leptin first binds to the Ob-Rb receptor, which is a type I cytokine 
receptor. Binding of leptin activates a JAK (Janus Kinase), which phosphorylates the 
intracellular region of the receptor. This then serves as a binding site to which a 
member of the STAT (Signal Transducer and Activator of Transcription) family can 
bind. Once STAT is activated it moves to the nucleus, where it stimulates 
transcription of genes (Good, 2000). There is very little published data looking at the 
actual time-course of leptin's effects on transcription and gene expression. The few 
studies that have investigated the effect of leptin on neuropeptide expression do not 
look at expression over such a detailed and immediate time-scale as is done here; 
instead they look at expression starting from I hour up to periods of weeks 
(Schwartz et al., 1997; Thornton et al., 1997; Sahu, 1998; Ahima et al., 1999; 
Komer et al., 200 1; Swart et al., 2002). The time-course used here therefore provides 
new information on the regulation of the neuropeptides NPY and POMC by leptin 
over a detailed time-scale. 
The first experiment was repeated using fasted animals. The results showed 
that leptin significantly up-regulated both NPY and POMC at 30 mins, with 
relatively minor changes at all other time points. In this study the whole of the 
hypothalamus was used which is in contrast to previous studies that have focused 
predominantly on the ARC. Whereas previous studies have shown that leptin down- 
regulates NPY in the ARC, (Stephens et al., 1995; Schwartz et al., 1996), the results 
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from this study showing an up-regulation must be considered in light of the fact that 
other areas of the hypothalamus are also being looked at alongside the ARC. In other 
areas of the hypothalamus, such as the DMH, it has been shown that both leptin and 
diet-induced obesity lead to a differential regulation of NPY gene expression 
compared to the ARC (Guan et al., 1998; Bi et al., 2003; Bi, 2007), leading to a 
different level of expression of NPY across the whole hypothalamus compared to 
just the ARC. The POMC data are in accordance with previous studies showing an 
up-regulation of POMC by leptin (Schwartz et al., 1997; Thornton et al., 1997). 
However, it must be considered that these data are influenced by three outliers and 
therefore this experiment may not be very conclusive. 
AgRP was subsequently investigated. AgRP is only found in the ARC and is 
co-expressed with NPY neurones (Hahn et al., 1998). Like NPY, AgRP is down- 
regulated by leptin (Ebihara et al., 1999). The results from the fed animals showed 
that leptin significantly down-regulated AgRP expression, with peak down- 
regulation occurring at 30 mins. The fasted data were slightly ambiguous as there 
was a significant down regulation of AgRP at 15,45 and 120 mins but there was a 
significant up-regulation of AgRP at 30 and 240 minutes. 
Finally we decided to see if a change in glucose concentration would affect 
the gene expression of NPY and POMC. Explants were subjected to both 
hyperglycaernic (2 to 5 mM) and hypoglycaernic (2 to 0.2 mM) conditions. Inducing 
hypoglycaemia induced a down-regulation of both POMC and NPY levels. Inducing 
hyperglycaernia did not significantly change NPY and POMC levels. NPY and 
POMC neurones within the hypothalamus have been shown to be glucose-sensing 
neurones (Spanswick et al., 1997; Muroya et al., 1999; Ibrahim et al., 2003). These 
neurones can detect changes in glucose concentration and alter their activity and 
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subsequent neuropeptide expression, which explains why NPY and POMC 
expression were affected by a change in glucose. Several features of hypothalamic 
circuitry may help to explain why POMC and NPY levels were regulated in the same 
way under hypoglycaemic conditions. Neurones in particular areas of the 
hypothalamus, for example orexin neurones in the lateral hypothalamus (LH), have 
reciprocal connections with neurones in other areas of the hypothalamus, for 
example NPY neurones in the ARC (Broberger et al., 1998; Elias et al., 1998b, 
1999). Orexin neurones may have detected a decrease in glucose and subsequently 
altered the activity of NPY neurones in the ARC. POMC neurones may have 
detected the decrease in glucose and altered their own activity if they were glucose- 
sensing, or alternatively may have been inhibited by neurones in other hypothalamic 
nuclei, for example MCH neurones in the LH. The reciprocal connections between 
the hypothalamic nuclei, which are maintained in the hypothalamic explants, are 
therefore important when considering the effects of glucose. 
There are several technical issues that need to be discussed concerning the 
development of this new experimental protocol. Several stages of the technique may 
need to be refined. Firstly great care must be taken to ensure the hypothalamic 
explants are handled carefully as any damage to them may result in abnormal results. 
The process of incubating the explants in leptin may not provide enough penetration 
to the tissue; therefore it may be more beneficial to use hypothalamic slices rather 
than a single explant containing the whole hypothalamus, in order to increase access 
of leptin to the tissue. The time course that was chosen may have missed the crucial 
points in the expression of the genes as we were only looking every 15 minutes. it 
may be necessary to include more time points in order to fully determine the gene 
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expression profile. Alternatively we may not have incubated the explants for long 
enough, perhaps more than an hour is needed to observe further changes. 
In the fasted experiments, the animals were only fasted for 24 hours. This 
may not be long enough to fully detect changes due to fasting as many experiments 
in the literature use a 48 hour fast. Therefore we may not be seeing the full benefit of 
the fasting protocol. In future a license may need to be obtained for a 48 hour fast. 
The processes of RNA extraction through to quantitative real-time PCR are 
very sensitive and require a great deal of care. It is possible that during these 
processes errors may occur, for example, due to human error, problems with 
solutions, contamination of RNA or solutions or errors in the processes themselves, 
particularly reverse transcription. 
This was an initial pilot study that aimed to compare activity versus non- 
activity-dependent gene regulation and to look at the effects of leptin on regulation 
of gene expression of hypothalamic neurotransmitters and neuropeptides. Due to 
time constraints the original aims were not completely fulfilled but the study was 
successful in providing novel evidence of the specific time-course over which leptin 
regulates NPY and POMC gene expression in a whole hypothalamic explant. Future 
work needs to be done to compare the activity versus non-activity-dependent gene 
regulation by leptin using selective antagonists for sodium channels and calcium 
channels as described earlier. Also, the hypothalamic explants in this study contained 
all regions of the hypothalamus whereas previous studies have isolated single areas 
of the hypothalamus and only study expression levels in each discrete area. It may be 
interesting in future to try to dissect out particular areas of the hypothalamus in order 
to isolate those areas and measure gene expression more region specifically. 
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Figure 6.1 The effect of GABA on c-fos gene expression in hypothalamic 
explants from rats fed ad libitum 
Ai: A bar-chart to show the effects of GABA on the expression of c-fos mRNA in 
fed animals. Hypothalamic explants were exposed to either I pM or I mM GABA 
for 10 minutes and the expression of c-fos mRNA was compared to control explants 
that had not been exposed to GABA. In this chart and all subsequent bar-charts 
control explants have an expression level of 1.0. GABA down-regulated expression 
of c-fos at I ýM but up-regulated expression of c-fos at I mM, although not 
significantly. Error bars represent S. E. M in this and all subsequent figures. 
Afi: A scatter graph to show the effects of GABA on the expression of c-fos mRNA 
in each of the four individual hypothalamic explants from Ai, at I gM and I mM. 
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Figure 6.2 The effect of AMPA on c-fos gene expression in hypothalamic 
explants from rats fed ad libitum 
Ai: A bar-chart to show the effects of AMPA on the expression of c-fos mRNA in 
fed animals. Hypothalamic explants were exposed to either I ýtkl or 50 pM AMPA 
for 10 minutes and the expression of c-fos was compared to control explants that had 
not been exposed to AMPA. AMPA non-significantly up-regulated expression of 
c-fos at I gM and 50 gM. 
Aii: A scatter graph to show the effects of AMPA on the expression of c-fos mRNA 
in each of the four individual hypothalamic explants from Ai, at I pM and 50 gM. 
-251 - 
Figure 6.2 
Ai 1.6 n 
1.4 
1.2 
1.0 
0.8 
0.6 
Aii 
2.2 
2.0 
1.8 
1.6 
1.4 
1.2 
1.0 
0.8 
o. 6 
0.4 
Chapter Six 
Figure 6.3 The effect of leptin on NPY and PONIC gene expression in 
hypothalamic explants from rats fed ad libitum 
Ai: A bar-chart to show the effects of leptin on the expression of NPY mRNA. 
Hypothalamic explants were exposed to leptin for 15,30,45 or 60 minutes, and the 
expression of NPY was compared to control explants that had not been exposed to ' 
leptin. Leptin non-significantly down-regulated expression of NPY at all time points, 
with a peak decrease at 30 mins. 
Aii: A bar-chart to show the effects of leptin on the expression of POMC mRNA. 
Hypothalamic explants were exposed to leptin for 15,30,45 or 60 minutes, and the 
expression of POMC was compared to control explants that had not been exposed to 
leptin. Leptin non-significantly down-regulated expression of POMC at 15,30 and 
60 mins but up-regulated POMC at 45 mins. There was a significant difference in 
expression between 30 and 45 mins (P<0.05, indicated by *). 
AM: A line graph to compare the differential regulation of NPY and POMC gene 
expression by leptin. The dashed line indicates the level of control expression. There 
was a significant difference in the regulation of NPY and POMC by leptin at 30 mins 
(P<0.05, indicated by *). 
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Figure 6.4 The effect of leptin on NPY and POW gene expression in individual 
hypothalamic explants from rats fed ad libitum 
Ai: A scatter graph to show the effects of leptin on the expression of NPY mRNA in 
each of the individual hypothalamic explants from figure 6-3Ai- 
Aii: A scatter graph to show the effects of leptin on the expression of POMC mRNA 
in each of the individual hypothalamic explants from figure 6.3Aii. 
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Figure 6.5 The effect of leptin on NPY and PONIC gene expression in 
hypothalamic explants prepared from fasted rats 
Ai: A bar-chart to show the effects of leptin on the expression of NPY mRNA. 
Hypothalamic explants were exposed to leptin for 15,30,45,60,120 or 240 
minutes, and the expression of NPY was compared to control explants which had not 
been exposed to leptin. Leptin significantly up-regulated expression of NPY at 30 
and 240 mins, with a peak increase at 30 mins (P<0.01 indicated by **). At all other 
time points, NPY levels did not significantly change. 
Aii: A bar-chart to show the effects of leptin on the expression of POMC mRNA. 
Hypothalamic explants were exposed to leptin for 15,30,45,60,120 or 240 
minutes, and the expression of POMC was compared to control explants which had 
not been exposed to leptin. Leptin significantly up-regulated expression of PONIC at 
30 mins (P<0.01 indicated by **) but at all other time points, POMC levels were 
similar to control. 
Affi: A line graph to compare the differential regulation of NPY and PONIC gene 
expression by leptin. There were no significant differences at any time points. 
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Figure 6.6 The effect of leptin on NPY and POW gene expression in individual 
hypothalamic explants prepared from fasted rats 
Ai: A scatter graph to show the effects of leptin on the expression of NPY mRNA in 
each of the individual hypothalamic explants from figure 6.5Ai. 
Afi: A scatter graph to show the effects of leptin on the expression of POMC MRNA 
in each of the individual hypothalamic explants from figure 6.5Aii. 
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Figure 6.7 The effect of leptin on AgRP gene expression in hypothalamic 
explants from animals fed ad libitum 
Ai: A bar-chart to show the effects of leptin on the expression of AgRP mRNA in 
fed animals. Hypothalamic explants were exposed to leptin for 15,30,45 or 60 
minutes, and the expression of AgRP was compared to control explants which had 
not been exposed to leptin. Leptin down-regulated expression of AgRP at all time 
points, significantly at 30 and 45 mins, with a peak decrease at 30 mins (P<0.05, 
indicated by *) 
Afl: A scatter graph to show the effects of leptin on the expression of AgRP mRNA 
in each of the individual hypothalamic explants from Ai. 
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Figure 6.8 The effect of leptin on AgRP gene expression in hypothalamic 
explants prepared from fasted animals 
Ai: A bar-chart to show the effects of leptin on the expression of AgRP mRNA in 
fasted animals. Hypothalamic explants were exposed to leptin for 15,30,45,60,120 
or 240 minutes, and the expression of AgRP was compared to control explants which 
had not been exposed to leptin. Leptin significantly down-regulated expression of 
AgRP at 15,45 and 120 mins and significantly up-regulated expression of AgRP at 
30 and 240 mins (P< 0.01, indicated by **). There was a significant difference in 
expression between 30 and 45 mins (P<0.05, indicated by *). 
Afi: A scatter graph to show the effects of leptin on the expression of AgRP mRNA 
in each of the individual hypothalamic explants from Ai. 
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Figure 6.9 The effect of changing the glucose concentration on NPY gene 
expression in hypothalamic explants from rats fed ad libitum 
Ai: A bar-chart to show the effects of changing the glucose concentration on the 
expression of NPY mRNA. Hypothalamic explants were incubated in 2 mM glucose 
for 60 minutes. They were then exposed to either 0.2 mM or 5 mM glucose for 15 
minutes, and the expression of NPY was compared to control explants that had not 
been exposed to a change in glucose concentration. NPY expression was 
significantly down-regulated in the explants that were subjected to 0.2 mM glucose 
(P<0.01, as indicated by **) and was up-regulated in explants that had been 
subjected to 5 mM glucose. 
Afi: A scatter graph to show the effects of changing the glucose concentration on the 
expression of NPY mRNA in each of the individual hypothalamic explants from Ai. 
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Figure 6.10 The effect of changing the glucose concentration on POMC gene 
expression in hypothalamic explants from rats fed ad libitum 
Ai: A bar-chart to show the effects of changing the glucose concentration on the 
expression of POMC mRNA. Hypothalamic explants were incubated in 2 MM 
glucose for 60 minutes. They were then exposed to either 0.2 mM or 5 mM glucose 
for 15 minutes, and the expression of POMC was compared to control explants that 
had not been exposed to a change in glucose concentration. POMC expression was 
significantly down-regulated in the explants that were subjected to 0.2 mM glucose 
(P<0.01, as indicated by **) and was up-regulated in explants that had been 
subjected to 5 mM glucose. 
Aii: A scatter graph to show the effects of changing the glucose concentration on the 
expression of POMC mRNA in each of the individual hypothalamic explants from 
Ai. 
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The central control of energy homeostasis is a complex process involving 
multiple aspects of the central nervous system and periphery. The arcuate nucleus 
(ARC) within the hypothalamus is a key integrative centre for the control of energy 
homeostasis. It is exposed to circulating hormones and nutrients enabling it to 
monitor the energy status of the body and produce appropriate responses. 
Understanding the neural pathways and mechanisms underlying the regulation of 
energy homeostasis is essential to further understand this complex process. 
Therefore in the present study, the effects of extrinsic and intrinsic factors involved 
in energy homeostasis at the level of the ARC were investigated using 
electrophysiology, immunohistochemistry and molecular biology techniques. 
7.1 Effect ofglucose on electrophysiological properties ofARC neurones 
Glucose is an important metabolic factor involved in energy homeostasis, as 
not only is it utilised as the primary source of energy for most cells, but it is also able 
to alter the activity of a population of neurones. These neurones, called glucose- 
sensing neurones, are able to monitor changes in extracellular glucose and alter their 
membrane excitability accordingly. Subdivided into two populations, GE neurones 
are excited by increases in glucose whereas GI neurones are inhibited by increases in 
glucose (Levin et al., 1999). These glucose-sensing neurones have been localised 
within the ARC (Ashford et aL, 1990a; Spanswick et aL, 1997). The levels of 
glucose to which hypothalamic neurones are exposed is still unclear but is thought to 
be around 1.4 mM under normal physiological conditions (de Vries et al., 2003; 
Mayer et al., 2006) but could range between 0 and 8 mM under non-physiological 
conditions. In this study, the activity and electrophysiological properties of ARC 
neurones were investigated under two different glucose concentrations, 2 mM 
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glucose representing a euglycaemic condition and 10 mM representing a 
hyperglycaernic condition. Previous electrophysiological studies which looked at 
glucose-sensing neurones in the hypothalamus used glucose at concentrations 
between 0 and 20 mM but levels above 10 mM are thought to be too high, therefore 
the present study would also provide useful comparisons with these previous studies. 
The major findings of this study were that there were clear differences 
between the input resistance, the percentage of active neurones and the expression of 
the active conductance Ih in neurones recorded in 2 mM compared to 10 mM 
glucose-containing aCSF. In terms of activity, neurones were more active under 
physiological conditions (2 mM glucose) compared to hyperglycaemic conditions 
(10 mM glucose). These data provide strong evidence that under different 
extracellular glucose concentrations there is a clear change in the activity of ARC 
neurones. These data may force us to re-evaluate previous glucose-sensing studies 
which were carried out in non-physiological glucose levels. 
Input resistance showed a significant increase in neurones recorded in 10 mM 
glucose-containing aCSF compared to 2 mM glucose-containing aCSF. As the KATP 
channel has been shown to be important in glucose homeostasis (Ashford et al., 
1990a, b; Rowe et al., 1996; Spanswick et al., 1997; Lee et al., 1999; Spanswick et 
al., 2000; Miki et al., 2001; Zhang et al., 2004), it may be that closure of KATP 
channels may be responsible for the observed increase in input resistance in higher 
glucose conditions. 
The other major finding of this study was the difference in expression of the 
active conductance lh (time- and voltage-dependent inward rectification; Halliwell & 
Adams, 1982; Pape, 1996). There were a greater percentage of neurones expressing 
Ih in 10 mM glucose-containing aCSF compared to 2 mM glucose-containing aCSF. 
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As lh can contribute to the activity of neurones, including by influencing burst-firing 
(van Welie et al., 2006), it could potentially alter the functional output of neurones. 
Therefore under different glucose conditions lh could be contributing to the activity 
of neurones. 
The active conductance anomalous inward rectifier (la,, ) did not significantly 
change in this study but there did appear to be a 'stronger' or more active 1,.. in 
physiological conditions (2 mM glucose) compared to hyperglycaernic conditions 
(10 mM glucose). These results indicate that the expression of Ian may be greater in 
physiological glucose providing further evidence that the expression of ion channels 
is altered under different glucose concentrations. In addition the expression of the 
A-like transient outward rectifier (IA), also appeared to change in this study. The 
decay time of the A-current was smaller in 2 mM glucose-containing aCSF. As 
A-currents are thought to be involved in the regulation of repetitive firing 
(Rogawski, 1985) this change in the size of the A-current may lead to differences in 
the firing properties of neurones. In turn, this could lead to altered release of 
neuropeptides as firing patterns have been shown to be important for the release of 
neuropeptides from neurones (Dutton & Dyball, 1979). 
As these results indicate that the electrophysiological properties of neurones 
are able to change under different glucose conditions, it can be concluded that 
10 mM and 2 mM glucose represent quite different physiological and/or 
pathophysiological states. Therefore previous studies undertaken in these glucose 
and energy status-sensing networks which were carried out in high glucose 
concentrations may require a major re-evaluation. 
Further work which could be done to build upon this study could include the 
investigation of other electrophysiological properties in 10 mM and 2 mM glucose, 
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for example the expression of other subthreshold active conductances, or 
suprathreshold conductances. As the activity of neurones was shown to change, it 
would be interesting to identify the specific neuronal subgroups within the ARC and 
see how their individual activity changes. Other glucose concentrations could be 
tested to investigate the properties of neurones over a range of glucose levels. 
Ultimately it would be advantageous to determine what the physiological level of 
glucose is within the hypothalamus in order to identify the properties of neurones in 
a physiological state. 
In addition the expression of ion channels, peptides and receptors could be 
studied to see if these change under different extracellular glucose levels. In relation 
to receptor expression, potential differences in the responsiveness of ARC neurones 
to the extrinsic factor 5-HT were investigated. There was an increase in the number 
of 5-HT-induced excitations and non-responders in 10 mM glucose while there was 
an increase in 5-HT-induced inhibitions in 2 mM glucose. The ability of ARC 
neurones to respond to extrinsic factors and produce responses is therefore altered 
under different glucose states. It may be that in different glucose concentrations 
different levels of 5-HT receptors may be expressed. For example, in 10 mM 
glucose, where there were more excitations, more 5-HT2 receptors which mediate the 
5-HT-induced excitation may be expressed. Conversely, the reduced number of 
inhibitions in 10 mM glucose may have been due to reduced expression of the 5-HT, 
and 5-HT7 receptors that mediate the 5-HT-induced inhibition. Overall these data 
indicate glucose as a key signalling molecule affecting the ability of ARC neurones 
to respond to extrinsic factors. 
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Z2 Electrophysiological characterisation of ARC neurones 
The ARC contains a complex network of neurones, with a diverse array of 
neuronal subtypes and multiple neuronal inputs and outputs. How these networks 
function together to integrate and generate responses is still largely unknown; 
therefore in the present study an electrophysiological classification was performed in 
an attempt to functionally classify ARC neurones. The classification in this study 
was designed to be a framework upon which to build a functional classification of 
ARC neurones. This study was based upon the expression of subthreshold active 
conductances, as these active conductances have been shown to be important for 
shaping the electrophysiological properties of individual neurones by integrating 
synaptic inputs and controlling the output of neurones by altering their patterns of 
activity (Huguenard, 1996; Pape, 1996; van den Top et aL, 2004). Dividing neurones 
into groups that contain different active conductances might therefore help to 
functionally separate ARC neurones, as neurones with different electrophysiological 
properties could also have different functions within the ARC. The subthreshold 
active conductances utilised in this study to classify neurones were lam 6 the A-like 
transient outward rectifier and the T-type calcium conductance. Neurones were 
divided into 8 neuronal groups, termed clusters. 
Future studies which build upon this classification now need to be 
undertaken. These electrophysiological studies need to be combined with other 
techniques which identify the phenotype of the neurones, the inputs to and 
projections from the neurones, the membrane receptors that are expressed and the 
synaptic physiology and pharmacology of neurones. Studies have already identified 
the pharmacology of ARC neurones in relation to 5-HT (see next section). In 
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combination these techniques will aid in producing a more detailed classification of 
ARC neurones and will identify, in more detail, functional groups within the ARC. 
7.3 The differential effects of 5-HT on ARC neurones 
The monoaminergic neurotransmitter 5-HT controls many biological, 
behavioural and physiological processes. It exerts its effects through 14 subtypes of 
receptor, split into seven families (Hoyer et al., 1994). 5-HT has been implicated in 
the control of feeding and energy homeostasis (Blundell, 1977), and several 
serotonergic agents have been utilised in the pharmacological treatment of obesity 
(Luque & Rey, 2002). However despite the evidence implicating 5-HT in the 
control of energy homeostasis, the receptors and cellular mechanisms underlying the 
effects of 5-HT in the ARC are still not completely known. Therefore this study 
investigated the cellular mechanisms by which 5-HT regulates key hypothalamic 
neurones in the ARC involved in regulating energy homeostasis and elucidated 
which 5-HT receptor subtypes were mediating these effects. 
ARC neurones responded to 5-HT either with a depolarisation of the 
membrane, a hyperpolarisation of the membrane or they did not respond. The effect 
of 5-HT persisted in the presence of TTX indicating that it was a direct effect on 
ARC neurones. 
The 5-HT-induced depolarisation was accompanied with a concomitant 
increase, decrease or no change in input resistance, leading to identification of three 
possible mechanisms responsible for the 5-HT-induced excitation. The increase in 
neuronal input resistance is thought to be due to the closure of one or more resting 
potassium conductances whereas the decrease in input resistance is most likely due 
to activation of a non-selective cation conductance. The mechanism by which cells 
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responded with no change in resistance upon 5-HT application was likely due to the 
activation of an electrogenic pump in the membrane or to activation of a 
combination of ion channels. Overall, these data suggest that multiple conductances 
are responsible for mediating the 5-HT-induced depolarisation. 
The 5-HT-induced hyperpolarisation was associated with a concurrent 
decrease in input resistance, likely to be due to activation of a potassium 
conductance. Current-voltage relationships also revealed the enhancement of an 
inward rectifier by 5-HT. Further studies need to be carried out to investigate 
whether a GIRK channel is involved in mediating the 5-HT-induced 
hyperpolarisation, utilising specific blockers for this channel. 
Pharmacological studies identified the receptors mediating the 5-HT-induced 
depolarisation to be 5-HT2A, 5-HT2B and 5-HT2c receptors and mediating the 5-HT- 
induced hyperpolarisation to be predominantly 5-HTIA receptors, as well as 5-HTIB 
and 5-HT7 receptors. Further work needs to be done to clarify the mechanisms 
responsible for the agonist responses and in the presence of the antagonists to 
identify if a specific subtype of receptor is associated with a particular mechanism. 
In addition, the downstream signalling pathways at these receptors need to be 
investigated. 
A population of neurones excited by 5-HT were subsequently identified 
immunohistochernically as CART neurones. CART is an anorexigenic peptide that is 
co-expressed with POMC neurones (Elias et al., 1998a), which suggests that 5-HT is 
able to excite anorexigenic neurones. However 5-HT was also able to excite 
orexigenic neurones as identified by their response to ghrelin, a marker of orexigenic 
neurones. Therefore 5-HT may be exciting both anorexigenic CART neurones and 
other un-identified neurones. 
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Neurones inhibited by 5-HT were identified as orexigenic by their response 
to ghrelin and due to the fact that 5-HT inhibited identified NPY/AgRP neurones 
(van den Top et al., 2004) providing evidence that 5-HT hyperpolarises orexigenic 
NPY neurones. 5-HTIB receptors were subsequently identified on non-CART- 
positive neurones, which could potentially be orexigenic neurones but this needs 
further investigation. 5-HTIB receptors were also found co-localised in CART 
neurones indicating that these receptors are also localised to a subset of anorexigenic 
neurones. Further work needs to be done utilising immunohistochemistry, in situ 
hybridisation and single-cell RT-PCR to elucidate other neuronal subtypes that are 
excited or inhibited by 5-HT. 
Overall these data provide compelling evidence for the anorexigenic role of 
5-HT acting at the level of the ARC. The present study has identified the 
mechanisms by which 5-HT acts at the level of the ARC to control the excitability of 
ARC neurones. 5-HT excites identified anorexigenic CART neurones via the 
5-HT2A, 5-HT2B and 5-HT2c receptors. 5-HT inhibits identified orexigenic NPY 
neurones via the 5-HTIA, 5-HTIB and 5-HT7 receptors. A schematic of the effects of 
5-HT in the ARC can be seen in figure 7.1. These studies have provided further 
evidence for the involvement of 5-HT in the central control of energy homeostasis. 
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Figure 7.1 5-HT differentially regulates NPY and POMC neurones within the 
ARC 
A: NPY and POMC neurones within the ARC receive inputs from serotonergic 
neurones. 5-HT acts directly upon NPY/AgRP neurones, inducing an inhibition in 
these neurones via 5-HTIA, 5-HTIB and/or 5-HT7 receptors, which are coupled to 
Gi/o proteins. The mechanism responsible for the 5-HT-induced inhibition is likely 
due to activation of one or more potassium conductances, thought to be G-protein 
coupled inwardly-rectifying potassium channels (GIRK). 5-HT also acts directly 
upon POMC/CART neurones, inducing an excitation in these neurones via 5-HT2Aý 
5-HT2B and/or 5-HT2C receptors, which are coupled to Gq proteins. The mechanism 
responsible for the 5-HT-induced excitation is likely due to activation of a non- 
selective cation conductance, block of a potassium conductance or combination of 
the two, or due to activation of an unidentified pump in the membrane. 
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7.4 Effect of feeding signals on neuropeptide mRNA expression in the 
hypothalamus 
The adiposity signal leptin is an important factor in energy homeostasis. It is 
able to regulate the expression of many hypothalamic peptides, including NPY and 
POMC (Stephens et al., 1995; Schwartz et al., 1996,1997; Thornton et al., 1997). In 
addition, leptin is also able to regulate the electrical excitability of neurones 
(Spanswick et al., 1997; Cowley et al., 2001). Whether leptin regulates the 
expression of neuropeptides in an activity- or receptor-dependent way is unclear; 
therefore the present study aimed to investigate this. Initially a new protocol utilising 
hypothalamic explants was developed to determine the effects of leptin on 
neuropeptide gene expression. Explants prepared from rats fed ad libitum or fasted 
were incubated with leptin and expression of hypothalamic peptide mRNA was 
measured over a detailed time-course. 
Due to time constraints, this study only produced preliminary results. Leptin 
differentially regulated NPY and PONIC levels in fed animals at 30 mins though the 
data from the fasted animals showed that leptin significantly up-regulated both NPY 
and POW at one time point, 30 mins, although this result may have been influenced 
by outliers. Leptin was also able to down-regulate another orexigenic peptide, AgRP. 
Future work needs to be done to extend these results. Studies to investigate 
whether the effects of leptin are activity or non-activity-dependent need to be 
performed. This can be done using selective antagonists for sodium channels and 
calcium channels which regulate the activity of neurones. In addition, it may be 
interesting in future to try to dissect out particular areas of the hypothalamus in order 
to isolate those areas and measure gene expression more region specifically. 
-280- 
Chapter Seven 
7.5 Conclusions andfuture work 
The major findings of this study show that differential levels of extracellular 
glucose, representing physiological and pathophysiological states, have an effect on 
the electrophysiological properties of ARC neurones, particularly the activity of 
these neurones. As properties of neurones are altered under different states, a major 
re-evaluation of previous studies undertaken in glucose and energy status-sensing 
networks which were carried out in pathophysiological glucose concentrations may 
be needed. Studies need to be carried out to determine the physiological 
concentration of glucose in the ARC; subsequent studies looking at additional 
electrophysiological properties, the expression of ion channels, peptides and 
receptors can then be investigated at this physiological concentration. 
The major findings from the 5-HT studies are that the cellular mechanisms by 
which 5-HT acts at specific neuronal subtypes within the ARC have been identified. 
5-HT is able to differentially regulate ARC neurones, by inhibiting orexigenic 
NPY/AgRP neurones and exciting anorexigenic CART/POMC neurones. 5-HT- 
induced inhibition is mediated through the 5-HTIA, 5-HTIB and 5-HT7 receptors via 
activation of a potassium conductance. 5-HT-induced excitation is mediated through 
5-HT2A9 5-HT2B and 5-HT2c receptors via three cellular mechanisms: activation of a 
non-selective cation conductance, closure of a potassium conductance or a 
combination of the two, or activation of an electrogenic pump in the membrane. 
Further studies need to be done to identify whether a specific subtype of receptor is 
associated with a particular mechanism for 5-HT-induced excitations. Additional 
techniques, such as single-cell RT-PCR, need to be used to determine other neuronal 
subtypes within the ARC that are excited or inhibited by 5-HT. 
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